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ABSTRACT 
The work described in this thesis was undertaken to investigate 
one aspect of the immunobiology of murine cytomegalovirus (MCMV); 
the T cell response. 
The starting point was the adaption of a mur,ne model system 
described for Herpes simplex virus (Pfizenmaier et~- 1977) to 
the murine herpesvirus, MCMV. This consisted of hind footpad 
inoculation of virus into mice, followed by removal of draining 
popliteal lymph nodes, culture of the cell suspensions and assay 
for the presence of MCMV-specific effector cells. A reductionist 
approach was utilised for each step of the protocol to delineate 
some of the parameters that may affect the generation or detection 
of MCMV-specific cytotoxicity. The opportunity was also taken to 
examine another functional characteristic of T cells, that of 
lymphokine release. 
In Chapter 2 initial observations demonstrated that after 
hind footpad inoculation of MCMV a virus-induced increase in viable 
cell numbers occurred within the draining popliteal lymph nodes, 
but the extent of the increase after day 2 post-inoculation was 
inversely related to virus dose. Harvest of lymph node cells from 
MCMV-infected mice and direct application onto target cells 
produced no detectable virus-specific cytotoxicity at 2, 4, 6, 8, 
10, 12, 17 or 19 days post footpad inoculation, although lysis of 
uninfected syngeneic targets was obta~ned 4-8 days post-infection. 
Optimal cytotoxic activity against MCMV-infected target cells 
required harvest of draining popliteal lymph node cells 6-8 days 
lV 
post footpad inoculation of virus followed by culture for 4 days. 
Injections of MCMV from 102·6 up to 106· 1 plaque forming units 
into the footpad generated equivalent MCMV-specific cytotoxicity 
after 4 days of culture. 
The MCMV-specific cytotoxicity was mediated by Thyl.2+, Lyt2+, 
Class I H-2 antigen restricted effector cells, properties 
characteristic of cytotoxic T cells. By manipulation of the 
1n vitro conditions it was established that for optimal generation 
of cytotoxic T cells, cellular proliferation was necessary, that 
cellular proliferation was dependent upon Thyl.2+, Lyt2+ cell 
populations and that supernatants from Concanavalin-A activated 
spleen cells (CSS) enhanced the cytotoxicity levels obtained. 
In Chapter 4 the MCMV-immune lymph node cells generated by 
the in vivo-in vitro protocol were examined for both cytotoxic 
activity against MCMV-infected mouse embryo fibroblasts (MEF) and 
the capacity to release a particular lymphokine, Interleukin-3, 
upon stimulation with the same MCMV-infected MEF. Cytotoxicity 
and lymphokine release were Class I, H-2 restricted, viral specific 
and dependent upon Thyl.2+, Lyt2+ cells. MCMV-immune T cells 
produced detectable levels of Interleukin-3 by one hour after 
mixing with syngeneic MCMV-infected MEF. The level of Interleukin-3 
reached a plateau by 14 hours after stimulation. The stimulator 
ability of syngeneic MCMV-infected MEF was acquired at one hour 
after viral adsorption with a maximum ability attained by 8 hours. 
In Chapter 5 MCMV-immune and alloreactive T cells were 
utilised to examine the conditions required to produce optimal 
target and stimulator cells. The performance of virus-specific 
targets was dependent upon cell type, cell culture conditions, 
V 
type of virus preparation and viral adsorption protocols. MEF 
cultured in medium supplemented with CSS and adsorbed with salivary 
gland preparations of MCMV were used either as target or stimulator 
cells and showed more susceptibility to lysis and more stimulator 
activity than MEF not treated with CSS. 
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A. LY·PHOCYTES AND ADAPTIVE IMMUNITY 
Introduction to the Immune System 
The immune response is a mechanism for the removal of foreign 
material from a host. The vertebrate immune system is not only 
capable of a differential reaction (i.e., distinguishing between 
11 self 11 and foreign material) leading to removal of an immense 
variety of foreign antigenic molecules but is also adaptive, in 
that subsequent encounters with the same foreign material will 
elicit a more rapid and vigorous response. Consequently, the 
immune system can be defined in terms of the reactive cells and 
proteins that specifically bind to foreign antigens, the induction 
requirements for these reactive .cells and proteins,and the effector 
mechanisms mediated by these components that result in the el1mina-
tion of foreign material . Various complex foreign materials, 
including transplanted tissue (Medawar 1944, 1945), tumours 
(Mitchison 1953), bacteria (Mackaness 1962, 1969) and viruses 
(Blanden 1974) as well as purified antigenic molecules (McDevitt & 
Chinitz 1969) have been utilized to study the mechanisms by which 
the adaptive immune system operates . 
For experimentation I have chosen mur1ne cytomegalovirus as an 
example of a particular foreign agent that can evade immunological 
elimination and cause persistent infection, but in the introduction, 
to illustrate specific aspects of the immune system, I will draw 
upon data obtained from other models. Furthermore, I will not discuss 
those host factors that may prevent interaction between virus and 
the components of the adaptive immune system (Mims 1979), that is, 
I wish to focus on those interactions that are subsequent to virus 
entry and replication in the host. 
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Early investigations of the adaptive immune system emphasised 
the specific reactive serum factors capable of effecting diphtheria 
and tetanus toxin neutralisation, lysis of certain micro-organisms 
1n the presence of heat-labile serum factors, opsOnisation of bacteria 
to augment phagocytosis and virus neutralisation (Root 1979). 
That cells were also a component of the adaptive immune response 
was evidenced by the adoptive transfer of tuberculin reactivity 
using viable lymphoid cells from immunised donors. In contrast, 
adoptive serum transfers did not initiate tuberculin reactivity 
(Bloom & Chase 1967). The general importance of cell-mediated 
effects was subsequently established with the different model 
systems; resistance to lymphosarcoma (Mitchison 1953, 1954), skin 
graft rejection (Billingham et~- 1954), graft versus host disease 
(Billingham & Brent 1959) and recovery from bacterial (Mackaness 
1969) or viral infections (Blanden 1970, 1971a, 1971b). 
Small lymphocytes initiate immune responses (Gowans et al. 1962, 
Gowans & McGregor 1965) and reside in the . lymphoid system, but 
variation in the ability of different lymphoid organs to provide 
adoptive immune reactivity indicated that the lymphoid system was 
not uniform but was composed of heterologous cell populations 
(Billingham & Brent 1959). Furthermore different model systems 
varied with regard to which lymphoid organs behaved as sites con-
taining reactive cells (Mitchison 1954, Billingham & Brent 1959). 
Manipulations of lymphoid organs in chickens and mice provided 
proof of the existence of at least two categories of immunologically 
reactive cells, the Bursa dependent (B) cells and the thymus depen-
dent (T) cells. Surgical or hormonal removal of a lymphoid outpouch 
found proximal to the chicken cloaca, the Bursa of Fabricius, 
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abolished antibody responses to foreign antigens (Graetzer et~-
1963) but not the ability to reject skin grafts (Szenberg & Warner 
1962, Aspinall et~- 1963) whilst neonatal thymectomy resulted i n 
animals unable to reject skin grafts (Miller 1962a, 1962b) but wi th 
intact antibody responses to foreign antigens (Aspinall et~- 1963, 
Graetzer et al. 1963). Concomitant investigations of immunological 
deficiency disease in humans, including agammaglobulinaemias, 
Wiskott-Aldrich syndrome and thymic aplasias, confirmed a similar 
T-B cell dichotomy in man (Good et al. 1962, Peterson et al. 1965, 
-- --
Rosen & Janeway 1966, Lischner et al. 1967). Although a Bursa of 
Fabricius has not been found in non-avian species, the combined data 
from other species revealed a lymphoid system composed of func-
tionally different cells resposited within different organs and ,n 
different sites within the same organ (Cooper et~- 1965, 
Miller & Osaba 1967). 
B lymphocytes 
B lymphocytes are the precursors of antibody-forming plasma 
cells derived from stem cells in the yolk sac (Tyan & Herzenberg 
1968), foetal liver and spleen (Nossal & Pike 1973) or bone marrow 
in adults (Mitchell & Miller 1968). The precursors mature into 
B cells and migrate to the secondary lymphoid organs such as spleen 
and peripheral lymph nodes (Kincade & Cooper 1971) to occupy the 
B-dependent areas. 
B cells express a variety of cell surface markers including 
alloantigens such as Lyb4,5,6,7,8, heteroantigens, Fe and complement 
receptors (Katz 1977) but surface immunoglobulin (lg) is the most 
widely used marker for identification. B cell subsets expressing 
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one or more of the known Ig classes namely IgM, IgD, IgG, IgA and 
IgE, have been identified (Nisonoff et~- 1975). IgM is the first 
Ig class expressed on B cells, subsequently followed by IgD 
(Kearney et~- 1977, Lala et~- 1979) and then other classes 
(Parkhouse & Cooper 1977). Usually the Ig receptor for antigen 
expressed on the B cell surface represents the specificity that 
will be synthesised following antigenic stimulation. However, 
B cells do have the ability to switch Ig class synthesised whilst 
maintaining the same antigen specificity (Nossal et al. 1964) and 
to undergo post-antigenic somatic rearrangement (Homuzi & Tonegawa 
1976, Brack et al. 1978, Early et al. 1980) and mutation 
(Bothwell et al. 1981, Crews et al. 1981) of the genes coding for 
Ig antigen-binding sites. 
T lymphocytes 
Precursors of the thymus-dependent lymphoid cells also originate 
from haemopoietic tissues (Ford et al. 1956, Moore & Owen 1967). 
Stem cells migrate via the blood stream to the thymus (Gengozian 
et al. 1957, Metcalf & Wakonig-Vaartaja 1964, Harris et al. 1964) 
and differentiate into antigen-reactive T cells. Post-thymic 
T cells recirculate through blood, non-lymphoid tissues, lymph 
(Gowans 1959, Gowans & Knight 1964) and the thymus-dependent areas 
of the secondary lymphoid organs such as the spleen and lymph nodes 
(Parrot & Desousa 1971). 
As part of the differentiative process the cells acquire a 
variety of unique serologically detectable antigens on the cell 
membrane (McKenzie & Potter 1979). In the mouse, Thyl was the 
first alloantigen used to distinguish T cells from B cells and 1s 
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now used as the standard cell surface marker for murine T cells 
(Raff 1969, McKenzie & Potter 1979). Additional murine allo-
antigens have been described and correlated with functional subsets 
of lymphoid cells. The most useful cell surface antigens for T cell 
subset differentiation are the Lytl and Lyt2/3 alloantigens 
(Boyse et~- 1968). All T cells express the Lytl antigen but the 
density is variable (Mathieson et~- 1979, Ledbetter et~- 1980) 
with Lyt2/3+ cells expressing the least Lytl, and Lyt2/3 cells 
expressing the most Lytl. In most cases the helper T cell subset 
expresses Lytl but not Lyt2/3 while cytotoxic and suppressor cells 
express Lyt2/3 and little Lytl (Cantor & Boyse 1975). 
Major Histocompatibility Complex 
T cell functions are influenced by a genetic region known as 
the major histocompatibility complex (MHC) or the H-2 complex in 
the mouse (Klein 1975) . 
The H-2 complex is located on chromosome 17 as part of linkage 
group IX and spans about 0.5 centimorgans of DNA. The complex is 
divided into four regions (Klein 1979, Klein 1981), K, I, Sand D, 
and encodes products that can be divided into three groups or 
classes according to polypeptide structure. 
Class I molecules, encoded by the Kand D regions of the H-2 
are integral membrane proteins composed of three external domains, 
each approximately 90 amino acids in length, a transmembrane region 
-
and a cytoplasmic domain. The third external domain is non-
covalently associated with ~-2 microglobulin, a small polypeptide 
that shows homology to the constant region domains of Ig and is not 
encoded in the H-2 complex (Fig. l) (Nathenson et al. 1981, 
CLASS I CLASS II 
CYTOPLASM 
Fig. l. 
Diagram showing the domain structure of Class I and Class II, H-2 
molecules and the association of ~-2 micro-globulin with the 
Class I H-2 molecules. 
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Col igan et~- 1981) . A second category of Class I molecules 
denoted Qa-1, Qa-2 and TL (which are structurally closely related 
to the Class I molecules or transplantation antigens encoded by the 
H- 2K and D regions just described) are encoded by genes located 
telomeric to the classical H-2 complex (Goodenow et al. 1982). 
These two different categories of Class I molecules are also 
distinguished by different tissue distribution and the different 
degrees of polymorphism. The genes at the Kand D loci are 
extremely polymorphic with more than 50 alleles present in known 
mouse strains whilst the gene products are expressed by virtually 
all somatic cells of the mouse. Expression of the gene products of 
the less polymorphic Qa locus is restricted to Band T cells with 
the TL loci products on thymocytes and certain leukaemic cells 
(Klein 1975). 
Class II molecules are also integral membrane proteins, typified 
by the Ia antigens, that are composed of two non-covalently 
associated polypeptide chains denoted a and~' both of whi ch are 
encoded by the I region of the H-2 complex (Cullen et~- 1976). 
Each of these polypeptides has two external domains that are of 
similar size as for Class I molecules, a transmembrane region and 
a small cytoplasmic domain (Fig. 1). Two distinct types of Ia 
molecules, I-A and I-E, have been identified, each exhibiting 
extensive polymorphism (Hood et al. 1983, Steinmetz & Hood 1983). 
Tissue distribution is limited but B cells, T cells, macrophages 
and dendritic cells, which include lymphoid dendritic, inter-
digitating and Langerhan's cells (Steinman et al. 1979, Tew et al. 
1982), are Ia positive. 
Class III molecules are components of the complement pathway 
encoded in the S region. 
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Kand D regions control the classical transplantation 
antigens responsible for the discrimination of self from non-self 
as defined by the rejection or acceptance of grafts (Klein 1975). 
These regions are also involved with cytotoxic activity of virus-
specific T cells (Zinkernagel & Doherty 1974b), antihapten 
cytotoxicity (Shearer et~- 1975), and cytotoxic responses to 
minor histocompatibility antigens (Bevan 1975) and male H-Y 
antigens (Gordon et al. 1975). 
The I region controls the induction and quantity of the immune 
response to polypeptide antigens (McDevitt & Chinitz 1969), antibody 
production to T cell-dependent antigens (Katz et~- 1975), 
antigen-induced T cell proliferation (Rosenthal & Shevach 1973), 
proliferation in mixed lymphocyte reactions (Klein 1975) and the 
transfer of delayed-type hypersensitivity to proteins (Miller et al. 
--
1975, 1976) and inactivated influenza virus (Leung et~- 1980). 
The involvement of the H-2 complex in T-B cell interactions was 
initially explained on the basis of 11 physiological interaction'' 
(Katz et al. 1973a), whereby T cells possessed both antigen-specific 
receptors and H-2 gene complex encoded products involved in 
complementary recognition of somatic cells. However with the 
delineation of antiviral H-2 restriction it was proposed H-2 
molecules were self-markers antigenically altered in a specific way 
by each virus or that T cells immunologically recognised both H-2 
molecules and viral antigens together on the infected cell membrane, 
i.e., the K/D regions were involved in antigen presentation 
( Doherty et al . 1976) . The 11 physiological 11 hypothesis was 
eliminated when it was shown that antiviral effector T cells 1n the 
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viral - infected Fl hybrids consisted of two different ce l l popula-
tions, one recognising the first parental H-2 antigens and the other 
recognising the second parental H-2 antigens. There was no evi dence 
for individual Fl cells that recognised both parental antigens as 
predicted by "physiological interaction" (Zinkernagel & Doherty 1975). 
B. LYMPHOCYTES AND HERPESVIRIDAE 
Herpesviridae 
The Herpesviridae, a family of ubiquitous viruses with 
characteristic viral particles, replicative cycles and biological 
features contain many examples of viruses that produce persistent 
or latent infection in natural or experimental hosts (Plummer 1967, 
Andrewes et al . 1978). Herpesviridae occur in warm and cold-
blooded vertebrates and invertebrates. Each virus has its own host 
range which may vary considerably both in nature and in the 
laboratory . Transmission is usually by contact between moist 
mucosal surfaces although infection by blood transfusion, trans-
placentally, intrapartum and breast milk is possible (Ho 1982, 
Hamilton 1982). 
Morphologically the consensus v1r1on (120-200 nm diameter) 
consists of four structural components. The core 1s composed of a 
fibrillar spool on which one molecule of linear double stranded DNA 
(molecular weight (MW) 80-l50xl06) is wrapped. The capsid consists 
of 162 capsomeres arranged as an icosahedron. The globular material 
surrounding the capsid is known as the tegument, and the envelope 
is a bilayered membrane with surface pro jections. More than twenty 
structural polypeptides MW= 12,000- 222,000 have been detected 
whilst the lipid and carbohydrate contents have not been exactly 
9 
determined (Honess & Watson 1977). 
Replication involves viral envelope adsorption to plasma mem-
brane receptors of the host cell, fusion with the membrane and 
release of the viral capsid into the cell cytoplasm. Subsequently 
a DNA-protein complex is translocated into the nucleus where viral 
transcription occurs. Messenger RNA generated from these trans-
cripts is translated in the cytoplasm. Viral DNA is replicated in 
the nucleus and is spooled into preformed, immature nucleocapsids. 
The capsids acquire an envelope by budding through the inner 
lamella of the nuclear membrane and virus accumulates in the 
cisternae of the endoplasmic reticulum and is subsequently released 
by transport to the cell surface through the endoplasmic reticulum 
(Watson 1973, Roizman et al. 1981, Mathews 1982). 
Three subfamilies, Alphaherpesvirinae (Herpes simplex group), 
Betaherpesvirinae (Cytomegalovirus group) and the Gammaherpes-
virinae (lymphoproliferative group) are recognised on the basis of 
genome morphology, v1r1on antigenic properties and biological 
behaviour (Mathews 1982). I wish to focus on two murine models of 
adaptive immunity to herpesvirus infection involving (1) the natural 
mouse pathogen, murid herpes 1 (murine cytomegalovirus, MCMV), and 
(2) human herpes virus 1 (herpes simplex virus, HSV). 
The in vivo ~ole of T lymphocytes in Herpes Virus Infection 
The immune responses to herpesvirus infection can be categorised 
into those associated with the acute phase and those involved with 
the latent state and subsequent reactivation. An analysis of the 
mechanisms involved in latency and reactivation cannot be tackled 
without the necessary prerequisite of understanding the acute 
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immune response to viral infection. Fun damental information 1n 
other viral or bacterial infections has been derived from three 
approaches: (i) Quantitive studies of the course of infection 
in vivo in relation to various parameters of the normal host 
response such as antibody production, interferon production, 
macrophage activation or development of T cell-mediated immunity; 
(ii) Employment of animals depleted of T cells by anti-thymocyte 
serum treatment, neonatal thymectomy or congenitally athymic nude 
mice; (iii) Adoptive transfer of immune serum or lymphoid cells 
into infected recipients (Blanden 1974). The study of the adaptive 
immune response to herpesviruses has benefitXed from analysis by 
these methods but an extra complication related to virus quantita-
tion, that of latent infection, must be taken into account. 
Unequivocal evidence that T cell dependent mechanisms were 
important in murine mortality following HSV inoculation via 
intraperitoneal (i.p.) or intragenital routes was provided by 
Nahmias et al (1969), Zisman et al. (1970), Oakes (1975) and 
Worthington et al. (1980a). Route of HSV inoculation and viral 
--
dose were important variables (Nahmias et al. 1969). Anti-
lymphocyte serum treatment of mice prior to subcutaneous infection 
with MCMV similarly predisposed to increased mortality rates 
(Brody & Craighead 1974). Furthermore the mice had widely dis-
seminated rather than limited salivary gland infection. 
Neonatal thymectomy, under certain circumstances, indicated 
that factors dependent upon the thymus were involved in adaptive 
immunity to HSV. Neonatally thymectomised mice inoculated i.p. with 
HSV had higher mortality rates than similarly inoculated non-
thymectomised mice (\~orthington et~- 1980a). This was in contra-
l l 
distinction to Mori et al. (1967) where no significant mortality 
rate differences between subcutaneously HSV inoculated thymec-
tomised and non-thymectomised mice were observed. The experimental 
variables of mouse and virus strains, viral doses and inoculation 
route, and timing of neonatal thymectomy may account for the 
disparate outcomes. 
Experimentation with congenitally athymic nude mice also 
provided conflicting data. Zawatsky et~- (1979) found no sig-
nificant mortality differences between nude and phenotypically 
normal littermates following i.p. inoculation of various HSV doses. 
In contradistinction, Nagafuchi et~- (1979) found limitation of 
skin lesions and protection from death following intracutaneous 
HSV inoculation was dependent upon mechanisms absent in homozygous 
nude athymic mice and present in heterozygous nude littermates. 
Homozygous nude athymic mice developed local skin lesions followed 
by more extensive zosteriform eruptions and died on day 18 post 
inoculation whilst heterozygous mice developed herpetic lesions 
that regressed by day 16 with no resultant deaths. Variations 
between two experimental protocols such as mouse strains, viral 
dose and strain, and inoculation route may explain the different 
results. However, since nude athymic mice possess activated macro -
phages (Zinkernagel & Blanden 1975) and macrophages are involved 1n 
protection from mortality following i.p. inoculation of HSV 
(Johnson 1964, Hirsch et al. 1970), the i.p. route for HSV 
inoculation may be inappropriate. 
Quantitative estimation, by plaque forming unit (p.f.u.) assays 
of auricular lesions found in nude athymic BALB/c and normal BALB/c 
mice, revealed that the former were unable to eliminate virus from 
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the inoculated ear up to at least day 19, whilst all normal BALB / c 
mice had no detectable virus by day 14. Virus was undetectable on 
day 8 1n some normal mice (Kapoor et~- 1982). Ganglia, spinal 
cord, brain and contralateral adrenal gland were sequentially 
infected on day 5, 8, 14 and 19 respectively in nude, athymic mice. 
Normal mice subjected to the same inoculation protocol possessed 
no viral p.f.u. in extra-auricular organs, but establishment of 
latent infection was not excluded. With this proviso, these data 
showed that factors present in normal, and absent in nude, athymic 
BALB/c mice, were important for limitation of HSV p.f.u. spread 
from the original inoculation site and were responsible for viral 
elimination from that site. 
For MCMV, use of athymic nude mice (Starr & Allison 1977) 
showed these mice to be more susceptible to lethal infection with 
MCMV than heterozygous euthymic littermates. 
Although adoptive transfers of immune serum or cells have 
provided information relevant to protection from or elimination of 
virus infection in mice (Blanden 1974), care in interpretation 
must be accorded to this data since many experimental variables 
are involved (Zinkernagel et~- 1975). In addition the adoptive 
transfer experiments indicate only that a particular cell or serum 
preparation can influence the outcome of an infection protocol. 
For such data to achieve biological relevance (to the recovery of 
the infected animal) it must be established that (i) the cell or 
serum preparation adoptively transferred is normally evoked during 
the course of an infection and (ii) the preparation is evoked at 
such a time during the course of the infection as to be efficacious 
for recovery of the infected animal. 
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To show the effect of transferred HSV-immune cells the 
functional parameters of alteration in mortality rates or virus 
elimination from target organs of recipients were used. Cell 
suspension from spleens (Ennis 1973, Oakes 1975, Rager-Zisman & 
Allison 1976, Nagafuchi et al. 1979, Howes et al. 1979, Worthington 
et al. 198Ob) and lymph nodes draining subcutaneous HSV inoculation 
sites (Nash et al. 198Oa 1981) were sources of donor HSV-immune 
cells but since these cells were obtained only after multiple viral 
inoculations of donor animals (Ennis 1973, Oakes 1975, Nagafuchi 
et~- 1979, Worthington et~- 198Ob), ~tis unknown whether 
these donor cell populations would be evoked in the course of an 
acute primary HSV infection and be involved in recovery from such 
an infection. This necessarily mitigates conclusions drawn by the 
authors. 
Immune spleen cells or serum removed on day 6 after a single 
intravenous HSV inoculation of donor mice were used to establish 
that adoptive transfer of immune spleen cells and not immune serum 
significantly increased survival rates of HSV-infected recipient 
mice compared to adoptive transfers of normal spleen cells or 
serum (Rager-Zisman & Allison 1976). The survival figures were 
dependent upon the number of immune spleen cells transferred, 
inversely related to the time of donor cell transfer after i.p. 
HSV inoculation of recipients and abrogated by pretreatment of 
donor cells with anti-Thyl antibody and complement (C 1 ). In 
addition, quantitative estimation of HSV p.f.u. in brain and liver 
five days after HSV inoculation revealed reduction in HSV titres 
in both organs of immune spleen cell recipients compared with 
recipients that received immune serum or no transfers. Unfortunately, 
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interpretation of mechanisms responsible for such results is 
difficult since the immune cell recipients were pretreated with 
cyclophosphamide. From the control data that indicated increased 
mortality following HSV inoculation into cyclophosphamide-
treated animals and the altered viral growth patterns in liver, 
brain and spleen, it must be assumed that the pathogenesis of 
HSV infection was significantly altered. Hence this study 
indicated that day 6 HSV immune cells and not immune serum were 
capable of reversing the enhanced susceptibility to lethal 
infection with HSV of cyclophosphamide-treated animals and 
initiating viral elimination from two infected organs. 
Nash et al. (1980a) obtained donor cells from cervical and 
auricular lymph nodes (LN) of mice inoculated once into the ear 
with HSV 9 or 28 days previously. Recipient mice were inoculated 
into the ear with HSV 60 mins after intravenous immune cell transfer. 
Auricular viral p.f.u. were subsequently measured. Control mice 
that received only auricular HSV inoculation without cell transfer 
had higher auricular HSV p.f.u. titres on day l, 3 and 5 post 
inoculation than recipients of day 9 immune cells. The recipients 
of day 9 or day 28 immune cells showed a trend to viral elimination 
by day 5 post auricular HSV inoculation whereas the control mice 
did not. 
The temporal relationship between viral inoculation of 
recipients and immune cell transfer may be of critical importance 
for interpretation of these results. To establish that T cells 
have a role in recovery from HSV infection, virus elimination 
after initiation of infection must be shown. In this regard the 
above mentioned experiments hint at the possibility (lower viral 
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p.f.u. on day 5 versus day 3 and 1 post immune cell transfer and 
auricular inoculation). The lower viral titres on day 1 in immune 
cell recipients compared to control animals may be explained by 
variations in virus load generated in the animal after inoculation. 
The ability of immune spleen cells, mixed with HSV in vitro, to 
release lymphokines including interferons, lymphotoxins, chemo-
tactic factor and migration inhibitory factor (Rosenberg et al. 
1974; Rasmussen~~- 1974; Valle et~- 1975; Dannenberg et~-
1980) may also occur in vivo and alter the events at the inocula-
tion site that lead to productive infection and replication. 
The H-2 restriction pattern of these effects was also addressed 
(Nash et al. 1981) with recombinant mouse strains. Whole H-2 
haplotype or H-2K and I region homology between immune spleen cell 
donors and HSV-infected recipients was necessary to effect a 
lowering of HSV p.f.u. in the ear. Homology in H-2K, Dor I regions 
alone was not sufficient to reduce viral titres. The interpreta-
tion of this data is dependent upon the factors discussed above. 
Studies with nude athymic and normal BALB/c mice reported by 
Kapoor et~- (1982) obviated the possible variations in productive 
infection and replication at the inoculation site, since recipient 
mice received immune cells 3 days after HSV inoculation. Immune 
cervical and auricular LN cells from donors inoculated into the 
ear with HSV 6 days previously, adoptively transferred into nude 
athymic mice, initiated elimination of HSV from the pinna and 
prevented HSV spread to dorsal root ganglia, spinal cord, brain and 
adrenal gland. Although latent infection of extra-auricular 
tissues was not excluded the data suggested a role for immune LN 
cells in elimination of acute HSV infection. Further 
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investigations are needed to determine the cell phenotypes involved. 
For MCMV, the adoptive transfer of spleen cells, removed from 
donors 6 days after i . p . i no cu l at i on of MC ·1 V , i n to rec i p i en ts 
MCMV-infected i.p. 24 hours previously, produced the ability to 
mediate viral elimination from liver and a reduced mortality rate 
compared with animals recipient of normal spleen cells (Starr & 
Allison 1977). Adoptive transfer of day 6 serum was ineffective. 
Furthermore, these effects were dependent upon anti-Thyl antibody 
and C1 treatment-sensitive cells, the number of spleen cells 
transferred and the viral dose of MCMV inoculated into cell 
recipients. These findings were confirmed and extended (Ho 1980). 
Spleen cell donors used day 6 to day 14 post i.p. inoculation of 
MCMV or immune cells generated by~ vitro restimulation of MCMV 
primed spleen cells, provided the ability to mediate viral elimina-
tion from spleen in a cell dose-dependent manner. Furthermore, 
H-2 restriction analysis showed a requirement for donor and 
recipient homology in the H-2K or H-2D region. Homology at the 
H-21 region did not result in viral elimination from the spleen. 
The~ vitro Generation of Herpes Virus-specific T lymphocytes 
The activity of virus-immune cells can be assessed by various 
detection systems that include adoptive transfer of protection from 
or elimination of virus infection, delayed-type hypersensitivity 
reactions and in vitro cytotoxicity. The in vitro cytotoxicity 
assay first used to measure cytopathic and lytic changes of tumour 
cells following exposure to immune sp leen cells (Rosenau & Moon 1961) 
was subsequently extended to virus-infected target cell monolayers 
reacted with virus-immune lymphocytes (Speel et al. 1968, 
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Lundstedt 1969). Radioactive techniques using 51 chromium labelled 
allogeneic (Brunner et~- 1968) and virus-infected target cells 
(0ldstone & Dixon 1970, Zinkernagel & Doherty 1974a,b) allowed 
rapid quantitative and qualitative measurement of immune lymphoid 
cell lytic activity. 
For ectromelia and influenza viruses the cytotoxic immune cells 
are non-adherent to plastic, sensitive to anti-Thyl antibody and 
C' treatment, insensitive to anti-mouse lg and C' treatment and 
absent from rosettes with anti-mouse-lg-coated red blood cells 
(i.e . , negative for both lg and Fe receptors). Direct contact 
between effector and target cell was required and no mandatory 
role for lymphokine was found (Gardner et al. l974a,b, Yap & Ada 
1977). Furthermore the immune cells were virus-specific, Class 1, 
+ + H-2 restricted (Blanden et al. 1975) and of the Lyt2 3 phenotype 
(Pang et~- 1976). These characteristics were similarly 
established for other viruses (Zinkernagel & Doherty 1979). Such 
criteria specifically exclude other forms .of cytotoxicity related 
to natural killer cells or antibody-dependent cell-mediated 
immunity (Cerrotini & Brunner 1974). 
Detection of HSV-immune cells by in vitro cytotoxicity from 
mice exposed to primary infection with HSV has produced different 
results dependent upon experimental protocols used by investigators. 
HSV-specific cytotoxicity, dependent upon nylon-wool non-adherent, 
+ -Thyl , lg cells was detected in the spleen 4 to 10 days after i.p. 
inoculation of live HSV. Neither ultraviolet (UV) or heat-
inactivated virus, nor detergent treated HSV-infected cell 
preparations were capable of inducing cytotoxicity (Lawman et al. 
1980a). These observations are in contradistinction to others 
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where virus-specific cytotoxicity was not detected in LN cell 
populations draining primary inoculation sites of HSV in footpad 
or ear (Pfizenmaier et al. 1977a, Nash et al. 1980b). However, 
if mice were pretreated for 2 days with 80 mg/kg of cyclophos-
phamide prior to primary HSV footpad inoculation some cytotoxicity 
was detected within the draining popliteal LN cell populations 
(Pfizenmaier et al. 1977b): this enhancement was dependent upon 
cyclophosphamide dosage since the administration of 200 mg/kg 
resulted in no improved cytotoxicity. 
For MCMV low levels of virus-specific cytotoxicity were 
detected on day 4 to 10 in spleen and LN cell populations following 
primary i.p. or intranasal virus inoculation (Quinnan et al. 1978, 
1980) but reproducibility has been a problem (Ho 1980). The amount 
of virus-specific cytotoxicity was dependent upon viral dose. 
Intraperitoneal inoculation with UV-irradiated MCMV also generated 
virus-specific cytotoxicity in spleen cell populations but the 
possibility of Sendai virus contamination .of MCMV stock may 
mitigate these results (Sethi & Brandis 1979). 
No primary in vitro cytotoxicity for HSV or MCMV has been 
reported but this experimental protocol has also been difficult 
with other viruses (Blanden et al. 1977). A protocol with combined 
in vivo and in vitro steps produced HSV-specific cytotoxic cells 
(Pfizenmaier et al. 1977a). Cytotoxicity was generated if draining 
popliteal LN cells removed 4 to 9 days post live virus inoculation 
of footpads ~ere incubated for 2 to 6 days in vitro. Levels of 
cytotoxicity were dependent upon viral dose inoculated into the 
footpad, the time of popliteal LN cell removal after virus inocu-
lation and the length of time of in vitro incubation prior to 
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cytotoxicity assay. No extra viral antigen or virus was added 
during in vitro incubation and cytotoxicity was sensitive to 
mitomycin C treatment prior to culture. A similar system with 
auricular viral inoculation followed by harvest of cervical and 
auricular LN cells confirmed these findings (Nash et~- 1980b). 
Both groups noted the occurrence of cytotoxicity at high levels 
directed against uninfected self cells as well as HSV-infected 
cells. 
Virus-primed spleen cells restimulated in vitro with additional 
virus have been utilised for HSV (Lawman et al. 1980a) and MCMV 
(Ho & Ashman 1979, Ho 1980) as convenient sources of cytotoxic 
+ reactivity that is dependent upon Thyl , nylon -wool non-adherent 
and I g - c e l l s ( Lawman et ~. l 9 8 0 a ) . Secondary i n v i tr o HS V -
specific cytotoxic T cell generation is dependent upon both the 
primary and restimulation events. Induction of HSV-primed spleen 
cells required live virus inoculation and was virus dose-dependent. 
Both HSV-l and HSV-2 live virus preparations were satisfactory 
(Eberle et al. 1981). Spleen cells from 4 days to 6 months post 
i.p. inoculation of HSV were capable of cytotoxicity generation 
after in vitro restimulation. Antigen preparations of UV-
irradiated or heat-inactivated virions, and detergent extracts of 
HSV-infected cells were unable to prime spleen cells. 
Secondary restimulation in vitro of primed spleen cells was 
achieved with live virus, UV-inactivated HSV, gluteraldehyde 
inactivated HSV-infected L cells (Lawman et~- 1980a) and antigens 
from deoxycholate solubilised HSV-infected cells prepared in 
phosphatidyl choline and cholesterol liposomes (Lawman et al. 1981). 
--
Neither heat-inactivated virus nor soluble extracts of HSV-infected 
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L cells alone stimulated cytotoxicity. The virus-specific cyto-
toxicity measured after 5 days in vitro was also directly dependent 
upon the number of HSV p.f.u. added in vitro and inversely related 
to the exposure time of HSV to UV-irradiation prior to addition 
into spleen cell culture. Use of homologous HSV serotype in priming 
and restimulation events resulted in more virus-specific cyto-
toxicity than if heterologous preparations were used (Eberle et~-
1981) . 
Reductionist analysis of cellular requirements for secondary 
,n vitro restimulation of virus primed spleen cells showed cyto-
toxicity was dependent upon nylon-wool adherent (Rouse & Lawman 1980) 
+ or Thyl cells (Lawman et al . 1980a ) . With the nylon-wool non-
adherent cell population cytotoxicity was restored subsequent to 
addition of syngeneic resident peritoneal or L cells. The amount 
of cytotoxicity restored was directly proportional to the numbers 
of per itoneal or L cells added. Viable cells were required since 
heated or sonicated cell extracts were ineffective. Soluble 
factors provided from metabolically active L cells or resident 
peritoneal cells may have produced these results since supernatants 
from 24 hour mixed lymphocyte cultures also restored the cytotoxic 
response of nylon-wool non-adherent spleen cells (Rouse & Lawman 
1980, Schmid et al. 1981). 
MCMV-specific cytotoxicity was generated~ vitro by restimu-
lation of primed spleen cells with MCMV-infected cells provided 
the latter were UV- or gamma-irradiated and syngeneic with the H-2 
haplotype of the primed spleen cells. The cytotoxicity was 
dependent upon anti-Thyl Jntibody and C1 treatment-sensitive cells 
and was H-2 restricted (Ho 1980). The requirement for irradiated 
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cells was not explained but may relate to the immunosuppressive 
capability of live MCMV (Loh & Hudson 1982). 
The~ vitro Generation of Herpes Virus-specific Target Cells 
Target cell requirements for the detection of antiviral cyto-
toxic T cells must involve cell surface expression of Class I MHC 
gene products and virus-specific antigens. Both F9 teratoma and 
RTL cell lines lack detectable MHC antigens at the cell surface 
and are not susceptible to lysis by antiviral or antiminor histo-
compatibility antigen-specific cytotoxic T cells respectively 
(Zinkernagel & Oldstone 1976, Doherty et al. 1977, Bevan & Hyman 
1977). Blocking of antiviral cytotoxicity with antibody directed 
against Class I MHC antigens further supported the notion that 
Class I MHC cell surface antigens are necessary for susceptibility 
to lysis (Koszinowski & Ertl 1975 ). Manipulation of Class I 
encoded gene products via use of H-2 mutants indicated minimal gene 
and amino acid sequence alterations, not detectable by means of 
anti-H-2 antibodies, impaired target cell recognition by virus-
specific cytotoxic T cells (Kees & Blanden 1976, Blanden et al. 
1976a, Zinkernagel 1976) and provided definitive evidence of 
Class I gene product involvement in target-T cell interactions. 
Mutations clustered 1n the second external domain were most 
frequently observed to alter target cell recognition (Klein et al. 
1983). 
To define the viral antigen(s) necessary for target cell sus-
ceptibility to lysis by virus-specific effectors has proved more 
difficult. With ectromelia (Gardner et al. l974a,b) antiviral 
antibodies did not block virus-specific cytotoxicity. On the other 
22 
hand anti-vaccinia and anti-vesicular stomatitis virus (VSV) 
antiserum from rabbits or mice inhibited virus-specific cytotoxi-
city (Koszinowski & Thomssen 1975, Hale et al. 1978) provided 
certain immunisation protocols were followed for antiserum 
production. Vaccinia infectious virions and early antigens from 
vaccinia-infected cells generated blocking antiserum whilst late 
antigens from vaccinia-infected cells did not induce blocking 
antiserum. Disrupted virions or glycoprotein G were successfully 
used for anti-VSV blocking serum production (Hale et~- 1978, 
Sethi & Brandis 1980). In the latter instance the VSV-G glyco-
protein was postulated as the antigenic molecule recognised by 
virus-specific cytotoxic T lymphocytes but it 1s not possible to 
exclude steric hindrance as the mechanism for blocking rather than 
direct blockade of the virus-specific antigen-T cell interaction. 
Furthermore, since antigenicity as defined by cytotoxic T cells 
and antibody may be disparate (Blanden et al. 1976, MQllbacher et al. 
1979), this approach to viral antigen detection relevant to T cell-
target cell interactions may be of limited usefulness. 
Minimal requirements for target cell production indicate that 
with some viruses no viral replication is necessary (Ada et al. 1976, 
Koszinowski et~- 1977, Sugamura et~- 1977, Pfizenmaier et~-
1977b, Hapel et~- 1978). Furthermore no viral genome or protein 
synthesis was required for Sendai (Schrader & Edelman 1977) or 
vaccinia provided high multiplicity of infection was employed 
(Hapel et~- 1978). With Sendai the generation of virus-specific 
targets for cytotoxicity was dependent upon the fusion activity of 
the virus envelope (Sugamura et~- 1978). 
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Cells adsorbed with live ectromelia or HSV acquired suscepti-
bility to lysis by virus-specific cytotoxic T cells within 90 mins, 
provided cellular protein synthesis was not impaired . Inhibition 
of cellular DNA synthesis did not abrogate development of suscepti-
bility to lysis (Ada et al. 1976, Pfizenmaier et al. 1977b). The 
importance of protein, and in particular glycoprotein metabolism, 
in target cell generation was further supported by the ability of 
glycosylation inhibitors tunicamycin and 2 deoxy-0-glucose to 
decrease susceptibility to lysis of HSV-infected target cells by 
virus-specific effectors, but since both inhibitors also affected 
susceptibility to lysis by alloreactive cytotoxic T cells a dis-
tinction between effect on viral glycoprotein versus Class I~ H-2 
antigen modulation was not possible (Lawman et~- 1980b, 
Carter et al. 1981). Glycoprotein viral antigens were implied 
target antigens when temperature sensitive HSV mutants, defective 
in viral protein synthesis, were used to generate target cells at 
non-permissive temperatures. Wild type HSV-specific cytotoxic 
T cells lysed temperature sensitive mutant infected targets much 
less efficiently than targets adsorbed with wild type HSV 
(Lawman et al. 1980b). Similar implications were drawn from VSV 
temperature sensitive mutants, also defective in protein synthesis 
(Hale et~- 1978, Zinkernagel et~- 1978), but the variables of 
multiplicity of infection and effects of lower temperature upon 
viral adsorption must be addressed prior to the resolution of the 
importance of viral glycoproteins as targets for virus-specific 
cytotoxic T cells. 
Although the use of liposomes containing purified viral and H-2 
antigens cannot address directly the nature of virus-specific target 
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antigens for cytotoxic T cells, the minimal antigenic requirements 
for stimulation of a virus-specific cytotoxic T cell population 
must, according to the clonal selection th eory, be equivalent to 
the virus-specific target antigens. Secondary in vitro anti-VSV 
cytotoxic T lymphocytes could be stimulated provided the synthetic 
liposomes contained viral and H-2 molecules in the same vesicle and 
the H-2 antigen was homologous with the H-2 antigen of the virus-
primed spleen cell source (Finberg et~- 1978, Loh et~- 1979). 
Viral antigen limited to VSV glycoprotein G was satisfactory for 
stimulation, but optimal cytotoxicity was generated with glyco-
protein G obtained from viral preparations serologically homologous 
with priming virus (Hale et al. 1980). 
C. LYMPHOCYTES AND LYMPHOKINES 
Definition of Lymphokines and Nomenclature 
The development and regulation of immune responses, and immuno-
effector mechanisms, are in part dependent upon soluble mediators 
derived from leucocytes (Pick & Turk 1972, Rocklin et al. 1980). 
These non - immunoglobulin factors obtained from supernatant medium 
of appropriately stimulated heterogeneous cell populations derived 
from thymus, spleen, lymph nodes, peritoneal exudate, peripheral 
blood or respiratory tract (Pick & Turk 1972) were termed lympho-
kines (Dumonde et al. 1969). Unprimed lymphoid cells were 
stimulated to lymphokine production with mitogens (Wheelock 1965, 
Watson & Mochizuki 1980) or alloantigens (Gifford et al. 1971, 
Kirchner et al. 1979) whilst with bacteria l (Green et al. 1969, 
Milstone & Waksman 1970) or viral antigens (Epstein et~- 1972, 
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Rassmussen et~- 1974, Rosenberg et~- 1974, Ihle et~- 1981) 
primed lymphoid cells were required. Spleen cells as early as day 3 
to as late as 5 months post viral inoculation were suitable for 
lymphokine production subsequent to in vitro restimulation with 
homologous virus (Waldman et~- 1972, Cambridge et~- 1976, 
Be 11 et ~. 1978, Dannenberg et ~. 1980). 
Consequent to the use of such heterogeneous cell populations 
and stimulation protocols, the minute quantities of soluble 
materials produced and lack of satisfactory physicochemical charac-
terisation, a nomenclature based upon typical biological activities 
resulted. Use of different biological assays by different inves-
tigators has generated a plethora of nomenclature (Aarden et~-
1979). For convenience the known lymphokines can be divided into 
four major groups according to the effects mediated. 
(i) Growth or maturation of haemopoietic stem cells, e.g., colony 
stimulating factors (CSF) for granulocyte, macrophage, eosinophil 
or erythroid precursors (Metcalf & Johnson 1978). 
(ii) Delayed-type hypersensitivity reactions with macrophages, 
granulocytes and other inflammatory cells and/or the vascular 
endothelium (Adelman et al. 1978). 
(iii) Regulation of the antibody-forming response of mature B cells 
(Schimpl & Wecker 1978). 
(iv) Regulation of differentiation and proliferation of antigen-
reactive T cells. 
These categories may not be exclusive since one lymphokine source 
may contain multiple biological activities (Nabel et al. 1978) or 
one particular lymphokine may exert multiple biological effects 
(Gresseretal. 1979). 
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Nevertheless, recently two factors that modulate activation of 
murine lymphocytes have been distinguished on the basis of bio-
chemical and biological criteria (Aarden et al. 1979). Both of 
these factors enhance the mitogenic effects of Phytohaemagglutinin-A 
and Concanavalin-A upon thymocytes and stimulate antigen-dependent 
cell-mediated and humoral immune responses in vitro. One of these 
factors can be obtained from human and mouse macrophages and from 
supernatants of macrophage tumours (Lachman et al. 1977, Mizel et al. 
1978). This lymphokine was originally designated lymphocyte-
activating factor (LAF) (Gery et~- 1972). The second factor 1s 
a murine spleen cell product described by Chen & DiSabato (1977) as 
thymocyte stimulating factor (TSF). This factor promotes and 
maintains long-term culture of primary T cell lines. LAF does not 
have this biological capability. Subsequent to the Second 
International Lymphokine Workshop (Ermatingen, Switzerland, 
May 2 7 -3 l , l 9 7 9 ) L AF was des i gnat e d I n t er l e u k i n - l ( I L - l ) and TS F 
designated Interleukin-2 (IL-2). 
~ vitro Generation of Lymphokines 
Use of heterogeneous cell populations and stimulation protocols 
has also complicated characterisation of the lymphokine-producing 
cells, assessment of the mechanisms controlling lymphokine pro-
duction and definition of the number of factors produced by one 
cell. Co-operative interaction between two or more cell populations 
appears necessary for primary in vitro stimulation of spleen cells 
with Concanavalin-A or alloantigen to release IL-2 (Paetkau et al. 
1976, Andrus & Lafferty 1980) or ,'-interferon (Newman & Sorg 1977); 
·r-interferon production by in vivo primed spleen cells restimulated 
27 
1n vitro with homologous bacterial or viral antigens (Milstone & 
Waksman 1970, Sonnenfeld et al. 1979), and migration inhibition 
factor production from spleen cells primed to tumour antigens 
Landalfo et al. 1978). Depletion experiments with phenotypic 
antisera and C' treatment or cell separations according to physico-
chemical criteria have not unequivocally resolved the issue of 
which cell(s) are producing lymphokines but have indicated which 
phenotypic groups are involved in the sequence of cellular inter-
actions controlling lymphokine production. 
However, constitutive production by T cell hybridomas or T cell 
clones of macrophage activating and inhibitory factors (Jones et al. 
1981), granulocyte-macrophage stimulating and T cell proliferation 
factors (Nabel et al . 1978, Howard et al. 1979, Stull & Gillis 1981) 
suggests that for these lymphokines the T cell is the lymphokine 
producing cell . Similarly, the ability to stimulate with mitogens 
or antigens, phenotypically homogenequs cloned T cell lines 
(Nathan et~- 1981, Glasebrook et~- 1981), T cell hybridomas 
(Schrader et~- 1980, Katz et~- 1980, Kappler et~- 1981) and 
long term activated T cells (Lafferty et al. 1980, Marcucci et al. 
--
1981) to IL-2 , y - interferon, polyclonal B cell stimulating factor, 
granulocyte-macrophage CSF and allogeneic effect factor production 
also indicates lymphokine production is a T cell function. 
The control mechanisms involved in lymphokine production by non-
constitutive lymphokine producers appears dependent upon the type 
of immunologically reactive cell populations and antigen preparations 
used for investigations. Resting T cells, exposed to alloantigen 
or mitogen, required cell to cell contact with metabolically viable 
accessory cells to produce lymphokine (Paetkau et al. 1976, 
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Larsson & Countinho 1979, Lafferty et a 1. 1980). On the other hand, 
--
Landolfo et~- (1978) showed migration inhibitory factor product ion 
by in vivo activated Moloney sarcoma virus-immune T cells was 
dependent upon viable accessory cells only if soluble antigens 
from sonicated sarcoma cells were used for stimulation. When 
viable Moloney sarcoma tumour cells were used, accessory cells were 
not required. Similarly, no viable accessory cell contact was 
essential for lymphokine release from homogeneous populations of 
alloantigen-activated T cells (Lafferty et al. 1980). Addition of 
Concanavalin-A alone or of metabolically inactive (UV-irradiated) 
allogeneic tumour cells, H-2 matched with the original priming cells 
stimulated IL-2 release from T cells. 
Lymphoid cells have been primed to viruses, tumours, a large 
array of soluble proteins including tetanus and diphtheria toxoids, 
ovalbumins, amino acid polymers, keyhole limpet haemocyanin, and 
pa r ticulate antigens such as red blood cells and allogeneic spleen 
cells . Higher lymphokine titres were obtained by in vitro stimu-
lation of primed lymphoid cells with homologous priming antigen, 
rather than with heterologous antigen (Rubin & Coons 1971, 
Taussig 1973, Waldman & Munro 1973) or mitogen (Green et al. 1969). 
With alloantigen-activated T cells, lymphokine release in vitro was 
dependent upon stimulation with allogeneic cells H-2 matched with 
the original priming cells (Eshhar et al. 1977, Lafferty et al. 1980) 
and the sources of allogeneic stimulator cells. Fibroblasts, 
thymocytes and P815 tumour cells were not as efficient stimulators 
as spleen cells (Eshhar et~- 1977). T cell clones and hybridomas 
derived from antigen-primed spleen cells released lymphokine 
in vitro provided restimulation occurred with both the specific 
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pr1m1ng antigen and accessory cells that were H-2 homologous 1n 
the I region with the primed spleen cells from which the clone or 
hybridoma originated (Schreier & Iscove 1980, Schreier et~- 1980, 
Kappler et~- 1981). Hence lymphokine release is an antigen-
specific T cell function stimulated by appropriate cell-associated 
antigen . 
Lymphokines and Herpesviridae 
Detection of cellular immunity to Herpesviridae by in vitro 
lymphokine assays has been reported with human (Rasmussen et~-
1974, Rosenberg et~- 1974), bovine (Babiuk & Rouse 1976), guinea-
pig (Bell et~- 1978, Dannenberg et~- 1980) and murine 
(Rytel & Hooks 1977, Kirchner et al. 1978, Zawatsky et al. 1981) 
models. 
Primed lymphoid cells restimulated in vitro with heat-activated 
HSV released·y-interferon (Rasmussen et al. 1974, Valle et al. 1975) 
and chemotactic or lymphotoxin factors (Rosenberg et~- 1974). 
Preparations of heat- or UV-inactivated virus, virus-infected 
cells and virion-neutralising antibody complexes stimulated lympho-
kine production from primed spleen cells (Babiuk & Rouse 1976). 
Peripheral blood lymphocytes or spleen cells provided the 
cellular components for lymphokine production with at least two 
cellular populations characterised as essential for ,•-interferon 
production; glass or plastic adherent cells and nylon-wool non-
adherent, anti-Thyl-antibody and C1 treatment-sensitive cells 
(Valle et al. 1975, Babiuk & Rouse 1976, Sonnenfeld et al. 1979). 
Spleen cells removed 3 to 20 days post i.p. inoculation of live 
HSV released lymphokine (leucocyte migration inhibition factor or 
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~-interferon) when stimulated with B-propionolactone-inactivated 
HSV (Kirchner et al. 1978) or soluble antigen extracts from 
HSV-infected cells (Bell et~- 1978, Dannenberg et~- 1980). No 
analyses of cellular phenotypes or antigen ic requirements for 
stimulation of lymphokine production were reported. 
CHAPTER 2 
The Cytotoxic Response to Murine Cytomegalovirus. 
I. Parameters in vivo 
INTRODUCTION 
The importance of T cells in recovery from acute viral 
infections such as the poxvirus, ectromelia (Blanden, 1974), 
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and the myxovirus, influenza (Ada et al., 1981), has been firmly 
established . The role of T cells in viral diseases associated 
with persistent infection is less well defined. How T cell 
responses relate to the phenomena of chronic infection, latency 
and virus reactivation has not been clearly elucidated . The 
family Herpesviridae contains human and animal viruses that 
exhibit such clinical and subclinical phenomena during infection 
of natural hosts. Murid herpesvirus l or murine cytomegalovirus 
(MCMV), a natural mouse pathogen, is an example of such a member 
of this family. The murine infection also has many of the 
clinical and subclinical manifestations found in humans that 
contract infection with human herpesvirus 5 (human cytomegalo-
virus), making the mouse model a possible analogue of human 
infection. 
That T cells play a role in protection from fatal infection 
with MCMV has been demonstrated using T cell transfer into 
T cell deficient nude mice (Starr & Allison, 1977). In non-fatal 
MCMV infections of normal mice, MCMV immune T cell transfer 
resulted in viral clearance from spleens (Ho, 1980). This 
phenomenon was Class I, H-2 restricted, implying that the cells 
responsible for viral elimination were anti-MCMV cytotoxic T (Tc) 
cells (Blanden et~-, 1975), though this cannot be proven 
without obtaining anti-MCMV Tc clones and transferring them into 
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infected mice. The study of inductive requirements for such 
T cell responses and their regulation during primary MCMV 
infection are necessary prerequisites for an understanding of the 
latent state and how reactivation of infection may occur. 
In the present studies, a method reported for human herpes-
virus l (HSV) (Pfizenmaier et~-, 1977) was adapted to MCMV. 
It was demonstrated that after hind footpad (f.p.) inoculation 
of MCMV there was an increase in viable cell numbers within the 
draining popliteal lymph nodes (LN). Upon direct in vitro assay 
of these LN cells no anti-MCMV cytotoxic activity was detected, 
but anti-MCMV cytotoxicity was generated after several days in 
culture of the LN cells. 
METHODS 
Mice. BALB/c, CBA/H and WEHI-3, 6-12 weeks of age were 
obtained from the Animal Breeding Establishment of the 
John Curtin School of Medical Research. 
Viruses. The Smith strain of MCMV was obtained from 
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Dr. G. Shellam, University of Western Australia. Salivary gland 
virus stock was prepared by intraperitoneal (i.p.) inoculation 
of 104· 3 plaque-forming units (p.f.u.)/0.2 ml into 4-week-old 
BALB/c female mice. At day 17 post inoculation, salivary glands 
were harvested and a 50% wt/vol homogenate prepared in Dulbecco 1 s 
Modified Eagle 1 s Medium (Cat. No. Hl6, GIBCO, Grand Island, N.Y., 
U.S.A. ), supplemented with 5% foetal calf serum (FCS) (Flow Labs, 
Stanmore, N.S.W., Australia), 200 ug/ml Streptomycin, 200 U/ml 
Penicillin G and 125 ug/ml Neomycin sulphate. (The complete 
medium is referred to hereafter as DMEM.) Aliquots were stored 
at -7o0 c. For dilution of virus stock 0.2M borate-buffered 
gelatin saline (pH 7.2-7.4) was used. Normal salivary gland 
homogenate was prepared from normal 6-week-old female BALB/c 
mice using the same methods and diluents. 
Target cell culture. Mouse embryo fibroblast (MEF) cultures 
were prepared from 16-18 day BALB/c or CBA/H embryos by trypsin 
dispersion and grown in DMEM. 75cm2 tissue culture flasks 
(Nunc, Roskilde, Denmark) were seeded at 106·3 cells/flask and 
incubated at 37°c for 4 days in 10% co2, 7% o2 and 83% N2 (special 
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gas) (Commonwealth Industrial Gases, Alexandria, N.S.W., 
Australia), after which time the cells were either subcultured 
immediately or kept at room temperature for up to 2 weeks prior 
to subculture. Conditions of subculture were the same as 
described for the primary cultures, except that these secondary 
MEF cells were always used after 4 days at 37°c as the source for 
tertiary MEF target cells in cytotoxicity assays. 
Generation of anti-viral effector cells. Anti-MCMV effector 
cells were generated as follows: Seven days after inoculation of 
40 ul of MCMV stock (104·6 p.f.u.) into the hind f.p., popliteal 
LN were collected in Hank's balanced salt solution (HBSS), and 
passed through a stainless steel mesh to produce a single-cell 
suspension. The LN cells were cultured in Eagle's Minimal 
Essential Medium (EMEM) (Cat. No. F-15, GIBC0, Grand Island, 
N. Y., U.S.A.) supplemented with 10% FCS, 200 ug/ml Streptomycin, 
100 U/ml Penicillin G and 125 ug/ml Neomycin sulphate (anti-
biotics), l0- 4M 2-mercaptoethanol (2ME) and usually 3% vol/vol 
Concanavalin-A activated cell supernatant. The LN cells were 
cultured at 105·8 cells/ml in 5 ml Costar wells (Cat. No. 3512, 
Costar, Cambridge, Mass., U.S.A.) and incubated at 34°c in 
atmosphere containing special gas. 
Removal of immunoglobulin-positive (Ig+) cells. 
Popliteal LN cells were depleted of Ig+ cells by a one-step 
procedure (Parish et~-, 1974). Briefly, rosettes containing 
Ig+ cells were obtained by reacting LN cells with sensitized 
sheep red blood cells coated with sheep anti-mouse immunoglobulin. 
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The rosetted cells were separated from non-rosetting lymphocytes 
by sedimentation on Ficoll-Hypaque. 
Cytotoxicity assay. For MEF target cells, 96-well flat-
bottomed microtitre trays (Nunc, Roskilde, Denmark) were seeded 
with tertiary MEF at 104·0 cells/0.2ml/well 3 days prior to assay. 
After 2 days in culture, each well was drained and the cells were 
infected with 25 ul volume of MCMV stock in DMEM at 37°C in 
special gas mixture, providing a multiplicity of infection (M0I) 
of 5 p.f.u./cell. Subsequent to viral adsorption for l hr 
. 51 51 6 uc, of Na 2[ Cr]o4 ( Cr) (Amersham Int. Ltd., Amersham, U.K.) 
in 150 ul of DMEM was added to each well. At 16 hrs incubation, 
the targets were washed twice with DMEM and 100 ul of effector 
cells added immediately. Triplicate cultures were set up for each 
dilution of effector cells and incubated for 10 hrs at 37°c in a 
humidified atmosphere containing special gas. 
51 cr release from the targets assayed by gamma emissions was 
measured and lysis calculated using the following formula: 
% lysis of infected or uninfected targets= 
51 cr counts in presence 51 cr counts released 
51 
of effector cells in medium 
Cr counts water-lysed 
targets 
51 cr counts released 
in medium 
X 100% 
% specific lysis = % lysis infected targets - % lysis uninfected 
targets. 
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Preparation of Concanavalin-A activated spleen cell 
supernatant (CSS). CSS was prepared using a modification of a 
published method (Pick & Kotkes, 1977). Spleen cells from WEHI-3 
mice were cultured in serum-free EMEM with l0-4M 2ME and 
Concanavalin-A (Pharmacia Fine Chemicals A.B., Uppsala, Sweden) at 
a final concentration of 5 ug/ml. All CSS preparation was carried 
out in the absence of FCS. Cultures were set up in 75cm2 plastic 
tissue culture flasks and maintained at 37°c in an atmosphere of 
special gas for 2 hrs. The cell monolayer was then washed gently 
3 times with warm HBSS and replenished with 30 ml fresh serum-free 
EMEM containing ,o-4M 2ME. The flasks were reincubated at 37°c 
in a humidified atmosphere of special gas for 17 hrs. The 
supernatant was harvested, centrifuged to remove any cells and 
concentrated 10-fold on an Amicon PM-10 membrane (Amicon, Danvers, 
Mass ., U.S.A.). The concentrated CSS preparation was sterilized 
by filtration and stored at -20°c. The preparation was added to 
cultures at a concentration of 3% volume/volume. 
Plaque assay for MCMV. A modification of an MCMV plaque 
assay (Gould & Mims, 1978) was utilised. Briefly, secondary 
BALB/c MEF cells were seeded into 24 well Linbro tissue culture 
trays (Cat. No. 76-033-05, Flow Labs, Maclean, Virginia, U.S.A.) 
at 105· 3 cells/well/2 ml in DMEM and incubated at 37°c in special 
gas. After 24 hrs the medium was aspirated and 50 ul volumes of 
virus suspension in DMEM was added to the cell monolayer. 
Adsorption was carried out at 37°c for 60 ~ins after which time 
2 ml of a 0.5% carboxymethylcellulose in DMEM overlay was added 
and incubation continued for 5 days at 37°c in special gas. The 
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overlay was then aspirated and a staining solution composed of 
0. 005% crystal violet in Formol Saline added for 30 m1ns. Plaque 
counting was performed using a binocular microscope with l0x 
magnification . All virus suspensions were sonicated for 30 seconds 
using a Branson 812 Sonifier (Branson Sonic Power Co., Danbury, 
Conn ., U.S.A.) at 50 c.p.s. prior to plaque assay. 
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RESULTS 
The experimental program investigated modifications of the 
method reported by Pfizenmaier et~- (1977), to determine whether 
anti-MCMV Tc cell responses could be generated in cells from 
popliteal LN draining the site of MCMV inoculation if they were 
removed from the animal and maintained in vitro. The initial 
experiments were designed to determine the optimal time intervals 
in vivo and in vitro for anti-MCMV cytotoxic cell generation. For 
each in vivo and in vitro time point combination, 3 BALB/c female 
mice were inoculated into both hind f.p. with 104·6 p.f.u. of MCMV. 
The six popliteal LN were removed on day 0, 2, 4, 6 or 8 post 
inoculation. The LN cells were pooled, cultured for 0, 2, 4, 6 or 
8 days without addition of viral antigen and then assayed for 
cytotoxic activity against MCMV-infected and uninfected control 
BALB/c MEF target cells. The assays for a particular time point 
in vivo coupled with variable times in vitro were performed as one 
experiment, e.g., the assays for day 6 in vivo with days 0, 2, 4, 
6 or 8 in vitro were performed on one day. 
Cytotoxicity against uninfected control MEF target cells was 
maximal in LN cell populations harvested 4 days after viral 
inoculation and cultured for 2-6 days (Fig. 1). Lysis of MCMV-
infected MEF targets over and above the lysis of uninfected 
controls required minimum intervals of 4 days in vivo post 
inoculation of virus plus 2 days in vitro prior to the cytotoxicity 
assay (Fig. 2). Maximum antiviral cytotoxic responses required 
6-8 days in vivo post inoculation of MCMV plus at least 4 days of 
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culture. The culture of LN cells from animals at day O and day 2 
post f.p. inoculation of MCMV did not produce cytotoxic activity 
even after 6-8 days in vitro (Fig. 2). 
Infectious MCMV titres in lymph nodes on different 
days after f.p. inoculation 
Twenty BALB/c female mice, 6-12 weeks of age, were inoculated 
into both hind f.p. with 104·6 p.f.u. MCMV. At 1 hr, 3 days, 
6 days or 9 days after inoculation, draining popliteal and iliac LN 
were removed from 5 animals into DMEM and stored at -7o 0c until 
assayed for p.f.u. On the day of assay, the LN were thawed and 
sonicated for 30 secs. The results (Table 1) showed that infectious 
virus could be detected in draining popliteal LN of all 5 mice on 
day 3, in 1/5 LN on day 6, and in no LN on day 9. The iliac LN 
revealed a similar temporal profile for virus titres except that 
not all the iliac LN were infected on day 3. 
Kinetics of anti-MCMV cytotoxic activity with 
different viral doses 
Four groups of 15 BALB/c female mice were inoculated into 
both hind f.p. with 106· l, 105·6, 104· 6 or 102·6 p.f.u. of MCMV. 
On days 0, 2, 4, 6 and 8 post inoculation the draining popliteal LN 
from 3 mice of each group were collected and single cell suspensions 
were prepared. The viable cells were counted, cultured for 4 days 
at 105·8 cells/ml and then assayed for cytotoxic activity against 
MCMV-infected and uninfected BALB/c MEF. The f.p. inoculations 
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for a particular viral dose were staggered at 2-day intervals such 
that LN harvest, cell culture and subsequent cytotoxicity assays 
could be performed at the one time. The assays for the different 
viral doses were performed on different days for logistic reasons, 
hence the absolute values for% lysis induced by different viral 
doses are not comparable; only the temporal profiles can be 
compared. 
The results (Fig. 3) showed the development of anti-MCMV 
cytotoxic activity in all cell pools with maximum activity at 
days 6-10 post MCMV inoculation. Cytotoxic activity did not relate 
to the viable cell numbers in the popliteal LN at the time of 
harvest (Fig. 4). Cytotoxic activity against uninfected targets 
was maximal on day 4 for all viral doses (data not shown). 
Because cell numbers in the popliteal LN did not correlate 
with the anti-MCMV cytotoxic activity generated in vitro from these 
cells, it was of interest to determine if the salivary gland homo-
genate in the stock virus preparations rather than MCMV caused the 
changes in LN cell numbers. Therefore on days 0, 2, 4, 6 and 8 
after bilateral hind f.p. inoculation of 104·6 p.f.u. of MCMV in 
40 ul of diluted, infected salivary gland homogenate, both 
popliteal LN of 3 BALB/c mice were obtained, cells pooled and 
viable cell counts performed. All mice were injected on the same 
day with the subsequent LN collections staggered 2 days apart. A 
similar protocol was used for control mice that were injected with 
normal salivary gland homogenate. 
Cell numbers in the popliteal LN of MCMV-infected mice 
increased to a maximum at 6-8 days post viral inoculation (Fig. 5). 
No significant cellular increase occurred after normal salivary 
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gland injection. A subsequent experiment that utilized a similar 
sampling protocol was performed on days 0, l, 2, 5, 6, 8, 10, 14 
and 19 after bilateral hind f.p. inoculation. There was an 
increase in cell numbers in the popliteal LN of MCMV-infected mice 
with a peak in cell numbers at 6-8 days post MCMV inoculation and 
a decrease to normal cell numbers by day 19 (data not shown). 
Similar responses to MCMV were obtained using CBA/H mice (data not 
shown). 
The data in Fig. 3 suggested that viral doses from 102· 6 p.f.u. 
up to 106· 1 p.f.u . stimulated anti-MCMV cytotoxic responses 
provided 6-10 days elapsed between viral inoculation and LN cell 
harvest followed by 4 days in culture. On this basis, 7 days post-
inoculation in vivo and 4 days in vitro were selected as the 
standard interval for further studies. An example of such an 
experiment using different viral doses is shown in Table 2. Viral 
doses of 102· 6 or 104·6 p.f.u. were then used in further experiments 
using this protocol to be described in this and the following 
paper (Sinickas et al., 1984, submitted). 
--
Direct lymph node assay 
Tests were conducted to ascertain if anti-MCMV cytotoxic 
activity could be detected in draining popliteal LN of MCMV-infected 
mice without the 4 days in culture. Groups of 3 BALB/c mice were 
inoculated with 104· 6 p.f.u. into both hind f.p. at intervals of 
2-5 days. On days 0, 2, 4, 6, 8, 10, 12, 17 and 19 post inoculation, 
the six popliteal LN of each group were harvested and a l/12 
aliquot of each group's pooled LN cells were assayed for cytotoxic 
activity on MCMV-infected and uninfected BALB/c MEF targets. 
Positive control anti-MCMV cytotoxic cells (to ascertain MCMV-
infected MEF target sensitivity to lysis) were obtained as 
described above by harvesting LN on day 7 post inoculation of 
MCMV, pooling LN cells and culturing for 4 days. 
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To test the possibility that infected B cells 1n the LN cell 
pool were acting as cold competitor targets in the cytotoxicity 
assay, a cell suspension was prepared from another group of six 
LN at day 7 post MCMV inoculation and the cell population was 
+ depleted of lg cells prior to cytotoxic assay of a 1/12 aliquot 
of remaining cells. 
Anti-MCMV cytotoxicity was not detected by direct assay of 
popliteal LN cell pools at any time post infection (data not shown). 
+ The removal from the day 7 cell pool of lg cells did not unmask 
the presence of cytotoxic cells (Table 3). 
43 
DISCUSSION 
This paper describes experimental procedures leading to the 
generation of murine cytotoxic cells that lyse MCMV-infected 
MEF target cells. The system chosen for study was similar to that 
described for HSV (Pfizenmaier et al., 1977) and utilised bilateral 
hind f.p. inoculation of salivary gland MCMV, and harvest of 
draining popliteal LN followed by culture of single-cell 
suspensions. This and the accompanying paper (Sinickas et al., 
1984, submitted) report the detailed characterisation of the 
individual steps of the experimental protocol in order to study 
the kinetics, specificity and other relevant parameters of the 
cytotoxic response. As with HSV, the expression of cytotoxic 
potential against MCMV-infected MEF target cells was dependent 
upon a further period of time in vitro after the LN cells were 
removed from the mouse. Four days in vitro was consistently 
sufficient for this purpose. 
MCMV doses from 104·6 up to 106· 1 p.f.u. resulted in cells 
with anti-MCMV cytotoxic potential being present in the popliteal 
node from 4 to 10 days after infection with maximal levels at about 
8 days. After a dose of 102·6 p.f.u., potential cytotoxicity did 
not appear until 6 days after infection and then persisted at 
maximal levels until day 10. Time points after day 10 were not 
studied but it would be of interest to investigate the temporal 
decline of cytotoxicity. MCMV was detected in the draining 
popliteal LN (>103·0 p.f.u.) 3 days after inoculation of 
104·6 p.f.u. into the f.p., was barely detectable on day 6, and was 
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undetectable by day 9. These results suggest that several days may 
be needed for MCMV to multiply in some cells of the tissues of the 
foot and/or of the LN, resulting in display of MCMV-dependent cell 
surface antigens recognised by precursors of cytotoxic lymphocytes. 
However, even the lowest dose of virus used (102· 6 p.f .u. ) was 
sufficient to stimulate an anti-MCMV response. 
Numbers of viable cells in the draining popliteal LN increased 
after MCMV inoculation in the f.p. and the extent of increase was 
inversely related to the dose of virus. Thus, up to 10-fold 
increases 1n cell numbers were found 6-8 days after 102· 6 or 
104· 6 p.f .u. of MCMV, but 106· 1 p.f.u. caused only an initial 
increase in cell numbers that was not sustained beyond the second 
day after inoculation. These data imply that high doses of MCMV 
wh~c..J-, 
can interfere with processes WR-at would lead to increases in LN 
cell numbers such as local cell proliferation or migration of cells 
into the LN via the blood or afferent lymph, but we have not 
evaluated this aspect further. The majority of the cells contri-
buting to the increase in cell numbers were not directly relevant 
to the anti-MCMV cytotoxic response since the anti-MCMV cytotoxic 
potential was unrelated to the numbers of cells in the LN at time 
of removal for culture. 
A feature of the popliteal LN cell response to MCMV infection 
was that from 4 days after infection significant cytotoxicity was 
expressed against uninfected self MEF target cells. This effect 
was most pronounced with LN cells taken 4 days after infection and 
cultured for 2-6 days, but was also present in uncultured L cells 
taken from 4-8 days after infection. Autoreactivity has been 
reported previously as a feature of antiviral responses in vivo 
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(Blanden & Gardner, 1976) and in vitro (Gardner & Blanden, 1976) 
and has been attributed to either cytotoxic T cells (Blanden & 
Gardner, 1976, Gardner & Blanden, 1976) or natural killer cells 
(Welsh & Zinkernagel, 1977). It is a possible complication in the 
interpretation of recent work involving limiting dilution to 
isolate clones of Tc cells responding to MCMV infection (Reddehase 
et al., 1984). Since the clones were not divided and assayed on 
both MCMV-infected self targets and uninfected self targets, it was 
not determined with certainty which clones were MCMV-specific and 
which were autoreactive. 
Although autoreactive cytotoxic activity was present 1n 
popliteal LN cells taken directly from MCMV-infected mice 4-8 days 
after infection, MCMV-specific cytotoxicity over and above auto-
reactivity was not directly detectable at any time up to 19 days 
after infection. The possibility that infected cell populations 
within the LN pool were acting as cold competitor targets during 
the direct 1n vitro cytotoxicity assay, thereby decreasing the 
sensitivity of the assay for MCMV-specific cytotoxic cell detection, 
was tested by removal of the largest cell pool likely to be 
MCMV-infected (Ig+ cells, Olding et~-, 1975) prior to~ vitro 
iv .. 1 ' (..J I rzll'a,; 0-/ 
cytotoxicity testing. No anti-MCMV cytotoxic activityAfrom the 
draining popliteal LN on day 7 post inoculation of 104· 6 p.f.u. 
MCMV. This does not exclude the presence of other infected cells 
in the non-Ig+ cell fraction, since we made no assessment of viral 
antigen expression within this cell pool. Nevertheless, since Ig+ 
cells comprise approximately 50% of the LN cell pool, a major 
possible infected cell source was removed without effect. 
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The inability to detect direct cytotoxicity agrees with 
difficulties reported by other workers for MCMV (Ho, 1980) and HSV 
(Pfizenmaier et al., 1977), but is in contradistinction to others 
who were able to detect cytotoxicity to MCMV from two lymphoid 
populations, spleen and cervical LN after intraperitoneal and 
intranasal routes of inoculation respectively (Quinnan et al., 
1978, 1980). The discrepancy may be accounted for by technical 
differences in target cell and virus preparations and manipulations 
of variables such as mouse ages, route of inoculation and viral 
dose. All of the latter are important parameters for mouse 
survival against MCMV infection (Mannini & Medearis, 1961), and 
hence may be important factors affecting the generation of effector 
cells responsible for viral elimination. 
In our hands 2-4 days in vitro were always required for anti-
MCMV cytotoxicity activity to develop in popliteal LN cells taken 
from the mouse 6-10 days after infection. The presence of CSS 1n 
the culture medium was necessary for the consistent expression of 
this anti-MCMV cytotoxic potential, thus ra1s1ng the possibility 
that soluble factors which are necessary for the proliferation 
and/or differentiation of anti-MCMV cytotoxic cells are limiting or 
are insufficient to overcome some suppressor mechanism in vivo. 
The lack of a detectable cytotoxic response in vivo is an important 
feature of the immunobiology of herpesvirus infections, since many 
other virus groups have been shown to provoke primary antiviral 
Tc cell responses in vivo within 4-8 days (Blanden & Gardner, 1976, 
Yap & Ada, 1977). Therefore, we have undertaken a thorough 
reductionist approach to the separate steps of the experimental 
protocol required to generate and assay anti-MCMV cytotoxic cells, 
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beginning with the in vivo parameters studies here. Future report s 
will deal with the in vitro parameters, characterization of 
effector cells, and factors affecting the efficiency of their 
recognition of MCMV-infected target cells. 
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SUMMARY 
Combined in vivo-in vitro protocols for the generation of 
anti-MCMV cytotoxic responses were investigated using BALB/c mice 
and syngeneic MEF target cells. Injections of doses of MCMV from 
102· 6 up to 106· 1 p.f.u. into the hind f.p., harvest of draining 
popliteal LN cells after 6-8 days, followed by 4 days culture of 
these cells gave similar and optimal cytotoxic activity against 
MCMV-infected target cells. After injection of 104· 6 p.f.u. into 
the hind f.p., MCMV was detectable at about 103-104 p.f.u. per 
popliteal node after 3 days, but became undetectable in most 
animals by 6 days. Cell numbers in the draining popliteal LN 
increased following MCMV inoculation into the hind f.p., but the 
extent of the increase was inversely related to virus dose and bore 
no relationship to the anti-MCMV cytotoxic potential of the cells. 
LN cells applied directly to target cells upon harvest from 
MCMV-infected mice never gave detectable anti-MCMV cytotoxic 
activity at 2, 4, 6, 8, 10, 12, 17 or 19 days post infection, but 
lysis of uninfected syngeneic targets was obtained 4-8 days post 
infection. 
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Fig. 1. 
Lysis of uninfected BALB/c MEF target cells by effector cells 
generated from 6 BALB/c popliteal L removed on various days 
(indicated by vivo on figure) after f . p. inoculation of 
104· 6 p. f . u. of ~CMV and cultured as single -cell suspensions 
(indicated by days in vitro) for various times. The% lysis 
values are the means of three replicates obtained by addition of 
a 1/12 aliquot of cultured cells from 6 popliteal LN onto targets . 
The standard errors of the mean were <4% and are not shown . 
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Fig 2. 
Specific lysis of MCMV-infected BALB/c MEF target cells by 
effector cells generated as described in Fig. l. Percent lysis 
values were obtained by addition of a l/12 aliquot of cultured 
cells from 6 popliteal LN onto MCMV-infected and uninfected 
target cells. The% specific lysis values are the result of 
subtraction of the lysis obtained on uninfected targets from lysis 
detected on MCMV -infected targets. Each point represents the mean 
of 3 replicates. The standard errors of the mean were <4% and are 
not shown. 
TABLE 1 
Infectious MCMV titres in lymph nodes at different times after infection* 
Time after infection 
(days) 
0.04 
3 
6 
9 
Infectious virus titre (Log 10 p.f.u./organ) t 
Popliteal LN+ 
3.54, 3.38, 3.51, 3.0, 3.51 
1.78 
Iliac LN § 
2. 45, 2. 96, - 2.45 
l. 78 
* Mice were infected with 104·6 p.f.u. salivary gland preparation of MCMV into 
both hind footpads. 
t Viral p.f.u. values are shown for individual mice. ( - ) indicates no 
infectious virus detected. 
+ Two popliteal LN/animal are treated as one lymphoid organ. 
§ Four iliac LN/animal are treated as one lymphoid organ. 
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Fi g. 3. 
Kinetics of anti -MCMV cytotoxic activity with different viral 
doses . Effector cells were generated from 6 BALB/c popliteal LN 
r emoved at various days after f . p. inoculation of 106· 1, 105·6, 
104·6 or 102· 6 p. f . u. MCMV and cultured as single-cell suspensions 
fo r 4 days . The% specific lysis values were obtained as 
des cr i bed in Fi g. 2. The standard errors of the mean were <4% 
and are not shown . 
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Fig . 4. 
Vi able cell numbers in draining popliteal LN after hind f . p. 
inoculation of different doses of MCMV. Each point represents 
the mean numbers of viable cells per LN obtained from six pooled 
popliteal L at t :·,e indicated t ir:,es post inoculation of the viral 
doses sh own (p . f . u. ) . 
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Cell numbers 1n the draining popliteal LN following hind f.p. 
inoculation with 104·6 p.f.u. of MCMV (o....__-----.o) and normal salivary 
gland suspension (o----o). Each point represents the mean numbers 
of viable cells per popliteal LN + standard deviation of the mean 
(in groups of 5). 
TABLE 2 
Effect of viral dose on cytotoxicity mediated by 
MCMV -i mmune cultured LN cells* against MCMV -infected 
target cells 
% lysis of BALB/c MEF targets t 
Viral dose 
(p.f.u./f.p.) 
MCMV-infected 
48.5 + 2.6 
41.9 + 3.0 
39.8 + 2.4 
Uninfected 
14.5 + 0.7 
5.5 + 0. 1 
6.4 + 0.4 
* Effector cells were generated from 3 groups of 6 BALB/c 
popliteal LN removed 7 days after f.p. inoculation of 
106· 1, 104·6 or 102·6 p.f.u. MCMV and cultured as single-
cell suspensions for 4 days. 
T The% lysis values are the means+ standard errors of the 
mean of 3 replicates obtained by addition onto targets of 
a 1/36 aliquot of cultured cells from 6 BALB/c popliteal LN. 
TABLE 3 
Cytotoxic activity of LN cells from BALB/c mice 7 days 
after ~CV - infection assayed directly or after a further 
4 days in culture 
Effector 
cells 
*Direct LN assay 
. + 
Trg cells removed 
+Positive control 
% lysis of BALB/c MEF targets§ 
MCMV -infected 
13.5 + 1.9 
12.4 + 1.0 
72.8 + 1.3 
Uninfected 
9.8 + 0.7 
14.6 + 1.0 
15.6 + 0.5 
* Popliteal LN cells were obtained from 3 BALB/c mice infected 
7 days previously with 104· 6 p.f.u. of MCMV and assayed 
directly. 
LN cells obtained as in* above were treated as described 1n 
+ Materials and Methods to remove Ig cells and assayed 
directly. 
+ The positive control effector cells were obtained as 1n * above, 
but were cultured for an additional 4 days. 
~ % lysis values are means+ standard error of the mean of 
3 replicates obtained by addition of a 1/ 12 aliquot of cells 
from 6 BALB/c popliteal LN. 
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CHAPTER 3 
The Cytotoxic Response to Murine Cytomegalovirus. 
II. In vitro requirements for generation of 
cytotoxic T cells 
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INTRODUCTION 
The generation of a cytotoxic T (Tc) cell response both~ vivo 
and in vitro has been reported for many viruses (Zinkernagel & 
Doherty, 1979). Usually these T cell responses have been studied 
using either direct assay from primary spleen cell populations 
in vivo or restimulation in vitro of secondary spleen cell 
populations. The situation with the Beta-herpesvirus, murine 
cytomegalovirus (MCMV) has been more difficult in that reports of 
direct primary cytotoxicity are few and show low levels of cyto-
toxicity on MCMV-infected target cells (Quinnan et~-, 1979) or 
lack of reproducibility (Ho, 1980). Secondary stimulation in vitro 
with MCMV has been reported (Ho, 1980), but 1n our hands cyto-
toxicity against MCMV-infected targets over and above that expressed 
against uninfected targets has been low and unreliable. 
However, now that we can consistently generate cytotoxicity 
against MCMV-infected targets above that observed for uninfected 
targets by a combination of in vivo and in vitro methods 
(Sinickas et al., 1984, submitted) we have been able to characterise 
the effector population and the in vitro conditions needed to 
optimize specific anti-MCMV specificity. 
METHODS 
Mice. BALB/c, CBA/H, and WEHI-3 mice, 6-12 weeks of age, 
were obtained from the Animal Breeding Establishment of the 
John Curtin School of Medical Research. 
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Viruses. Standard methods were used for preparation of the 
Smith strain of MCMV (Sinickas et al., 1984, submitted) and 
influenza A/WSN (Yap & Ada, 1977). 
Generation of antiviral effector cells. Anti-MCMV effector 
cells were generated as described previously (Sinickas et~-, 
1984, submitted) with variations given in details in Results. 
Anti-influenza A/WSN effector cells were generated by secondary 
cultures of primed spleen cells as described by Yap & Ada (1977). 
Target cell culture. The DBA/2 mastocytoma cell line 
P-815-X2 (P815) and mouse embryo fibroblasts (MEF), obtained by 
trypsin dispersion, were grown at 37°c in a humidified atmosphere 
containing 10% CO2, 7% o2 and 83% N2 (special gas) in Dulbecco's 
Modified Eagle's Medium (Cat. No. Hl6, GIBCO, Grand Island, N.Y., 
U.S.A.) supplemented with 5% foetal calf serum (FCS) (Flow Labs, 
Stanmore, N.S.W., Australia), 200 ug/ml Streptomycin, 
200 U/ml Penicillin G and 150 ug/ml Neomycin sulphate (antibiotics). 
(The complete medium is referred to as DMEM.) 
Cytotoxicity Assay. 106·3 P815 cells in 0.5 ml of DMEM were 
infected with 0.2 ml of influenza A/WSN stock (allantoic fluid 
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Haemagglutinin titre 1:1024) for 60 m1ns at 37°c in special gas. 
Subsequently 600 uCi Na 2[
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cr]o4 (Amersham Int. Ltd., Amersham, 
U.K. ) in 5 ml of DMEM was added and incubation continued for 2 hrs, 
after which time the cells were centrifuged, washed and resuspended 
at 105·3 cells/ml. Aliquots of 100 ul were added to 96-well round-
bottomed microtitre wells (Nunc, Roskilde, Denmark) followed by 
100 ul of effector cells suspended in Eagle's Minimal Essential 
Medium (Cat . NO. Fl5, GIBCO, Grand Island, N.Y., U.S .A.) 
supplemented with 5% FCS and antibiotics (Assay medium). Cell-free 
supernatants were harvested after 10 hrs incubation as described 
for MEF. The MEF target cell protocol with MCMV, assay of gamma 
emissions, and calculations for cytotoxicity were unchanged from 
that previously described (Sinickas et~-, 1984, submitted) . 
Antiserum treatments. Cultured or uncultured popliteal lymph 
node (LN) cells were collected and suspended at 107·6 cells/ml in 
assay medium containing 100 ul of 1:40 dilution of Thyl.2 antiserum 
(Clone F7D5, Olac 1976 Ltd . , Oxon., England) per 108 cells. After 
incubation at 4°C for 45 minutes, the cells were washed twice and 
resuspended at 107·0 cells/ml in assay medium containing a 1:8 
dilution of low-Tox-M rabbit complement (C') (Cedarlane Laboratories 
Ltd., Ontario, Canada). After 45 mins incubation at 37°c, the cells 
were washed twice with assay medium and either utilised as effector 
cells in cytotoxicity assays or cultured. 
The Lyt2 antiserum 3. 168 was generously provided by 
Dr. J. Allen (originally described by Sarmiento et al., 1980) and 
--
was used to treat LN cells at a cell concentration of 107· 2 cells/ml 
1n assay medium with addition of 50 ul of l :20 dilution of Lyt2 
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antiserum per 107·3 cells. Washing procedures and C1 treatment 
was as described above for anti-Thyl.2. 
Gamma radiation . L cells were suspended at 107· 3 cells/ml in 
-4 ( assay medium and 10 M 2-mercaptoethanol 2ME) 1n siliconized test 
60 tubes and exposed to 400, 800, 1200 or 1600 rads from a Co source. 
Thymidine incorporation. On days 0, 1, 2, 3 and 4 of culture, 
0. 1 ml aliquots of LN cells were removed from culture vessels 
(Cat . No . 3512, Costar, Cambridge, Mass., U. S.A . ) and placed into 
96-well flat-bottomed microtitre trays (Nunc, Roskilde, Denmark). 
To each well, 50 ul of [methyl-3H]-Thymidine (Amersham Int. Ltd., 
Amersham, U. K.) at 25 uCi/ml was added . After 5 hrs incubation at 
37°c in special gas, the cells were harvested onto glass fibre 
paper using a MASH 11 multiple sample harvester (Microbiological 
Associates, Bethesda, Md . , U.S.A.) . The dried samples of glass 
fibre paper were placed in 7 ml of scintillation fluid and beta 
emissions counted in a liquid scintillation counter (Tricarb, 
Packard Instrument Co . , Downers Grove, Ill., U.S.A.). All samples 
were assayed in triplicate. 
Mitomycin C treatment. LN cells were collected and suspended 
at 107·0 cells/ml 1n Eagle's Minimal Essential Medium to which 
20 ug of Mitomycin C (Sigma, St. Louis, Mo., U.S.A.) 1n phosphate-
buffered saline (200 ug/ml) was added per 10 7· 0 cells. After 
30 mins incubation at 37°c, the cells were ashed three times and 
cultured. 
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Concanavalin A activated spleen cell supernatant (CSS). This 
was prepared as previously described (Sinickas et al., 1984, 
submitted) using spleen cells from WEHI-3 mice. 
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RESULTS 
An experimental program in vitro was undertaken to investigate 
the characteristics of the cytotoxic response against MCMV infection 
generated in cells from popliteal LN taken 7 days after hind footpad 
(f.p . ) inoculation of MCMV and then cultured for 4 days as described 
in the preceding paper (Sinickas et al . , 1984, submitted) . 
Effector :Target (E:T) cell ratio 
Six BALB/c popliteal LN were harvested at day 7 after bilateral 
f.p. inoculation of 104·6 plaque-forming units (p.f.u.) MCMV. 
Single cell suspensions were prepared and cultured without 
additional virus. On day 4 of culture the LN cells were harvested 
and assayed for cytotoxicity on MCMV-infected and uninfected 
BALB/c MEF targets. We have arbitrarily chosen to use pooled cells 
from six LN as one cultured unit and hence the effector:target 
(E:T) ratios are expressed as the reciprocal of the fraction of 
this unit (as log 10 ), placed onto the targets in the cytotoxicity 
assay . In this example there was significant lysis of MCMV-infected 
MEF at the 3 highest E:T ratios (Fig. 1) and lysis of uninfected 
MEF only at the highest E:T ratio. In other experiments, lysis of 
uninfected MEF in relation to lysis of infected MEF was sometimes 
higher and sometimes lower than the example shown in Fig. 1. 
Effect of anti-Thyl.2 serum, viral specificity and 
H-2 restriction 
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BALB/c and CBA/H female mice were inoculated into both hind 
f . p. with 102· 6 p. f . u. of MCMV and units of 6 popliteal LN from 
mice of each strain were used after 7 days to prepare single-cell 
suspensions . The LN cells were cultured for 4 days, harvested and 
subjected to treatment with Thyl.2 antiser~m and C', C' treatment 
alone, or left untreated prior to cytotoxicity assay. Anti-
influenza A/WSN effector cells were generated by in vitro 
restimulation of 108·0 primed spleen cells with 107·0 spleen cells 
infected with influenza A/WSN (Yap & Ada, 1977). Spleen cells 
were harvested on day 5 of culture and used in cytotoxicity assays. 
Target cells utilised were MCMV-infected or uninfected MEF 
from BALB/c(H-2d) or CBA/H(H-2k) mice, and influenza A/WSN - infected 
or uninfected P815(H-2d) cells. MCMV-infected MEF were lysed by 
effector cells that were sensitive to treatment with Thyl.2 serum 
and C' (Table l), were H-2-restricted (Table 2), and were virus-
specific with respect to MCMV and influenza A/WSN (Table 3). These 
are the properties of antiviral Tc cells . 
Effect of anti-Lyt2 serum upon cytotoxicity 
Nine BALB/c female mice were inoculated into both hind f.p. 
with 102·6 p.f.u. MCMV. Draining popliteal LN were removed on 
day 7 post inoculation when single-cell suspensions were prepared 
and cultured for 4 days. The cells were then harvested, pooled at 
107·6 cells/ml in assay medium, divided into 3 equal aliquots and 
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subjected to treatment with C' alone, Lyt2 antiserum and C', or 
left untreated. 
The recovery of viable cells after anti-Lyt2 plus C' treatment 
and after C' alone was 75% and 80% respectively. Cytotoxicity was 
tested after all the aliquots were adjusted to equal volumes and 
1/108 aliquot of the adjusted volume added to MCMV-infected or 
uninfected MEF. Lyt2 antiserum and C' treatment abrogated the 
cytotoxic activity compared to C' alone or no treatment (Table 4). 
Effects of temperature and CSS 
Draining popliteal LN from 12 BALB/c female mice were removed 
7 days after bilateral hind f.p. inoculation with 102· 6 p.f.u. MCMV. 
The cells from 24 LN were pooled, adjusted to 105·8 cells/ml, 
divided into 4 aliquots which were cultured for 4 days (a) at 34°c 
with css, (b) at 37°c with css, (c) at 34°c without css, (d) at 37°c 
without CSS, and then assayed for cytotoxic activity against 
MCMV -infected and uninfected BALB/c MEF. 
34°c and 37°c were used in an attempt to duplicate popliteal LN 
temperature and visceral body temperature respectively. However, 
incubation temperature had no effect upon Tc cell generation, but 
the presence of CSS significantly increased cytotoxic activity 
against both infected and uninfected target cells (Table 5). 
LN cell concentration 1n vitro 
Popliteal LN from 12 BALB/c female mice inoculated into both hind 
f.p. with 102·6 p.f.u. MCMV were obtained on day 7. A single-cell 
60 
suspension pool was prepared, divided into 4 aliquots and then 
cultured at concentrations of 106·8, 106· 3, 105·8, 105· 3 cells/ml. 
On day 4 the cells were harvested and assayed for cytotoxicity 
against MCMV-infected and uninfected BALB/c MEF. Cell concentra-
tions of 105·8-105·3 cells/ml were optimal for generation of 
MCMV-specific Tc cells (Table 6). 
Effect of gamma irradiation 
To determine whether proliferation in vitro of cells derived 
from MCMV-stimulated popliteal LN was required for Tc cell 
generation, LN cells were subjected to various doses of gamma 
irradiation prior to culture. Twenty BALB/c mice were inoculated 
with 102·6 p. f . u. MCMV into both hind f . p. On day 7 the forty 
popliteal LN were removed, and a cell suspension was prepared at 
107·3 cells/ml in assay medium supplemented with 10-4 2ME. This 
suspension was divided into 5 aliquots which were subjected to 
0, 400, 800, 1200 or 1600 rads of . d. t· f 60c gamma irra ia ion rom a o 
source . One quarter of the cells of each aliquot was cultured at 
105·8 cells/ml for 4 days . On days 0, l ' 2 and 4 of culture, 
triplicate 0. 1 ml samples were removed from each culture vessel and 
assayed for [3H]-thymidine incorporation. The remaining three 
quarters of each aliquot were cultured for 4 days after which a 
1/12 fraction was placed onto MCMV-infected and uninfected BALB/c 
MEF targets for a cytotoxicity assay. 
[3H]-thymidine incorporation increased over the 4 days in 
culture for the unirradiated cell population, whilst for irradiated 
cells proliferation was decreased, with an inverse relationship 
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between radiation dose and proliferative response (Fig. 2). Con-
comitant with the decreased proliferation, there was decreased 
cytotoxicity against MCMV-infected targets (Table 7). An experiment 
utilizing Mitomycin C instead of gamma irradiation revealed complete 
abrogation of cytotoxic activity on day 4 (data not shown). 
Effect of Thyl.2 antiserum and C' treatment on 
anti-MCMV LN cells prior to culture 
Twelve BALB/c female mice were inoculated with 102·6 p.f.u. 
MCMV into both hind f.p. On day 7 the 24 popliteal LN were removed 
and a cell suspension was prepared at 107·6cells/ml 1n assay medium. 
This suspension was divided into 3 equal aliquots which were 
treated with Thyl.2 serum plus C', C' alone or assay medium only. 
(The recovery of viable popliteal LN cells after anti-Thyl.2 plus 
C' treatment and after C' alone was 55% and 80% respectively.) 
One quarter of the cells from each aliquot was cultured at 
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cells/ml for 4 days. On days 0, l, 2, 3 and 4 of culture 
replicates of six 0.1 ml samples were removed from each culture 
vessel and assayed for [3H]-thymidine incorporation. The remaining 
3 quarters of each aliquot were cultured for 4 days, after which a 
1/36 fraction was placed onto MCMV-infected and uninfected BALB/c 
MEF targets for a cytotoxicity assay. 
[3H]-thymidine incorporation increased to a peak at 3 days for 
the LN cells that were untreated or subjected to C' alone (Fig. 3). 
Anti-Thyl.2 plus C' treatment decreased LN cell proliferation 
(Fig. 3). Cytotoxicity against MCMV-infected targets by LN cells 
treated with anti-Thyl.2 plus C' was markedly decreased compared 
with cells treated with C' alone or untreated (Table 8). 
Effect of Lyt2 antiserum and C' treatment on 
anti-MCMV LN cells prior to culture 
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Fifteen BALB/c female mice were inoculated with 102· 6 p.f.u. 
MCMV into both hind f.p. and on day 7 the 30 popliteal LN were 
removed and a cell suspension prepared in assay medium. This 
suspension was divided into 3 equal aliquots which were treated 
with anti-Lyt2 serum plus C', C' alone or assay medium only. The 
recovery of viable popliteal LN cells after anti-Lyt2 serum plus C' 
treatment or C' alone treated cells was 86% and 81% respectively. 
One-fifth of the cells from each aliquot was cultured at 
105·8 cells/ml for 4 days and another fifth was cultured in two 
equal portions with or without 5 ug/ml Concanavalin A at 
106· 0 cells/ml in assay medium plus l0- 4M 2ME without CSS for 
4 days. On days 0, l, 2, 3 and 4 of culture, replicates of six 
0. 1 ml samples were removed from each culture vessel and assayed 
for [3H]-thymidine incorporation. The remaining three-fifths of 
each aliquot were cultured for 4 days in assay medium plus 2ME with 
CSS, after which a l/36 fraction was placed onto MCMV -infected and 
uninfected BALB/c targets for a cytotoxicity assay. 
In the absence of Concanavalin A, [3H]-thymidine incorporation 
increased to a peak at 3 days, for the LN cells that were subjected 
to C' alone or untreated (Fig. 4). The cells treated with anti-
Lyt2 plus C' showed a delayed onset of incr ased [3H]-thymidine 
incorporation (day 3) and never achieved the same level of activity 
as the untreated control cells during the four-day culture. 
Cytotoxicity (Table 9) was markedly reduced by the Lyt2 anti-
serum plus C' treatment. 
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The LN cells stimulated by Concanavalin A showed increased 
[3H]-thymidine incorporation to a peak on day 3; the temporal 
profiles and the peak levels attained were similar, irrespective 
of antiserum treatments (data not shown). 
.... 
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DISCUSSION 
In this investigation popliteal LN cells taken 7 days after 
bilateral hind f.p. inoculation of MCMV and then cultured for 
4 days have been used to further characterise the cytotoxic cells 
thus generated which lyse MCMV-infected target cells, and to define 
the conditions in vitro which support this response. The cytotoxic 
cells were destroyed by both Thyl.2 antiserum or Lyt2 antiserum and 
complement, were specific for MCMV in comparison with influenza 
virus, and were apparently H-2-restricted in that they did not lyse 
allogeneic MCMV-infected target cells. These properties are 
characteristic of virus-specific Tc cells described previously 
(Blanden et al., 1975; Ada et al., 1981). 
The conditions under which the popliteal LN cells were cultured 
for 4 days determined the magnitude of the anti-MCMV Tc cell 
response. The addition of CSS to the culture medium significantly 
increased cytotoxic activity against both MCMV-infected and 
uninfected self MEF target cells, suggesting firstly that inadequate 
interleukin production may be a limiting factor in the anti-MCMV 
response, and secondly that the observed autoreactivity may be 
T cell-mediated as in other antiviral responses studied previously 
(Blanden & Gardner, 1976). However, it may be significant that the 
optimum LN cell concentrations for anti-MCMV Tc cell generation 
were 105· 3 to 105·8 per ml. This is 2- to 10-fold less than the 
106· 3 per ml established as the optimum for other primary and 
secondary anti-viral responses (Blanden et~-, 1977; Gardner & 
Blanden, 1976) and for the generation of Tc cells in mixed lympho-
cyte reactions (Lafferty et~-, 1974). It seems possible that 
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this phenomenon may ref1ect a need to di1ute an inhibiting 
inf1uence on Tc ce11 deve1opment that cou1d be present in MCMV-
or HSV-infected 1ymphoid tissues in vivo (Pfizenmaier et a1., 1976), 
but thus far we have not identified such an inhibitory factor. 
Both proliferation of the pop1itea1 LN ce11 population, and 
the generation of anti-MCMV Tc cells were decreased by gamma 
irradiation, mitomycin C treatment or anti-Thy1.2 p1us comp1ement 
of the responding pop1iteal LN ce11s taken 7 days after MCMV 
inocu1ation and before 4 days of culture. These experiments, 
together with the need for CSS, indicate that clona1 expansion of 
anti-MCMV Tc ce1ls was required during the 4 days of cu1ture in 
order for them to reach detectab1e levels. Therefore it seems 
un1ike1y that sufficient c1ona1 expansion had occurred in vivo by 
day 7 after infection, with on1y differentiation of effector 
function being required~ vitro (Pang & B1anden, 1976; Rau1et & 
Bevan, 1982) . Addition of purified inter1eukin-2 to the 4-day 
cu1ture step could further c1arify whether pro1iferation a1one or 
with differentiation is required for effector Tc ce11 activity to 
develop fu1ly in this system. 
+ -The idea that Lyt1 2 helper T ce11 function required for full 
c1onal expansion of Lyt1 2+ antiviral Tc cells (Ashman & Mullbacher, 1979) 
is 1acking in MCMV-infected mice was consistent with results 
obtained by treating anti-MCMV L cells harvested 7 days post-
infection with anti-Lyt2 plus comp1ement prior to 4 days of culture. 
Such treatment killed a numerica1ly insignificant proportion of the 
L ce11 popu1ation since> 80% viab1e cel1 recovery was obtained 
after both anti-Lyt2 plus C', and C' treatment a1one. In contrast, 
anti-Thyl.2 plus comp1ement gave a viab1e ce11 recovery of on1y 55%. 
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As expected from these data, anti-Lyt2 plus C' treated LN cell 
populations contained functional T cells as indicated by their 
proliferative response to Con A. However, there must have been 
very few Lyt2 anti-MCMV T cells (putative helper T cells) present 
or capable of proliferation under the culture conditions, si~ce 
very little proliferation of this population took place in the 
absence of Con A. Also as expected, anti-Lyt2 plus C' treatment of 
7-day anti-MCMV LN cells markedly impaired the development~ vitro 
of the anti-MCMV cytotoxic potential of these cells, thus suggesting 
that the majority of anti-MCMV Tc cells were Lyt2+, similar to 
other anti-viral Tc cells (Ada et al., 1981). 
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SUMMARY 
A cytotoxic response to mur1ne cytomegalovirus was obtained 
by the culture of lymph node cells from mice inoculated with MCMV 
into both hind footpads seven days previously. The cytotoxicity 
was mediated by Thyl.2+, Lyt2+, H-2 restricted effector cells 
and was virus-specific. Investigation of the in vitro conditions 
established that T cell proliferation was necessary for optimal 
generation of cytotoxicity, that proliferation was dependent 
upon Thyl.2+, Lyt2+ cell populations and that supernatants from 
Concanavalin A activated spleen cells enhanced the levels of 
cytotoxicity obtained. 
Fig. 1. 
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Cytotoxic activity of popliteal LN cells generated from 3 BALB/c 
mice after bilateral hind f.p. inoculation with 104·6 p.f.u . MCMV. 
The LN cells were harvested on day 7 after inoculation and cultured 
for 4 days . Tripling dilutions of 1/12 aliquot of cultured LN cells 
were placed onto MCMV -infected C6 .. ) and uninfected (Q) BALB/c 
MEF targets. E:T ratio is expressed as the log 10 of the reciprocal 
of the fraction of the culture placed onto targets . In this 
experiment the highest E:T ratio= 90:1. The standard errors of 
the mean percent lysis were less than 4%. All cytotoxicity assays 
were performed in triplicate . 
TABLE 1 
Effect of Thyl.2 antiserum and C1 on 
cytotoxicity mediated by MCMV-immune cultured 
L cells* against MEF target cells 
% lysis of BALB/c MEF targets+ 
J., 
MCMV-immune cell 1 
Treatment 
None 
C1 alone 
Thyl.2 antiserum+ C' 
MCMV-infected 
25.9 + 1.3 
26.8 + 3.6 
3.3 + 2.4 
Uninfected 
2.5 + 0.6 
5.7 + 1.9 
0.7 + 0.9 
* Effector cells were generated from 18 BALB/c popliteal LN 
removed 7 days after f.p. inoculation of 102· 6 p.f.u. MCMV 
and cultured as single-cell suspensions for 4 days. This 
cell pool was divided into 3 equal aliquots for different 
treatments prior to cytotoxicity assay. 
t Conditions for antiserum treatment and assay are described 
in Materials and Methods . 
+ The% lysis values are the means+ standard errors of the 
mean of 3 replicates obtained by addition of a 1/12 aliquot 
of cultured cells from 6 BALB/c popliteal LN onto targets. 
TABLE 2 
H-2 restriction of anti-MCMV Tc cells* from 
BALB/c and CBA/H mice 
Tc cell strain 
BALB/c 
CBA/H 
% specific lysis of MCMV-infected 
MEF targetst 
BALB/c 
38.6 
l . 8 
CBA/H 
-12.2 
32. l 
* Effector cells were generated from 12 BALB/c and 12 CBA/H 
popliteal LN removed 7 days after f.p. inoculation of 
102· 6 p.f.u. MCMV and cultured as single-cell suspensions 
for 4 days. 
t % specific lysis = % lysis of MCMV-infected MEF - % lysis 
of uninfected MEF obtained by addition of a l/12 aliquot 
of cultured cells from 6 BALB/c and 6 CBA/H popliteal LN 
onto targets. % lysis values are the means of 3 replicates. 
The standard errors of the mean were <2. 1%. 
TABLE 3 
Viral specificity of anti-MCMV BALB/c Tc cells 
Tc cell type 
Anti-MCMV* 
Anti-influenza t 
A/ WSN 
MCMV-infected 
BALB/c MEF 
33. l + 0.4 
3.2 + 0.5 
% lysis of targets+ 
Uninfected 
BALB/c MEF 
2 . l + 0.4 
4. l + 0.8 
Influenza A/WSN 
infected P815 
9.0 + 0.4 
89.7 + 0.4 
Uninfected 
P815 
2.3 + 0.3 
14.3 + 6.4 
* Effector cells were generated from 12 BALB/c popliteal LN removed 7 days after f.p. inoculation of 
102·6 p.f.u. MCMV and cultured as single-cell suspensions for 4 days. 
t Anti-influenza A/WSN effector cells were generated using secondary cultures of primed spleen cells 
(Yap & Ada, 1977). 
+ The % lysis values are the means+ standard errors of the mean of 3 replicates. In the case of anti-
MCMV LN cells, a 1/108 aliquot of cultured cells from 6 BALB/c popliteal LN was added to targets (an 
approximate E:T ratio of 15:1). In the case of anti-influenza spleen cells an E:T ratio of 15:l was used. 
TABLE 4 
Effect of Lyt2 antiserum and C1 on 
cytotoxicity mediated by MCMV-immune 
cultured LN cells* against MEF target cells 
MCMV-immune t 
cell treatment 
% lysis of BALB/c MEF targetst 
None 
C' alone 
Lyt2 antiserum+ C' 
MCMV-infected 
MEF 
55.6 + 1.6 
72. 7 + 1 . 1 
2.6 + 0. 1 
Uninfected 
MEF 
8.5 + 0.6 
4.8 + 0.2 
2. 1 + 0.2 
* Effector cells were generated from 18 BALB/c popliteal LN 
removed 7 days after f.p. inoculation of 102· 6 p.f.u. MCMV and 
cultured as single-cell suspensions for 4 days. This cell pool 
was divided into 3 equal aliquots for various treatments prior 
to cytotoxicity assay. 
t Conditions for antiserum treatment are described 1n Materials 
and Methods. 
+ The % lysis values are the means+ standard errors of the mean 
of 3 replicates obtained by addition of a 1/108 aliquot of 
cultured cells from 6 popliteal LN onto targets. 
TABLE 5 
The effect of temperature and CSS upon 
anti-MCMV Tc cell generation in vitro* 
% lysis of BALB/c MEF targets t 
Culture 
Conditions 
CSS+, 34°c 
CSS+, 37°c 
CSS-, 34°c 
CSS-, 37°c 
MCMV -infected Uninfected 
52.6 + 1.4 18.4 + 1.0 
55.l + 0.7 15.5 + 0.4 
28.0 + 1.0 5.3 + 0.7 
27. l + 2. l 5. l + 0.5 
* Effector cells were obtained from 24 BALB/c popliteal LN 
removed 7 days after f.p. inoculation of 102·6 p.f.u. MCMV 
and cultured as single-cell suspensions for 4 days with or 
without CSS at different temperatures. 
t The% lysis values are the means+ standard errors of the 
mean of 3 replicates obtained by the addition of a 
1/12 aliquot of cultured cells from 6 BALB/c popliteal LN 
onto targets. 
TABLE 6 
The effect of cell concentration upon 
anti-MCMV Tc cell generation in vitro* 
% lysis of BALB/c MEF targets t 
Cells/ml 
MCMV-infected Uninfected 
106.8 39.7 + 2.4 4. 1 + 0.3 
106.3 51.6 + 1.9 ll.9 + 1.0 
105.8 69. l + 2.8 15.2 + 0. 1 
105.3 68.9 + 1.7 16.6 + 0.6 
* The effector cells were derived from 24 BALB/c popliteal LN 
removed 7 days after f.p. inoculation of 102· 6 p.f.u. MCMV 
and cultured at different cell concentrations, as single-cell 
suspensions for 4 days . 
t The% lysis values are the means+ standard errors of the 
mean of 3 replicates obtained by the addition of a 
1/36 aliquot of cultured cells from 6 BALB/c popliteal LN 
onto targets. 
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Fig. 2. 
Effect of gamma radiation on proliferation~ vitro of popliteal LN 
cells obtained on day 7 post f.p. inoculation of 102· 6 p.f.u. MCMV 
and treated with various doses of gamma irradiation prior to 
culture. 0. l ml aliquots of cultured LN cells were assayed for 
[ 3H]-thymidine incorporation on days 0, l, 2 and 4. Data points 
are means of triplicate counts per minute (c.p.m.) and the stan-
dard errors are smaller than the symbols in the figure. Background 
[3H]-thymidine incorporation was 320 c.p.m. Gamma irradiation 
doses 0, 400, 800, 1200 and 1600 rads are represented byQ,6, 
,0, and_., respectively. 
TABLE 7 
The effect of gamma radiation on 
anti-MCMV Tc cell generation in vitro* 
Radiation 
dose 
(rad) 
% lysis of BALB/c MEF targets t 
0 
400 
800 
1200 
1600 
MCMV-infected 
63.3 + 1.0 
50.9 + 8.6 
24. 1 + 3.0 
3.5 + 1.6 
-1.8+2.1 
Uninfected 
18.6 + 2.1 
9.9 + 1. 1 
1.4 + 0.5 
-1.5 + 0.7 
-2.2 + 1.0 
* The effector population was derived from 30 BALB/c popliteal LN 
removed 7 days after f.p. inoculation of 102· 6 p.f.u. MCMV. 
These LN cells were irradiated prior to culture for 4 days. 
t % lysis values are the means+ standard errors of the mean of 
3 replicates obtained by addition of a 1/12 aliquot of cultured 
cells from 6 BALB/c popliteal LN onto targets. 
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Fig. 3. 
Effect of Thyl .2 antiserum+ C' treatment on proliferation~ vitro 
of anti-MC~V popliteal LN cells. Popliteal LN cells were removed 
on day 7 post f.p. inoculation of 102· 6 p.f .u. MCMV and treated 
with Thyl.2 antiserum+ C' (•), C' alone (6) or untreated (Q). 
0. 1 ml aliquots of cultured LN cells were assayed for [3H]-thymidine 
incorporation on days 0, l, 2, 3 and 4. Data points are the mean 
c.p.m. ~ standard deviations of the mean for six replicates . The 
error bars are smaller than the symbols in the figure. Background 
[3H] -thymidine incorporation was 90 c.p . m. 
TABLE 8 
Effect upon Tc cell generation of Thyl.2 
serum+ C1 treatment of day 7 popliteal LN 
cells prior to culture 
MCMV-immune* 
cell 
treatment 
% lysis of BALB/c MEF targets t 
Nil 
C1 alone 
Thyl. 2 + C 1 
MCMV -infected MEF 
58.4 + 0.8 
55.3 + 4.8 
3.9 + 4.8 
Uninfected MEF 
10.0 + 0. l 
4.9 + 0.5 
7.1 + 0.6 
* Effector cells were obtained from 18 BALB/c popliteal LN 
removed 7 days after f.p. inoculation of 102· 6 p.f.u. MCMV, 
treated as described 1n Methods and cultured as single-cell 
suspensions for 4 days. 
t % lysis values are the means+ standard errors of the mean 
of 3 replicates obtained by the addition of a l/36 aliquot 
of cultured cells from 6 BALB/c popliteal LN onto targets . 
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Effect of Lyt2 antiserum+ C' treatment on proliferation in vitro 
of anti-MCMV popliteal LN cells. Popliteal LN cells were removed 
on day 7 post f.p. inoculation of 102· 6 p.f.u . MCMV and treated 
with Lyt 2 ant i serum + C ' ( 0) , C ' a l one ( 6 ) or u n treated ( 0 ) . 
0. 1 ml aliquots of cultured LN cells were assayed for [3H]-thymidine 
incorporation on days 0, 1, 2, 3 and 4. Data points are the mean 
c.p.m. + standard deviations of the mean for six replicates. The 
error bars are smaller than the symbols in the figure. Background 
[3H]-thymidine incorporation was <370 c.p.m. 
TABLE 9 
Effect upon Tc cell generation of anti-
Lyt2 + C' treatment of day 7 popliteal LN 
cells prior to culture 
MCMV-immune* 
ce 11 
treatment 
% lysis of BALB/c MEF targets t 
Nil 
C' alone 
Lyt2 antiserum+ C' 
MCMV-infected MEF 
54.6 + 0.9 
50.3 + 2.3 
24.6 + 0.5 
Uninfected MEF 
14.2 + 0.3 
9.2 + 0.2 
10.9 + 0.4 
* Effector cells were obtained as described 1n Table 8, except 
for different antiserum treatments. 
t % lysis values were calculated as described 1n Table 8. 
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CHAPTER 4 
The Cytotoxic Response to Murine Cytomegalovirus. 
III. Lymphokine release and cytotoxicity are dependent upon 
phenotypically similar immune cell populations 
71 
INTRODUCTION 
Murine cytomegalovirus (MCMV) is a member of a sub-family of 
herpesviruses termed Betaherpesvirinae and as such is a useful 
model for the study of viral infections that usually result in non-
fatal and latent illnesses. As part of the study of the immuno-
biology of MCMV infection we have investigated the cytotoxic T cell 
response to this virus, a response which may contribute to the 
clearance of infection (1). We have now utilised MCMV-immune 
lymph node (LN) cell populations to investigate the nature of 
T lymphocytes that release lymphokine after stimulation with MCMV. 
One particular lymphokine, Interleukin-3 (IL-3), a glycoprotein 
belonging to a family of glycoproteins known as colony-stimulating 
factors (CSF) that are essential for survival, growth and differen-
tiation of haemopoietic progenitor cells~ vitro (2), has been 
used in this study. We present evidence that IL-3 release from 
the MCMV-immune LN cell population was dependent upon Thyl.2+, 
+ Lyt2 cells, that were triggered by Class I H-2-restricted and 
virus-specific antigen recognition: cytotoxic activity against 
MCMV-infected target cells was mediated by a phenotypically similar 
cell population. 
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MATERIALS AND METHODS 
Mice. BALB/c, CBA/H, WEHI-3, Bl0.T(6R) and BlO.AQR mice were 
obtained from the Animal Breeding Establishment of the 
John Curtin School of Medical Research and used between 6-12 weeks 
of age. 
Viruses. The Smith strain of MCMV was obtained from 
Dr. G. Shellam, University of Western Australia. Salivary gland 
virus stock was prepared by intraperitoneal (i.p.) inoculation of 
2xl04 plaque-forming units (p.f.u.)/0.2 ml into 4-week-old 
BALB/c female mice. At day 17 ~ost inoculation, salivary glands 
were harvested and a 50% wt/vol homogenate prepared in Dulbecco's 
Modified Eagle's Medium (Cat. No. Hl6, GIBCO, Grand Island, N.Y., 
U.S.A.), supplemented with 5% foetal calf serum (FCS) (Flow Labs, 
Stanmore, N.S.W., Australia), 200 ug/ml Streptomycin, 
200 U/ml Penicillin G and 125 ug/ml Neomycin sulphate (antibiotics). 
(The complete medium is referred to hereafter as DMEM.) Aliquots 
were stored at -7o 0c. For dilution of virus stock 0.2M borate-
buffered gelatin saline (pH 7.2-7.4) was used. Influenza A/WSN 
was prepared by standard methods (3). 
Generation of Antiviral Immune Cells. Anti-MCMV immune 
LN cells were generated as described (4). Briefly, mice were 
inoculated into hind footpads (f . p.) with 40 ul of MCMV 
2 (4xl0 p.f.u.). Seven days after inoculation, the draining 
popliteal LN cells were harvested and cultured at 
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6.3xlo5 cells/ml in 5 ml Costar wells (Cat. No. 3512, Costar, 
Cambridge, Mass . , U.S.A.) containing Eagle's Minimal Essential 
~edium (EMEM) (Cat. No. F-15, GIBCO, Grand Island, N.Y., U.S.A.) 
supplemented with 10% FCS, antibiotics, l0-4M 2-merceptoethanol 
(21E) (Sigma Chemical Co., St. Louis, Mo., U.S.A.) + 3% vol/vol 
supernatant from Concanavalin-A-stimulated spleen cells (CSS). 
After 4 days incubation at 37°c in 83% N2, 7% o2 and 10% CO2 
(special gas) (Commonwealth Industrial Gases, Alexandria, N.S.W., 
Australia) effector cells were harvested . Anti-influenza A/WSN 
effector cells were generated by secondary cultures of primed 
spleen cells (3) . After 5 days incubation the cells were harvested 
and debris removed by centrifugation through an Isopaque-Ficoll 
gradient . 
Cell culture . Mouse embryo fibroblast (MEF) cultures were 
prepared from 16 - 18 day embryos by trypsin dispersion and growth 
in DMEM . 75 cm2 tissue culture flasks (Nunc, Roskilde, Denmark) 
were seeded at 2xlo6 cells/flask and incubated at 37°c for 4 days 
in special gas, after which time the cells were either subcultured 
immediately or kept at room temperature for up to 2 weeks prior to 
subculture . Conditions of subculture were the same as described 
for primary cultures, except that these secondary MEF cells were 
always used after 4 days at 37°c as the source for tertiary 
MEF target or stimulator cells . 
The DBA/2 mastocytoma cell line P-815-X2 (P815) was grown in 
D 1E~ at 37°c in a humidified atmosphere cont ining 5% co2 in air. 
The IL-3-dependent cell line, FDC-Pl (6) was grown in RPMI-1640 
(Cat . No . 10-601-20, Flow Labs, Maclean, Virginia, U.S.A.) 
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supplemented with 5% heat-inactivated FCS (HI-FCS) and 10% WEHI-3B 
cell line conditioned medium (kindly provided by Dr. A.J. Hapel). 
Preparation of Stimulator cells for Lymphokine production. 
Secondary MEF were subcultured into 30 cm2 plastic dishes 
(Cat. No. P.D.S. 6515H, Kayline Plastics, Thebarton, S.A., 
Australia) at 106 cells/10 ml DMEM, supplemented with 3% vol/vol 
CSS/dish. The cells were incubated for 2 days at 37°c in special 
gas, after which time the cell monolayers were washed twice with 
DMEM and adsorbed with 1 ml of 1:8 dilution of MCMV stock 
(4xl07 p.f.u./ml) per dish. The cell monolayers were centrifuged 
at 800g for 20 mins at room temperature and then incubated at 37°c 
1n special gas for 40 mins. Subsequently 10 ml of DMEM was added 
and incubation continued for 16 hrs. Uninfected control MEF were 
subjected to the same protocol, except no virus was added to the 
monolayer. At 16 hrs the cell monolayers were washed, trypsinized 
and resuspended in DMEM at 106 cells/ml, and 10 ml aliquots were 
then added to 65 cm2 plastic petri dishes (Cat. No. 992550, 
Medical Plastics, Edwardstown, S.A., Australia) and subjected to 
ultraviolet (UV) irradiation from an 80 watt germicidal lamp for 
4 mins at an intensity of 960 uW/cm2 1n the 230/270 nm range. 
These cells were then washed twice and resuspended at an appropriate 
concentration in EMEM supplemented with l0-4M 2ME. Aliquots of 
0. 1 ml were dispensed into 96-well flat-bottomed trays (Nunc, 
Roskilde, Denmark). Serial twofold dilutions were prepared prior 
to addition of antiviral effector cells. 
For P815 cells, 107 cells/500 ul DMEM were adsorbed with 
200 ul influenza A/WSN stock (Haemagglutinin titre 1:1024) for 
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sixty minutes, after which 5 ml DMEM was added and incubation 
continued for another 6 hrs. Subsequent treatment for the 
influenza A/WSN-infected and uninfected P815 was similar to that 
described for MEF. 
Conditions for stimulation of Lymphokine production. Anti-
viral effector cells were harvested, washed twice and resuspended 
in EMEM supplemented with l •- 4M 2ME at 5xl•6 cells/ml. 100 ul ali-
quots were dispensed into 96-well flat-bottomed plates containing 
100 ul aliquots of infected or uninfected stimulator cells. These 
cell mixtures were incubated at 37°c in special gas mixture for 
6 hrs, after which time cell-free supernatants were removed and 
stored at -20°c until assayed for IL-3. 
IL-3 Assay . IL-3 activity was assayed by measuring the ability 
of lymphokine preparations to maintain in vitro proliferation of 
the IL-3-dependent FDC-Pl cell line. After a period of 16-24 hrs 
without IL-3, FDC-Pl cells cease dividing. Serial twofold dilutions 
of the test supernatants were prepared in 96-well flat-bottomed 
plates (Linbro Cat . No. 76-203-05, Flow Labs, Maclean, Virginia, 
U.S.A.) with 50 ul RPMI-1640 plus 5% HI-FCS as diluent. Sub-
sequently 50 ul of a FDC-Pl cell suspension (4xl•5) was added to 
each culture well. Control preparations consisted of 48 replicate 
cultures containing 50 ul of the FDC-Pl cell suspension and 
50 ul of RPMI supplemented with 5% HI-FCS. The cultures were 
incubated at 37°c for 16-20 hrs 1n 5% co2, afte r which time 
50 ul of [methyl-3H]-thymidine (Amersham Int. Ltd., Amersham, U.K.) 
(25 uCi/ml) were added and incubation continued for a further 5 hrs. 
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[Methyl-3H]-thymidine incorporation was then determined by har-
vesting the cells onto glass fibre paper using a MASH II multiple 
sample harvester (Microbiological Associates, Bethesda, Md ., 
U.S.A.). The dried samples of glass fibre paper were placed into 
7 ml of scintillation fluid and beta-emission counted in a liquid 
scintillation counter (Tricarb, Packard Instrument Co., Downers 
Grove, Ill., U.S.A.). All samples were assayed in duplicate. 
The titration endpoint was set at three standard deviations (S.D.) above 
the mean control level of [methyl-3H]-thymidine uptake, according 
to a previously described method (6). 
Cytotoxicity assays. Previously described protocols for 
cytotoxicity assays using anti-influenza A/WSN (3) and anti-MCMV 
effector cells (4) were used. Briefly, 96-well flat-bottomed 
microtitre trays were seeded with tertiary MEF at 104 cells/0.2 ml 
DMEM/well, 3 days prior to assay. After 2 days in culture, the 
cells were adsorbed with MCMV stock as described for stimulator 
cell preparation, except adsorption volume was 25 ul. Sixty 
minutes later, 150 ul of DMEM supplemented with 6 uCi of 51 cr 
(Amersham Int. Ltd., Amersham, U.K.) was added and incubation 
continued at 37°c in special gas for 16 hrs. Uninfected control 
MEF were treated 1n a similar manner except for no viral adsorption. 
The target cells were then washed twice, followed by addition of 
100 ul of fresh DMEM and 100 ul of antiviral effector T cell 
suspension. 
Triplicate cultures were set up for each dilution of anti-
viral effector cells and incubated for 10 hrs at 37°c. 
51 cr release from the targets was measured and lysis 
calculated using the following formula: 
% lysis of infected or uninfected cells= 
51 C . r counts 1n presence 
of effector cells 
51
cr counts from 
water-lysed targets 
51 Cr counts released 
in medium 
51
cr counts released 
in medium 
Antiserum treatments. Cultured MCMV -immune LN cells were 
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harvested, centrifuged and resuspended in EMEM plus 5% FCS at 
4xl07 cells/ml containing 300 ul of 1:40 dilution of Thyl.2 
antiserum (Clone F705, Olac Ltd., Oxon., U.K.) per 108 cells. 
After incubation at 4°c for 45 mins, the cells were washed twice 
and resuspended at 107/ml in EMEM plus 5% FCS containing a 
1:8 dilution of low-Tox-M rabbit complement (C 1 ) (Cedarlane 
Laboratories Ltd., Ontario, Canada). After 45 mins incubation at 
37°c, the cells were harvested, washed twice and resuspended in 
EMEM and l0- 4M 2ME at 5xl07 cells/ml in preparation for stimula-
tion of lymphokine production. Seven ul of neat Lyt2 antiserum 
3. 168 (8) (generously donated by Dr. J. Allen) was added to 
0.95 ml cultured MCMV-immune LN cells suspended 1n EMEM plus 
5% FCS at l.4xlo6 cells/ml. Treatment of cells subsequent to this 
step was as described for Thyl.2 antiserum and C1 treatment, 
except that a 1:6 dilution of C1 was used during the 1ytic phase. 
Concanavalin-A-stimulated spleen cell supernatant (CSS) . 
This was prepared as previously described (4) using spleen cells 
from WEHI-3 mice. 
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RESULTS 
Effect of different numbers of MCMV-infected or uninfected MEF 
upon lymphokine release from MCMV-immune LN cells 
Preliminary experiments investigated the optimal conditions for 
stimulation of IL-3 production and release from MCMV-immune LN cells 
obtained from various mouse strains. Three mice of each strain -
BALB/c , B10.AQR and B10 .T(6R) - were inoculated into both hind f.p. 
with 4xlo2 p.f.u. MCMV. The popliteal LN cells were obtained on 
day 7 and cultured for 4 days, after which time they were harvested 
and resuspended at 5xl06 cells/ml in EMEM supplemented with 
l0- 4M 2ME . MCMV-infected or uninfected MEF were suspended at 
2xl0 7 cells/ml and diluted in twofold steps down to 8xlo3 cells/ml. 
Subsequently 100 ul MCMV - immune LN cells were mixed with 100 ul of 
MCMV-infected or uninfected MEF from the same mouse strain and 
incubated at 37°c in special gas for 6 hrs. 
The amount of IL-3 released from a fixed number of B10.AQR 
MCMV-immune LN cells (5xl05) was directly proportional to the 
number of syngeneic MCMV-infected MEF added up to a maximum level 
between l.2-5xl05 MCMV-infected MEF (Fig. l). The results for the 
two other mouse strains tested were similar to the data obtained 
for B10.AQR. All subsequent lymphokine release experi ments utilized 
2xl05 MCMV-infected and uninfected MEF stimulators with 5xlo5 MCMV-
immune LN cells in a total volume of 200 ul. 
Kinetics of IL-3 release after stimulation of 
MCMV-immune LN cells with MCMV-infected or Uninfected MEF 
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The temporal relationship between antigenic stimulation and 
IL -3 release from MCMV-immune LN cells was examined, so that an 
appropriate time point for harvest of reaction supernatants could 
be chosen. 5xl05 BALB/c MCMV-immune LN cells were stimulated with 
2xl05 UV-irradiated MCMV-infected or uninfected BALB/c MEF in a 
total volume of 200 ul for 0, l, 2, 4, 6, 8, 14 or 23 hrs, after 
which time cell-free supernatants were removed and assayed for 
IL-3 levels. 
The results (Fig. 2) showed a maximum rate of increase in 
IL-3 titre between one and eight hrs after stimulation began. 
There was a further, slower increase in IL-3 titre until 14 hrs. 
With uninfected BALB/c MEF stimulators there was a maximum rate of 
increase of IL-3 titre from one to four hrs and a further, slower 
increase until 14 hrs, although the IL-3 titre reached was much 
lower than with infected MEF. 
For logistic reasons all reaction supernatants were harvested 
6 hrs after cell mixing in subsequent experiments. 
Effect of Thyl.2 and Lyt2 antiserum treatment of 
MCMV-immune LN cells upon their ability to release IL-3 
A batch of BALB/c MCMV-immune LN cells were harvested, divided 
into 4 equal portions and treated with C' alone, Thyl.2 antiserum 
and C', Lyt2 antiserum and C', or left untreated. Subsequently, 
the four populations of MCMV-immune LN cells were adjusted to the 
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same viable cell concentration (5xl0 5 cells/100 ul). For lympho-
kine stimulation 5xl05 MCMV-immune LN cells were mixed with 
2x105 MCMV-infected or uninfected BALB/c MEF in a total volume of 
200 ul. 
The results (Table 1) revealed that IL-3 release dependent 
upon recognition of MCMV-infected MEF involved Thyl.2, Lyt2+ 
immune LN cells, a phenotype similar to that of cytotoxic 
T lymphocytes. Thyl.2 antiserum plus complement treatment also 
resulted in a decrease in the IL-3 titre released upon stimulation 
with uninfected MEF or from MCMV-immune LN cells cultured alone, 
but Lyt2 antiserum and complement did not. These data suggest 
that Lyt2-, Thyl .2+ MCMV -immune T cells also exist and release 
IL-3, but that such T cells are not stimulated by MCMV-infected MEF . 
H-2 restriction of IL-3 stimulation 
MCMV-immune LN cells were obtained from the Bl0.T(6R) and 
CBA/H mouse strains. 5xl05 MCMV-immune LN cells from each strain 
were stimulated with 2xl05 MCMV-infected or uninfected MEF also 
derived from B10.T(6R) or CBA/H mice. The results (Table 2) showed 
that when the MCMV -immune LN cells and MEF stimulator cells were 
syngeneic, infected MEF stimulated considerably more IL-3 release 
than uninfected MEF. In contrast, when MCMV-immune LN cells and 
stimulator MEF were allogeneic, infected and uninfected MEF caused 
similar IL-3 release . These results are consistent with the inter-
pretation that IL-3 release can follow H-2 restricted recognition 
of MCMV antigens by MCMV-immune T cells. 
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Viral specificity of MCMV-immune LN cells 
BALB/c MCMV-immune LN cells and BALB/c influenza A/WSN-immune 
spleen cells were obtained and 5xl05 of each category of immune 
cells were stimulated with 2xl05 UV-irradiated MCMV-infected or 
uninfected BALB/c MEF and 2xl0 7 UV-irradiated influenza A/WSN-
infected or uninfected P815, in a total volume of 200 ul and 
assayed for IL-3 release (Table 3). Release of IL-3 above the 
levels caused by uninfected control stimulator cells only occurred 
when virus-infected stimulator cells were added to immune T cells 
primed with the same virus, i.e., the immune T cells were virus-
specific with respect to MCMV and influenza A/WSN . 
Lyt phenotypes and H-2 restriction patterns of MCMV-immune 
LN cells that mediate cytotoxicity and release lymphokines 
Previous experimentation revealed that the MCMV-immune LN cells 
generated according to the method described here were also cyto-
toxic to MCMV-infected MEF (5). Therefore, we investigated the 
phenotypic properties of the LN cell populations that were capable 
of lymphokine release or cytotoxicity. 
A batch of BALB/c MCMV-immune LN cells was harvested and 
divided into three portions 'tlhich were treated with C' alone, 
Lyt2 antiserum and C' or left untreated. Samples of each of the 
three portions were assayed for cytotoxicity on MCMV-infected or 
uninfected BALB/c MEF. A second sample of each of the three portions 
was suspended at 5xl06 cells/ml and 100 ul aliquots were removed 
and mixed with 2xlo5 MCMV-infected or uninfected BALB/c MEF in a 
total volume of 200 ul in a lymphokine release assay. 
The results (Table 4) indicated that cytotoxicity against 
MCMV-infected BALB/c MEF and the ability to release IL-3 upon 
stimulation with MCMV -infected BALB/c MEF were both largely 
dependent upon MCMV-immune LN cells of Lyt2+ phenotype. Lyt2 
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T cells were clearly not a prominent population in the assays used 
here. 
Further characterization of MCMV-immune LN cells was per-
formed by determining whether or not Class I H-2 antigens were 
capable of acting as the restriction element during assay for 
cytotoxic or lymphokine release functions. MCMV-immune LN cells 
from BALB/c and B10.AQR mice were harvested, pooled and then 
divided into equal portions such that each portion (l.2 ml) con-
tained MCMV-immune LN cells obtained from 6 LN. For assessment of 
cytotoxic activity a l/36 aliquot of the 6 LN equivalents were 
added to MCMV -infected or uninfected MEF target cells, whilst for 
lymphokine release assays 5xlo5 MCMV -immune LN cells were mixed 
with 2xl05 MCMV-infected or uninfected MEF in a total volume of 
200 ul. The infected or uninfected MEF used in both assays above 
were derived from BALB/c, CBA/H and Bl0.T(6R) mice. 
Cytotoxic activity (Table 5) against MCMV-infected MEF was 
above levels obtained on uninfected MEF when B10.AQR MCMV-i mmune 
LN cells were reacted with BALB/c and Bl0.T(6R) targets, but this 
was not observed with CBA/H targets. In fact, there was decreased 
cytotoxicity on MCMV-infected CBA/H MEF in comparison with 
uninfected CBA/H MEF. IL-3 release (Table 5) followed a similar 
pattern to that of cytotoxic activity, except for the finding that 
similar amounts of IL-3 were released in reactions with either 
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MCMV-infected or uninfected CBA/H MEF. The positive results 1n 
the B10.AQR-BALB/c combination showed that D region Class I H-2 
gene(s) code for restriction antigens involved in MCMV-specific 
T cell stimulation. Whether K region Class I H-2 genes are also 
involved has not yet been determined. The negative results for 
IL-3 release in the B10.AQR-CBA/H combination which shares 
Class II H-2 genes does not exclude the existence of Class II 
H-2-restricted anti-MCMV T cells, since MEF do not display Class II 
H-2 antigens (9). 
The effect of time after MCMV-infection upon the ability of 
MEF to stimulate IL-3 release from MCMV-immune LN cells 
Previous reports with ectromelia (10) and herpes simplex virus (HSV-1) 
(11) indicated that virus-induced antigenic changes recognised by 
cytotoxic T cells were expressed within 90 mins after viral adsorption. 
It was of interest to examine whether this was also the case for MCMV-
infected MEF with respect to their ability to stimulate IL-3 
release. 
BALB/c MEF were adsorbed with MCMV as described in the Methods, 
and incubated for 0, l, 2, 4, 6, 8, 16 or 23 hrs before trypsini-
zation, UV irradiation and utilization at 2xlo5 cells/100 ul to 
stimulate 5xlo5 BALB/c MCMV-immune LN cells in a total volume of 
200 ul. Uninfected BALB / c MEF stimulators were treated in a 
similar manner, except that virus was not adsorbed. Cell-free 
supernatants were harvested after 6 hrs an d assayed for IL-3. 
The results (Fig. 3) revealed maximum release of IL-3 from 
MCMV-immune LN cells when stimulated with syngeneic MEF infected 
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with MCMV for 8-24 hrs, but it seemed that there was antigen 
capable of stimulation by one hour post MCMV-infection, assuming 
that UV irradiation of the stimulator MEF arrested any further 
cell surface expression of MCMV antigens. 
Comparison of ability of different numbers of 3 hrs or 18 hrs 
MCMV-infected BALB/c MEF to stimulate IL-3 release from 
syngeneic MCMV-immune LN cells 
BALB/c MEF were infected with MCMV for either 3 hrs or 18 hrs 
prior to trypsinization and UV irradiation. These cells were 
resuspended at 2xlo7 cells/ml, twofold dilutions performed, and 
5xl•5 MCMV-immune BALB/c LN cells added to a total volume of 200 ul. 
After 6 hrs incubation cell-free supernatants were collected and 
assayed for IL-3. 
The results (Fig. 4) showed that for a fixed number of MCMV-
immune LN cells, 18 hrs MCMV-infected BALB/c MEF, at all cell 
numbers, were capable of stimulating more IL-3 release than 3 hrs 
MCMV-infected BALB/c MEF. The amounts of IL-3 released for 18 hrs 
MCMV-infected BALB/c MEF reached a plateau at 2.5-5.0xl05 cells/well, 
whereas 3 hrs MCMV-infected BALB/c MEF peaked at 5xl•5 cells/well. 
4~ 
.J 10 
With uninfected BALB/c MEF stimulators IL-3 titres were< 1.02. 
A 
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DISCUSSION 
It has been shown by other workers (12) that release of 
soluble T cell factors (generally termed lymphokines) from allo-
antigen -activated T cells is triggered by an antigenic signal. 
We have shown here that MHC-restricted, antiviral T cells release 
the lymphokine, IL-3 (a multipotential growth factor for lympho-
myeloid cells) when stimulated in vitro with syngeneic virus-
infected MEF and have conducted a detailed investigation of this 
phenomenon . 
Using MCMV - infection of mice as the model, it was shown that 
the release of IL-3 was dependent upon a Thyl . 2+, Lyt2+ immune 
LN cell population and that antigen recognition by those T cells 
was MCMV-specific and Class I H-2 restricted when MCMV-infected MEF 
were used as stimulator cells (Tables 1-3). These data are con-
sistent with, but do not prove, that the same T ~ells are capable 
of performing both cytotoxicity and IL-3 release functions . There 
is some precedent for this phenomenon in viral immunology, since 
anti - influenza A Lyt2+ cytotoxic T cell clones are capable of cyto-
toxicity and release of the lymphokine, gamma-interferon, upon 
stimulation with virus - infected MHC-matched stimulator cells (13). 
Proof that the same MCMV-immune T cells are capable of both 
functions awaits establishment of anti-MCMV cytotoxic T cell clones. 
evertheless, these investigations emphasize further that the 
Lyt2+ phenotype does not necessarily correlate only with the 
specific function of cytotoxicity as originally suggested by Cantor 
and Boyse (14). 
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The H-2 restriction pattern clearly indicated that H-2Dd acted 
as a restriction element for MCMV-immune T cells but we have not 
yet investigated H-2K antigens. Because MEF do not possess 
Class II antigens on the cell surface, these current experiments 
do not investigate the presence or absence of Class II-restricted 
MCMV-immune T cells. Data suggesting that Class II MHC-restricted 
Lyt2 anti-MCMV T cells were also present in immune LN cell 
populations will be the subject of a future report. 
Currently we are attempting to obtain cell populations that 
express Class II MHC and MCMV-specific antigens for use as stimu-
lators of IL-3 release or targets for cytotoxicity. 
With a fixed number of MCMV-imn1une T cells, sti~ulation 
with increasing numbers of MCMV-infected MEF caused a linear 
increase in IL-3 titres, plotted on log-log scale. It 1s 
noteworthy that this curve is typical of a single hit 
relationship between two interacting species. As IL-3 release is 
almost certainly dependent upon T cell-stimulator cell conjugate 
formation the curve can be easily explained by assuming that one 
stimulator cell is sufficient to trigger IL-3 release from one cell. 
Thus the early region of the curve represents T cell excess and 
IL-3 titre is directly proportional to the number of stimulator 
cells added whilst the plateau results from the maximum stimulation 
of all antigen-reactive T cells. This simple behaviour is not 
always the case as some alloreactive T cell-stimulator cell 
combinations display more complex kinetic characteristics 
(P. Hodgkin, unpublished results ) . The reaso ns for the decreased 
IL-3 titre produced at high MCMV-infected MEF numbers is unclear, 
but may reflect in vitro artefact rather than the release of 
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inhibitors during the 6 hrs assay period, because no evidence for 
inhibitor production was seen for up to 24 hrs of interaction 
between T and stimulator cells (Fig. 2). 
The effect of different time intervals between infection of 
MEF with MCMV and their utilization as stimulators of MCMV-
immune T cells is of interest. The results indicated that as time 
after MEF infection was increased, the capacity to stimulate IL-3 
release from MCMV-immune T cells was increased (Fig. 3). Three 
possible explanations for this phenomenon are proposed . l. The 
rate of lymphokine release can vary with the amount of antigenic 
stimulus received by the T cell. As antigen per stimulator cell 
increases the rate of IL-3 release is increased. 2. The MCMV-
immune T cell population is heterogeneous with a proportion of 
cells capable of recognising 11 early 11 expressed MCMV antigens. At 
later times the cummulative effect of T cell stimulation by all 
MCMV antigens is seen. 3. At early times less MEF are expressing 
MCMV antigen and therefore more 3 hrs MCMV-infected stimulators are 
required to achieve equivalence with the number of stimulators 
present in the 18 hrs MCMV-infected MEF population. Theoretically 
it is possible to distinguish model l and 2 from model 3 from a 
study of the antigen dose-response characteristics. Models l and 2 
predict that in the plateau region of antigen excess a difference 
will be seen between 3 hrs and 18 hrs MCMV-infected stimulator 
induced lymphokine release. For model l this difference would 
reflect the different rate of lymphokine release and for model 2 
it would indicate the proportion of 11 early 11 -antigen reactive 
T cells versus the total number of T cells triggered by MCMV 
antigens. Model 3 on the other hand predicts that 3 hrs MCMV-
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infected stimulators when added in excess will reach the same 
plateau level as for 18 hrs MCMV-infected stimulators. The results 
(Fig. 4) indicated the attainment of different plateaux which argue 
against model 3. Further investigation is required to distinguish 
between models l and 2. 
The relevance of these 1n vitro findings to the in vivo 
immunobiology of MCMV and other viral infections requires further 
study. Until the recent report of IL-3 gene cloning (15), this 
product was obtained in small amounts of variable purity from the 
myeloid leukemic cell line WEHI-3B (16), lectin-activated T cells 
(17), alloantigen-activated T cells (18) or viral antigen-activated 
T cells (19). This has limited investigations of in vivo function 
and therefore specific questions related to IL-3 release from 
virus-immune T cell populations and its effects upon haemopoietic 
function and immunobiology of various viral infections awaits an 
understanding of the general biology of this glycoprotein. 
Nevertheless, the role of IL-3 as a member of a class of glyco-
proteins known as CSF has been well established in vitro. It 
stimulates a wide range of lymphoreticular stem cells and some of 
their more differentiated progeny, and consequently on the basis of 
these biological activities, has been given several names which 
include burst-promoting activity (20), P-cell-stimulating factor 
(21), mast cell growth factor (22), haemopoietic cell growth 
factor (23), histamine-producing cell-stimulating factor (24) and 
multicolony-stimulating factor CSF (25). 
Concanavalin-A-stimulated T cell hybridomas are capable of 
liberating more than one lymphokine (26). Therefore it would seem 
important to investigate the spectrum of lymphokines (e.g., gamma-
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interferon, IL-2, B cell growth factor) produced by antiviral 
T cell populations (and clones) of different Lyt phenotypes and 
different MHC restriction patterns in different model infections. 
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SUMMARY 
MCMV-immune LN cells were generated following 4 days culture 
of draining popliteal LN cells removed after bilateral hind f.p. 
inoculation of mice with 4xl02 p.f.u. MCMV. This cell population 
expressed both cytotoxic activity against MCMV-infected MEF and 
the capacity to release lymphokine upon stimulation with MCMV-
infected MEF. Cytotoxicity and lymphokine release were Class I, 
H-2 restricted, viral specific and dependent upon Thyl.2+, Lyt2+ 
cells . 
Mixing of 5xl05 MCMV-immune T cells with an excess of syngeneic 
MCMV-infected MEF stimulators produced detectable levels of the 
lymphokine, IL-3, by 1 hr, a maximum rate of IL-3 release between 
1-6 hrs and plateau levels by 14 hrs. 
The capacity to stimulate virus-specific MCMV-immune T cells 
was acquired by MEF at 1 hr post MCMV-infection with maximum 
stimulator ability attained by 8 hrs. In the presence of a fixed 
number of MCMV-immune T cells, and titration of syngeneic 3 hrs or 
18 hrs MCMV-infected MEF to excess, lower IL-3 plateau levels were 
obtained with 3 hrs than with 18 hrs MCMV-infected stimulators. 
This suggested that fewer T cells responded to 3 hrs than to 18 hrs 
MCMV-infected MEF. 
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Fig. 1. 5 
Curve showing the increase in IL-3 release from 5xl0 B10.AQR, 
MCMV-immune L cells caused by increasing numbers of MCMV-infected 
( 6 ) or uninfected (Q) syngeneic MEF stimulator cells. Each 
point represents the mean of quadruplicates+ S.D. of the IL-3 
titre, for supernatants harvested after 6 hrs at 37°c. ( 9) IL-3 
titre was below detc~~ion levels. S.D. are so small that they 
cannot be seen outside the points. 
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Fig. 2. 5 
Kineti cs of IL -3 release from 5xl0 BALB/c MCMV-immune LN cells 
sti mul at ed wi th 2xl05 MCMV - infected ( 6 ) or uninfected ( Q ) syn -
gene ic MEF. Each point represents the mean of quadruplicates+ S. D. 
of the IL-3 titre for supernatants harvested after the interaction 
times indicated . Where no S.D . bars are shown the deviations were 
not outside the points . 
TABLE 1 
Effect of Thyl.2 and Lyt2 antiserum plus C' treatment of 
MCMV-immune L cells* upon their ability to release IL-3 
BALB/c MCMV-immune 
LN cell treatments 
Nil 
C' alone 
Thyl .2 antiserum+ C' 
Lyt2 antiserum+ C' 
BALB/c MEF stimulator cells 
MCMV -infected Uninfected T cells alone § 
2.81 + 0.05 
2.82 + 0.03 
1.03 + 0.02 
1.86 + 0.03 
+ 1.52 + 0.02 1.66 + 0 
1.29 + 0 1.42 + 0 
0.77 + 0.05 0.70 + 0 
1.62 + 0 1.78 + 0 
* C~V-immune LN cells were generated as described 1n Materials 
and Methods . 
lo~.o + IL-3 titre from 5xl05 MCMV - immune LN cells added to 
2xl05 MCMV -infected or uninfected MEF for 6 hrs at 37°c. 
Data given are the means of quadruplicates+ S.D. 
§ 5xlo5 BALB/c MCMV-immune L cells were suspended in 200 ul 
without syngeneic MCMV -infected or uninfected MEF for 6 hrs 
at 37°c. 
TABLE 2 
H-2 restriction of stimulation of IL-3 release from MCMV-immune LN cells* 
MEF stimulator cells (H-2 map) t 
MCMV-immune 
LN cells 
CBA/H 
B10.T(6R) 
* + As for Table 1 
CBA/H (kkkkkkk) 
MEF-infected 
2. 19 + 0.03 + 
2. 15 + 0.02 
Uninfected 
1.40 + 0.02 
2.24 + 0.05 
t H-2 map for K, Aa, A~, E6, J, Ea and D genetic regions. 
B10.&(6R) (qqqqqqd) 
MCMV-infected 
1.55 + 0.02 
2.60 + 0.05 
Uninfected 
1. 47 + 0 
1.04 + 0.03 
TABLE 3 
Viral specificity of stimulation of IL-3 release from MCMV- or Influenza-immune T cells 
Virus-immune* 
T cells 
MCMV-immune 
LN cells 
Influenza A/vJS N-
imm une spleen cells 
MCMV-infected 
BALB/c MEF 
2.64 + 0.03 t 
1.03 + 0.02 
Stimulator Cells 
Uninfected 
BALB/c MEF 
0.94 + 0.04 
1.20 + 0.02 
A/WSN-infected 
P815 
1.20 + 0.03 
2.43 + 0 
Uninfected 
P815 
l. 13 + 0.03 
1.20 + 0.06 
* MCMV-immune LN cells were generated as in Table 1. Influenza A/WSN-immune cells were obtained by 
in vitro restimulation of influenza A/WSN-primed spleen cells (Yap & Ada, 1977). 
+ As for Table l. 
TABLE 4 
Effect of Lyt2 antiserum and C' treatment upon cytotoxicity and IL-3 release 
mediated by MCMV-immune LN cells* 
BALB/c MCMV-
immune LN cell 
treatments 
Nil 
CI al one 
Lyt2 + C' 
* + As for Table l 
% Lysis § 
BALB/c MEF targets 
MCMV-infected 
72.5 + 2.9 
61.4 + 0.5 
ll.3 + 0.5 
Uninfected 
17.8 + 0.5 
9.9 + 0.3 
6.0 + 0.2 
IL-3 Titre+ 
BALB/c MEF stimulator cells 
MCMV-infected 
2.03 + 0. ll 
2. 19 + 0.08 
0.93 + 0 
Uninfected 
0.72 + 0 
0.60 + 0 
0.60 + 0 
§ The % lysis values are the means+ standard errors of the mean of 3 replicates obtained by the addition of 
a l/36 aliquot of cultured cells, obtained from 6 BALB/c popliteal LN, onto targets. 
TABLE 5 
H-2 restriction pattern of the cytotoxic and IL-3 release functions of target and stimulator cells 
Strain of MCMV-
immune LN cells* 
(H-2 map)t 
BALB/c 
(d d d d d d d) 
B10.AQR 
(q k k k k k d) 
Effector 
function 
BALB/c MEF 
(d d d d d d d) 
MCMV-
infected Uninfected 
% l ys is § 71 . 0 + 3 . 9 ll.4 + l.5 
IL-3 + 
titre 3.34 + 0.04 1.28 + 0.02 
% lysis 
IL-3 
titre 
65.5 + l. l 
3.3 + 0 
28.4 + 6.9 
1.59 + 0.04 
* + t As for Tables l and 2. 
§ % lysis values as for Table 4. 
CBA/H MEF 
(k k k k k k k) 
MCMV-
infected Uninfected 
Bl0.T(6R) MEF 
(q q q q q q d) 
MCMV-
infected Uninfected 
2.39 + 0. ll 2. 19 + 0.04 2.81 + 0.06 l .47 + 0 
38.0 + l.8 67.0 + 0.8 52.7 + 2.6 14.9 + 0.2 
2.81 + 0.02 2.75 + 0.02 2.93 + 0.02 0.87 + 0 
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Fig . 3. 5 
Curve indicating IL-3 release from 5xl0 BALB/c MCMV - immune LN cells 
when stimulated with 2xlo5 syngeneic MEF infected with MCMV for the 
times indicated ( 6 ) . Uninfected syngeneic MEF stimulators ( 0 ) . 
Each point represents the mean of quadruplicates+ S.D. of the IL-3 
titre for supernatants harvested after 6 hrs at 37°c . S. D. are so 
small that they cannot be seen outside the points. 
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Fig. 4. 5 
Curve showing IL-3 release from 5xl0 BALB/c MCMV-immune LN cells 
produced by increasing numbers of MCMV-infected syngeneic MEF 
infected for 18 hrs (6,) or 3 hrs ( D) prior to use as stimulators. 
Uninfected syngeneic MEF are not shown for reasons of clarity but 
L-3 titres were 1.02. Each point represents the mean of quad-
ruplicates+ S.O. of the IL-3 titre for supernatants harvested after 
6 hrs at 37°c. Where no S.O. bars are indicated the deviations 
were not outside the points. 
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CHAPTER 5 
The Cytotoxic Response to Murine Cytomegalovirus (MCMV). 
IV. Requirements for the generation of 
MCMV-specific target cells 
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INTRODUCTION 
It has been well-defined that T cells are important in 
recovery from acute viral infections (Blanden 1974, Ada et al. 
1981) and that these T cells are both H-2 restricted and virus 
specific (Kees & Blanden 1976). As an approach to the 1mmuno-
biology of viruses that cause latent infections, the T cell 
response to murine cytomegalovirus (MCMV) was investigated. 
Previous reports (Sinickas et~- in press) showed that hind foot-
pad inoculation of mice with MCMV, removal of popliteal lymph 
node (LN) cells at day 7 and subsequent culture of these LN cells 
for 4 days, was a reliable method for the generation of MCMV -
immune T cells. One functional characteristic of this immune-T 
cell population, cytotoxicity, was then utilised to study the 
requirements for generation of MCMV -specific target cells. 
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MATERIALS AND METHODS 
Mice. BALB/c, C57Bl/6J and WEHI-3 mice, 6-12 weeks of age 
were obtained from the Animal Breeding Establishment of the 
John Curtin School of Medical Research. 
Viruses. Standard methods were used for the preparation of 
salivary gland stock of the Smith strain of MCMV (Sinickas et al. 
--
1985, in press). Tissue culture passaged Smith strain MCMV was 
prepared by modification of a described method (Ebeling et~-
1983). Briefly, secondary mouse embryo fibroblasts (MEF) were 
seeded into 30 cm2 plastic petri dishes (Cat. No. P.D.S. 6515H, 
Kayline Plastics, Thebarton, S.A., Australia) at 106·0 cells in 
10 ml of Dulbecco's Modified Eagle's Medium (Cat. No. Hl6, GIBCO, 
Grand Island, N.Y., U.S.A.)supplemented with 5% foetal calf serum 
(FCS) (Flow Labs, Stanmore, N.S.W., Australia), 200 ug/ml 
Streptomycin, 200 U/ml Penicillin G and 125 ug/ml Neomycin 
sulphate (antibiotics) (the complete medium is referred to hereafter 
as DMEM) in an atmosphere of 10% CO2, 7% o2 and 83% N2 (special 
gas) (Commonwealth Industrial Gases, Alexandria, N.S.W., Australia) 
and infected 20 hrs later with 0.5 plaque forming units (p.f.u.)/ 
cell of salivary gland stock MCMV in 0.8 ml. The adsorption 
protocol involved centrifugation at 800g for 20 mins at room 
temperature and an additional 40 mins at 37°c in special gas. 
Subsequently the cells were trypsinised and added to trypsinised 
uninfected secondary MEF at a ratio of l:100. This cell suspension 
was seeded at 107· 18 cells/60 ml DMEM into 175 cm2 tissue 
culture flasks (Nunc, Roskilde, Denmark), and incubated at 37°c 1n 
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special gas. Two days later cytopathic effects were seen in 
monolayers and after 3 days all the cells were detached from the 
tissue culture flask. The cells and culture fluid were collected 
and centrifuged at 22,000 rpm for 2 hrs at 40C (Beckman SW27 rotor). 
The pellet was resuspended in DMEM at l/20 of the original volume 
and sonicated for 60 secs at 50 cps (Sonifier Bl2, Branson Sonic 
Power Company, Danbury, Conn., U.S.A.). All aliquots were 
stored at -7o0c. 
Concanavalin-A-stimulated spleen cell supernatant (CSS). 
This was prepared as previously described (Sinickas et al. 1985, 
--
in press) using spleen cells from WEHI-3 mice. 
Cell culture. Mouse embryo fibroblasts and the continuous 
cell line BALB/c-3T3 were cultured as previously described 
(Sinickas et~- 1985, in press). The DBA/2 mastocytoma cell 
line P-815-X2 (P815) was cultured 1n DMEM at 37°c in special gas 
atmosphere. Similar conditions were utilised for the murine 
macrophage cell line PU5-l.8, except that the medium was 
supplemented with l0-4M asparagine. The Interleukin-3 (IL-3) 
dependent cell line, FDC-Pl, was grown in RPMI-1640 (Cat. No. 
10-601-20, Flow Labs Inc., Maclean, Virginia, U.S.A.) supplemented 
with 5% heat-inactivated FCS (HI-FCS) and 10% WEHI-3B cell line-
conditioned medium (kindly provided by Dr. A.J. Hapel). 
Cytotoxicity assays. Peritoneal cell s (PEC) were harvested 
using 10 ml ice-cold Puck's saline from mice inoculated intra-
peritoneally with 2 ml of 3% wt/vol thioglycollate medium 
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(DIFCO Labs, Michigan, U.S. A. ) 5 days previousl y. The cells were 
centrifuged at 600g for 5 mins and resuspended in Eagle's Minimal 
Essential Medium (EMEM) (Cat. 1 o. F15, GIBCO, Grand Island, N.Y . , 
U. S.A.) supplemented with 10% FCS and antibiotics (Assay medium) 
at the required cell concentration. After 60 mins viral adsorption 
0 51 51 at 37 C in 5% CO2, 600 uCi Na2[ Cr ]o4 ( Cr) (Amersham Int. Ltd., 
Amersham, U.K.) 1n l ml of assay medium was added and the cells 
reincubated for a further 60 mins. The cells were then washed 
twice with assay medium, reincubated at 370C in 5% co2 for 60 mins, 
washed again, concentration adjusted to 105· 3 cells/ml and 
100 ul aliquots dispensed into flat-bottomed 96 well trays (Nunc, 
Roskilde, Denmark). Subsequently, 100 ul of MCMV-immune LN cells 
were added . 
For P815 target cells, 106· 0 cells were infected with MCMV 
at a multiplicity of infection (MOI) of 5 p. f.u./cell 1n a total 
volume of 1.4 ml DMEM at 37°c in special gas for 60 mins. 
Subsequently 3.6 ml DMEM containing 6 uCi/ml of 51 cr was added 
and incubation continued under conditions described for PEC. 
After 16 hrs the cells were washed twice with DMEM and resuspended 
at 105· 3 cells/ml . 100 ul aliquots of cell suspension were 
added to 96-well round-bottomed microtitre trays followed by 100 ul 
of MCMV - immune LN cells. 
For PU5-l.8 target cells, 105· 7 cells were adsorbed with MCMV 
at a MOI of 5 p.f.u. / cell in a total volume of 600 ul DMEM at 
370C in special gas for 60 mins. Subsequently 2.5 ml of DMEM 
containing 6 uCi/ml of 51 cr was add ed an d i nc ubation continued 
for 16 hrs. All further manipulations were as for P815 cells. 
For MEF and BALB / c-3T3 targets the protocol was usually 
unchanged from that described previously (Sinickas et al. 1985, 
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1n press). 
Where the infection protocol was altered the changes are 
described in the Results section. 51 cr release from the targets 
was assayed, unless otherwise stated, after a 10 hrs incubation at 
37°c by gamma emissions and lysis calculated using the following 
formula: 
% lysis of infected or uninfected targets= 
51 . 51 Cr counts 1n presence Cr counts released 
of effector cells 
51 cr counts water-lysed 
targets 
51 
in medium 
Cr counts released 
in medium 
% lysis = % lysis infected targets - % lysis uninfected targets. 
Generation of antiviral and alloreactive T cells. 
A previously described protocol for MCMV-immune T cell 
(Sinickas et~- 1985,in press) generation was used. Briefly, 
BALB/c female mice were inoculated into both hind footpads (f.p.) 
with either 102· 6 or 104· 6 p.f.u. MCMV. At 7 days post-inoculation 
the draining popliteal lymph node (LN) cells were removed and 
cultured for 4 days. Subsequently, these cells were harvested, pooled 
and divided into portions equivalent to the cells obtained from 
6 MCMV-stimulated LN and added to different target cells in 
cytotoxicity assays. 
Alloreactive T cells were generated according to a published 
method (Woolnough & Lafferty 1979). 
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Preparation of stimulator cells for lymphokine production. 
Secondary MEF were subcultured into 30 cm2 plastic dishes 
(Cat. No . P.D.S. 6515H, Kayline Plastics, Thebarton, S.A., 
Australia) at 106 ml D~E , supplemented with or without 
3% vol/vol CSS/dish. The cells were incubated for 2 days at 
37°c in special gas, washed, fresh medium without CSS added and 
16 hrs later, trypsinized and resuspended in DMEM at 106 cells/ml. 
Ten ml aliquots were then added to 65 cm2 plastic petri dishes 
(Cat . No . 992550, Medical Plastics, Edwardstown, S.A., Australia) 
and subjected to ultraviolet (UV) irradiation from an 80 watt 
germicidal lamp for 4 mins at an intensity of 960 uW/cm2 1n the 
230/270 nm range. These cells were then washed twice and 
resuspended at an appropriate concentration in EMEM supplemented 
with l0-4M 2-mercaptoethanol (2ME). Aliquots of 0. l ml were dis-
pensed into 96-well flat-bottomed trays (Nunc, Roskilde, Denmark). 
Serial twofold dilutions were prepared prior to addition of allo-
reative T cells. 
Conditions for stimulation of lymphokine production. 
Alloreactive T cells were harvested, washed twice and resuspended 
in EME M supplemented with l0-4M 2ME at 5xl06 cells/ml . 
100 ul aliquots were dispensed into 96-well flat-bottomed plates 
containing 100 ul aliquots of CSS treated or untreated stimulator 
MEF cells. Duplicates of these cell mixtures were incubated at 
37°c in special gas mixture for 6 hrs, after which time cell-free 
supernatants were removed and stored at -20 C until assayed for 
IL-3. 
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IL-3 assay. IL-3 activity was assayed by measuring the ability 
of lymphokine preparations to maintain in vitro proliferation of 
the IL-3-dependent FDC-Pl cell line. After a period of 16-24 hrs 
without IL-3, PDC-Pl cells cease dividing. Serial twofold 
dilutions of the test supernatants were prepared in 96-well flat-
bottomed plates (Linbro Cat. No. 76-203-05, Flow Labs Inc., 
Maclean, Virginia, U.S.A.) with 50 ul RPMI-1640 plus 5% heat-
inactivated FCS (HI-FCS) as diluent. Subsequently, 50 ul of a 
FDC-Pl cell suspension (4xl05) was added to each culture well. 
Control preparations consisted of 48 replicate cultures containing 
50 ul of the FDC-Pl cell suspension and 50 ul of RPMI supplemented 
with 5% HI-FCS. The cultures were incubated at 37°c for 16-20 hrs 
in 5% co2, after which time 50 ul of [Methyl-
3H]-thymidine 
(Amersham Int. Ltd., Amersham, U.K.) (25 uCi/ml) were added and 
incubation continued for a further 5 hrs. [Methyl-3HJ-thymidine 
incorporation was then determined by harvesting the cells onto 
glass fibre paper using a MASH II multiple sample harvester 
(Microbiological Associates, Bethesda, Md., U.S.A.). The dried 
samples of glass fibre paper were placed into 7 ml of scintillation 
fluid and beta-emission counted in a liquid scintillation counter 
(Tricarb, Packard Instrument Co., Downers Grove, Ill., U.S.A.). 
All samples were assayed in duplicate. The titration endpoint 
was set at three standard deviations above the mean control level 
of [Methyl-3H]-thymidine uptake, according to a previously 
described method (Lafferty et al. 1980). 
--
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RESULTS 
Susceptibility of different H-2d MCMV-treated target cells to 
lysis by BALB/c (H-2d) MCMV-immune T cells 
A batch of MCMV-immune T cells were harvested and aliquots 
added to different target cells in cytotoxicity assays. Two 
experiments were conducted in which BALB/c MCMV-infected MEF were 
used as positive controls in comparison with MCMV-treated and 
untreated H-2d haplotype P815, PUS-1.8 and BALB/c-3T3 cells. 
Under the conditions used MCMV-treated BALB/c MEF were the 
targets most susceptible to lysis by MCMV-immune T cells over and 
above untreated control target cells (Table 1). 
Ways of improving the peformance of MEF as target cells were 
then investigated, based on the knowledge that expression of both 
host cell H-2 antigens and viral antigens on infected MEF are 
required for T cell recognition. 
The effect of BALB/c MEF culture 1n CSS-supplemented medium 
upon susceptibility to lysis by alloreactive T cells 
~-interferon, known to be present 1n CSS, can increase H-2 
antigen expression on the cell surface (Wong et~- 1983) thus 
increasing the sensitivity of the cell to recognition and lysis by 
T cells (O'Neill & Blanden 1979). BALB/c MEF were grown in DMEM 
supplemented with or without 3% vol/vol CSS for 48 hrs, then 
washed with DMEM and incubated for a further 16 hrs prior to 
utilisation as targets in cytotoxicity assays using C57Bl / 6J-
104 
anti-BALB/c T cells. 
Exposure to CSS significantly enhanced the susceptibility of 
target cells to lysis by alloreactive cytotoxic T cells, at all 
effector:target ratios (Table 2). 
Effect of BALB/c MEF culture in CSS-supplemented medium 
upon the ability to stimulate IL-3 release 
from alloreactive T cells 
BALB/c MEF were grown 1n DMEM supplemented with or without 
3% vol/vol CSS for 48 hrs, then washed with DMEM and incubated for 
a further 16 hrs prior to utilisation as stimulator cells in 
IL-3 assays. 105· 7 C57B1/6J-anti-BALB/c T cells were mixed with 
different numbers of CSS-treated or untreated BALB/c MEF, starting 
at 104· 2 cells with 0.3(log 10) increments up to 106· 3 cells in a 
total volume of 0.2 ml and incubated at 37°c in special gas for 
6 hrs. Subsequently, cell-free supernatants were removed and 
assayed for IL-3. 
The results (Fig. 1) showed that CSS-treated BALB/c MEF 
stimulated higher maximum levels of IL-3 from a fixed number of 
alloreactive T cells than did untreated BALB/c MEF . Fewer 
CSS-treated BALB/c MEF stimulators than untreated MEF were 
required to stimulate the same IL-3 titre. Also, the increase 1n 
IL-3 titre per unit increase in the number of BALB/c MEF stimulators 
was larger with CSS-treated BALB/c MEF than with untreated BALB/c 
MEF . 
Taken together the data in Table 2 and Fig. 1 strongly suggest 
that CSS treatment of MEF enhances their recognition by T cells. 
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Effect of centrifugation during viral adsorption upon 
susceptibility of MC V-infected BALB/c MEF target cells to 
lysis by syngeneic CV-immune T cells 
Tertiary MEF cultured in CSS supplemented DMEM were 
adsorbed with 25 ul of salivary gland stock of MCMV diluted 1:8 1n 
DMEM, with or without concomitant centrifugation at 800g for 20 m1ns 
at room temperature . A further 40 mins incubation at 37°c in 
special gas completed the adsorption protocol . In cytotoxicity 
assays, aliquots of MCMV - immune T cells were mixed with syngeneic 
16 hrs, MCMV - infected MEF . For uninfected MEF targets the 
protocols were similar except that 25 ul DMEM was added during the 
adsorption phase. 
Centrifugation of MEF and MC~V suspension during the viral 
adsorption phase significantly enhanced susceptibility to lysis of 
MCMV - infected BALB/c MEF (Table 3). 
The effect of CSS supplemented culture medium upon 
susceptibility of MCMV -infected or uninfected 
BALB/c MEF to lysis by syngeneic MCMV-immune T cells 
Tertiary MEF were cultured in DMEM supplemented with or 
without 3% vol/vol CSS for 2 days prior to infection using the 
centrifugation protocol with l :8, 1:16 and 1:32 dilution of 
salivary gland MC V stock 1n DEM . Sixteen hours after adsorption 
MC V- infected r EF targets were mixed with aliquots of ~C~V -i mmune 
L cells. Uninfected 1EF were treated in a similar manner except 
for lack of viral adsorption. 
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The results (Fig. 2) showed that lysis of MEF cultured with 
CSS was greater than untreated MEF provided the MCMV stock was 
used at 1:8 or 1:16 dilutions. 
Kinetics of 51 cr release from MCMV-infected and uninfected 
BALB/c MEF after addition of syngeneic MCMV-immune T cells 
Aliquots of BALB/c MCMV -immune T cells were added to MCMV-
infected or uninfected syngeneic MEF. Twenty-five ul aliquots of 
cell-free supernatant were removed 0, 2, 4, 6 and 10 hrs after 
mixing of MCMV-immune T cells and MEF targets. 
The results (Fig. 3) showed the rate of 51 cr release from 
MCMV-infected MEF was directly proportional to the number of MCMV-
immune T cells added. The maximum rate of 51 cr release was 
achieved using either 1/12 or 1/36 fraction of cultured LN cells. 
The kinetics of 51 cr release for cytotoxicity obtained with 
uninfected MEF also revealed that the rate of 51 cr release was 
directly proportional to the number of MCMV-immune T cells added 
to uninfected MEF . By 10 hrs, lysis of uninfected MEF was sub-
stantial at the higher effector:target ratios, and threatening to 
overtake lysis of infected MEF . Therefore, 10 hrs assays were 
used for MEF . 
Events contributing to 51 cr release over the 10 hrs interval 
include (a) development of virus-induced antigenic changes on the 
surface membrane of MEF; (b) contact between target MEF and 
effector T cells; (c) lysis of the target leading to 51 cr release. 
The contribution of (a) above was examined further. 
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The effect of time after MCMV adsorption upon susceptibility of 
MCMV-infected BALB/c MEF to lysis by syngeneic MCMV-immune T cells 
BALB/c MEF cultured in CSS-supplemented DMEM were washed and 
adsorbed with 25 ul salivary gland stock of MCMV diluted 1:8 in 
DMEM containing 51 cr using the centrifugation protocol. At 0, 2, 
4, 18 or 24 hrs after adsorption, the MEF were washed and 100 ul 
of MCMV-immune T cells added. The reaction vessel was then centri-
fuged for l minute at 800g to promote rapid contact between 
effector and target cells and incubated for 45 mins at 37°c 1n 
special gas to allow target lysis to be initiated. Subsequently, 
100 ul of DMEM supplemented with 0.04M EDTA was added to stop 
effector cell action, incubation continued at 37°c in special gas 
and after 4 hrs, 100 ul of cell-free supernatant removed and 
assayed for gamma em1ss1ons. A control assay was performed in 
which 100 ul of MCMV-immune T cells were mixed with 18 hrs MCMV-
infected BALB/c MEF and 100 ul of DMEM supplemented with 0.04M EDTA 
added immediately. The remainder of the assay was performed as 
described. All infection times were calculated from the end of 
the viral adsorption phase and up to the time of MCMV-immune T cell 
addition; but do not include the 4 hrs 51 cr release phase. 
The results showed that BALB/c MEF infected with MCMV for 
2 hrs were susceptible to lysis by MCMV-immune T cells (Table 4). 
Susceptibility was increased by 4 hrs and was not significantly 
higher by 18 hrs post MCMV infection. Immediate addition of DMEM 
supplemented with 0.04M EDTA to the centrifuged mixture of MCMV-
immune T cells and 18 hrs MCMV-infected BALB/c markedly diminished 
the amount of 51 cr released thus confirming the efficiency of EDTA 
in terminating effector T cell action. 
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Susceptibility of BALB/c MEF and PEC infected with salivary gland 
stock MCMV to lysis by syngeneic MCMV-immune T cells 
Since PEC have been successfully used as target cells with 
other viruses (Zinkernagel & Doherty 1975), they were investigated 
in the present series of experiments. 105· 7 BALB/c PEC in 300 ul 
assay medium were added to 300 ul of 1/4, 1/8, 1/16 or 1/32 dilu-
tions of salivary gland stock of MCMV (107· 3 p.f.u./ml) in DMEM 
for l hr adsorption at 37°c in 5% CO2. The cells were then used 
as target cells in a 6 hrs cytotoxicity assay with BALB/c MCMV-
immune T cells. Control BALB/c MEF target cells were either 
untreated or infected with a 1/8 dilution of salivary gland stock 
MCMV in DMEM using the centrifugation protocol and incubated for 
16 hrs prior to addition of MCMV-immune T cells. 
Control MCMV-infected BALB/c MEF were susceptible to lysis 
by syngene1c MCMV-immune T cells (Table 5) whereas MCMV-treated 
PEC were not . 
Susceptibility of BALB/c PEC treated with tissue culture stock of 
MCMV to lysis by syngeneic MCMV-immune T cells 
105· 7 BALB/c PEC in 125 ul assay medium were added to l ml of 
neat, 1/3 or 1/9 dilution of tissue culture stock MCMV 
(106· 3 p.f.u./ml) in OMEM for 1 hr adsorption at 37°c in 5% CO2. 
The subsequent steps were identical to the protocol described for 
salivary gland stock MCMV adsorption to PEC. Control BALB/c MEF 
were either untreated or infected with a 1/8 dilution of salivary 
gland stock of MCMV (107· 3 p.f.u./ml) in DMEM using the centrifuga-
tion protocol and incubated for 16 hrs prior to addition of 
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MCMV-immune T cells. Six hours after m1x1ng of target and effector 
cells, cell-free supernatants were harvested and assayed for gamma 
em1ss1ons. 
PEC treated with tissue culture stock of MCMV were lysed by 
MCMV-immune T cells (Table 6). The amount of cytotoxicity was 
improved by increased viral input. 
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DISCUSSION 
Initial experiments compared susceptibility to lysis by 
MCMV-immune T cells of MEF treated with salivary gland stock of 
MCMV and similarly treated BALB/c-3T3, P815, PU5-l.8. MEF were 
superior to the other cells tested for the detection of lysis of 
MCMV-treated target cells above the lysis obtained on untreated 
cells . Consequently, MEF and salivary gland MCMV were the starting 
point for the further manipulation of conditions that resulted in 
changes in susceptibility of infected MEF to T cell-mediated lysis. 
Since antiviral T cell function is dependent upon the recogni-
tion of H-2 and viral antigens (Zinkernagel & Doherty 1979), 
procedures calculated to improve the expression of these antigens 
on target or stimulator cells were investigated. Culture of 
various cell lines in medium supplemented with CSS increases 
H-2 antigen levels, as measured by increased surface binding of 
fluorescein labelled anti-H-2 antibodies (Wong et~- 1983). 
In our hands culture of MEF in CSS supplemented DMEM similarly 
increased binding of fluorescein labelled antibody specific for 
Class I H-2 antigens (King et~-, in press). 
That this phenomenon also reached physiological significance 
for target T cell interactions was suggested by the increased 
susceptibility of CSS-treated MEF compared with untreated MEF to 
lysis by alloreactive T cells (Table 2). Since at a fixed 
effector:target ratio more 51 cr was released from CSS-treated than 
from untreated MEF it appeared that CSS treatment of MEF caused 
more alloreactive T cell- EF interactions to result in lytic events. 
1 1 1 
This increased susceptibility to lysis was maintained for at 
least 16 hrs after removal of CSS-supplemented medium (data not 
shown) . Although it is not possible to exclude that the enhanced 
levels of apparent lysis are merely an indication of a physio-
logical alteration in 51 cr release, the increased ability of 
CSS - treated MEF to stimulate IL - 3 release from T cells (Fig. 1) 
makes this explanation unlikely. 
For a fixed number of alloreactive T cells, CSS-treated MEF 
stimulated more IL-3 release than untreated MEF. In addition, 
more IL -3 was released for each unit increase in the number of 
CSS-treated MEF stimulators compared with untreated MEF (Fig. 1). 
These observations suggest that more alloreactive T cell-stimulator 
cell interactions resulted in IL-3 release or that more IL-3 per 
T cell was released by stimulation with CSS-treated MEF than 
untreated controls . 
Since genetically determined differences in H-2 antigen 
expression of a magnitude similar to those produced by CSS treat-
ment lead to differences in T cell-mediated lysis of target macro-
phages, or stimulator ability of splenocytes (O'Neill & Blanden 
1979) it seems likely that increased H-2 antigens expressed on 
CSS-treated MEF (King et~- , in press) led to their improved 
recognition by T cells. 
The total number of MEF susceptible to lysis by MCMV - immune 
T cells and the amount of 51 cr released at a given effector:target 
ratio were increased if MEF were adsorbed with MCMV under centri-
fugation (Table 3). This may be explained by an increase in the 
number of virions entering each MEF under centrifugation 
(Osborn & Walker 1968) but other unknown factors may be involved. 
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Viral titrations undertaken using the centrifugation protocol 
showed increased MCMV-immune T cell-mediated lysis of infected 
MEF targets with increasing virus input into the target cells 
(Fig. 2) particularly if CSS-treated MEF were used. This would 
suggest that susceptibility to lysis of CSS-treated MEF is limited 
by virus input-related parameter(s) whereas susceptibility of CSS-
untreated, MCMV-infected MEF may be more limited by cellular 
factors sensitive to enhancement by alteration of culture 
conditions . One such candidate factor may be the level of H-2 
antigen expressed at the cell surface. 
With regard to the time taken after MCMV adsorption for MEF 
to acquire susceptibility to lysis by MCMV-immune T cells, 
susceptibility was detectable at 2 hrs post infection, was higher 
at 4 hrs and did not significantly increase by 18 hours. The 
ability to detect susceptibility to lysis by 2 hrs post-adsorption 
is similar to the findings for ectromelia virus (Ada et al . 1976) 
and for HSV (Pfizenmaier et al. 1977) where susceptibility to 
lysis occurred within 60 and 90 mins post adsorption respectively. 
MEF appear to express only Class I H-2 and not Class II, H-2 
antigens on their cell surfaces (King et~- , unpublished 
observations); thus they are inadequate for the detection of 
Class II H-2 restricted T cells. However, macrophage populations 
contain Class II antigen-positive cells (Steeg et~- 1982) and 
have been successful targets for T cell recognition using other 
viruses (Zinkernagel & Doherty 1975). Furthermore, peritoneal 
macrophages may be capable of MCMV infecti on as assessed by p.f.u. 
or infectious centre assays (Tegtmeyer & Craighead 1968). 
Further experiments are required to establish if these cells 
will act as MCMV-specific targets or stimulator cells for Class II 
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restricted T cells. 
In vitro assessment of peritoneal macrophage infection by 
salivary gland or tissue culture passaged MCMV stock using 
fluorescent antibody was conducted by Mims & Gould (1978) and 
indicated that tissue culture passaged MCMV had more ability to 
infect peritoneal macrophages than salivary stock. Our results 
using MCMV-immune T cells (Tables 5 & 6) are consistent with the 
findings of Mims & Gould (1978). PEC treated with tissue culture 
stock MCMV were susceptible to lysis by MCMV-immune T cells (Table 6). 
The maximum levels of cytotoxicity and the susceptibility to 
lysis at a fixed effector aliquot were directly related to the 
viral input of tissue culture virus stock used during adsorption. 
PEC treated with salivary gland MCMV stock at all dilutions were 
not susceptible to lysis. The total inability of salivary gland 
MCMV stock to confer susceptibility to lysis upon broth-stimulated 
PEC in our hands may be explained by the higher resistance to 
MCMV infection of broth-stimulated peritoneal macrophages 
compared to resident peritoneal macrophages (Mims & Gould 1978). 
That susceptibility of PEC to lysis by MCMV-immune T cells was 
obtained within 7 hrs of tissue culture stock MCMV adsorption 
(Table 6), compared with 24-48 hrs after adsorption required for 
MCMV-specific antiserum to detect viral antigen in cells 
(Mims & Gould 1978), suggests either that MCMV-immune T cells may 
be more sensitive indicators of MCMV-specific antigens or may be 
capable of detecting MCMV-specific antigens not detected by 
hyperimmune anti-MCMV mouse serum, as als 0 suggested previously 
in the case of alpha virus infected cells (Mullbacher et al. 1979). 
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SUMMARY 
The preparation of target cells susceptible to lysis by 
MCMV-immune T cells in vitro was investigated and found to be 
dependent upon target cell type, culture conditions, virus 
adsorption protocol and virus preparation. Optimally, sensitive 
MCMV-infected targets were obtained by preculture of MEF in 
3% vol/vol CSS-supplemented medium, adsorption of salivary gland 
stock MCMV under 800g centrifugation and at least 4 hrs further 
incubation at 37°c before addition of T cells. In contrast, 
salivary gland stock MCMV did not cause thioglycollate-induced 
peritoneal exudate cells to be susceptible to MCMV-specific T cell-
mediated lysis, whereas tissue culture-passaged stock MCMV was 
successful. The preparation of MCMV-infected target cells 1s 
discussed in terms of the need for H-2 and viral antigen 
expression for T cell recognition. 
TABLE 1 
Susceptibility of different H-2d MCMV -treated 
target cells to lysis by BALB/c (H-2d) MCMV -
1mmune T cells* 
Target 
ce 11 
type 
% lysis of target cellst 
Expt l 
Expt 2 
BALB/c MEF 
P815 
BALB/c MEF 
BALB/c-3T3 
PU5-l.8 
MCMV -treated+ 
29. 1 + 0.4 
21.3 + 1.1 
52.6 + 3.3 
16.5 + 3.3 
54. 1 + 8.6 
Untreated 
5.9 + 0.5 
24.5 + 0.7 
18.5 + 0.6 
7.8 + 1. 1 
40.0 + 3. 1 
* MCMV-immune T cells were generated from popliteal LN of BALB/c 
female mice inoculated into both hind f.p. with 104· 6 p.f.u. 
MCMV. Day 7 popliteal LN cells were removed and cultured for 
4 days. 
t % lysis represents the mean+ standard error of the mean of 
triplicate assays obtained by addition of a 1/12 aliquot of 
cultured cells from 6 BALB/c popliteal LN in a 10 hrs assay. 
+ Target cells exposed to virus as described 1n Methods . 
TABLE 2 
Effect of culture 1n CSS-supplemented medium upon 
susceptibility of BALB/c MEF to lysis by alloreactive T cells* 
Effector:target 
ratio 
30: l 
l O: l 
3. 3: l 
l . l : l 
+ 
+css+ 
78.6 + 1.6 
76.2 + 2.3 
60. l + 3.4 
32.3 + 2.3 
% lysis of BALB/c MEF t 
CSS-
58.7 + 1.4 
53. l + l . 7 
19.5 + 1.4 
8.1 + 0.5 
* Alloreactive T cells were generated from mixed lymphocyte 
cultures of C57Bl/6J mesenteric LN cells and irradiated BALB/c 
spleen cells according to Woolnough & Lafferty (1979). 
t % lysis represents the mean+ standard errors of the mean of 
triplicate assays obtained by addition of effectors. 
+ BALB/c MEF were cultured in medium supplemented with or without 
3% vol/vol CSS for 48 hrs prior to use as targets. 
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Fig. l. Curve showing the effect of culture in CSS-supplemented 
medium upon the ability of BALB/c MEF to stimulate IL-3 release 
from alloreactive T cells. BALB/c MEF were cultured for 48 hrs 1n 
medium supplemented with (6.) or without (Q) 3% vol/vol CSS. 
105· 7 alloreactive T cells, generated as described in Materials and 
Methods, were mixed with different numbers of BALB/c MEF stimulator 
cells for 6 hrs, after which time cell-free supernatants were 
harvested and assayed for IL-3. Each point represents the mean and 
standard deviation of the mean IL-3 titre of quadruplicate 
estimations. Wh ere no bars are indicated the standard deviations 
are within the points. 
limits. 
(0) represent IL-3 levels below detection 
' 
TABLE 3 
Effect of centrifugation during viral adsorption upon 
susceptibility of MCMV -infected BALB/c MEF target cells 
to lysis by syngeneic MCMV-immune T cells* 
% lysis of BALB/c MEFt 
Effector 
fraction 
l/12 
l/36 
l/108 
l/328 
centrifugation+ 
MCMV -INF 
65.8 + 1.3 
52.6 + 3.5 
43.6 + 2.0 
26.3 + l.6 
UNINF 
19.8 + 0.8 
ll.0 +·0.7 
5.7 + 0.5 
2.6 + 0.l 
no centrifugation 
MCMV -INF 
32.7 + l.5 
28.6 + 2.6 
20.0 + l.7 
13.2 + l.0 
UNINF 
19.3 + 0.6 
16.l + 0.9 
8.8 + 1.2 
5.6 + 0.5 
* As for Table 1 except mice were inoculated with 102·6 p.f.u. 
MCMV into hind f.p. 
t As for Table l except syngene1c MEF were cultured in medium 
supplemented with 3% vol/vol CSS prior to MCMV infection and 
addition of aliquots of MCMV-immune T cells. 
+ As for Table l except for centrifugation as described 1n 
Results. 
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Fig . 2. Curves showing the effect of culture in medium supplemented 
with CSS upon susceptibility of BALB/c MEF to lysis by syngeneic 
MCMV - immune T cells . BALB/c MEF were cultured for 48 hrs in medium 
with (A) or without (B) added CSS and infected with salivary gland 
stock MCMV , diluted 1/8 (~ ), 1/16 (Q) and 1/32 (0 ) in DMEM, or left 
uninfected ( ) . % lysis represents the mean of triplicate assays 
obtained by the addition of MCMV-immune T cells to MEF target cells 
for 10 hrs . The standard errors of the mean were <4% and are 
not shown . 
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Fig. 3. Curves indicating the kinetics of 51 cr release from MCMV-
infected or uninfected BALB/c MEF following addition of different 
numbers of MCMV -i mmune T cells. BALB/c MEF were infected with 
1:8 dilution of salivary gland stock MCMV in DMEM for 16 hrs (A) or left 
uninfected (B). 1/12 '-6), 1/36 (Q), 1/108 (0) and l/324 ( ) 
dilutions of MCMV -i mmune T cells were added and supernatants removed 
at the times indicated. % lysis represents the mean of triplicate 
assays. The standard errors of the mean were <4% and are not shown. 
TABLE 4 
Effect of time after MCMV adsorption upon the susceptibility 
of MCMV-infected BALB/c MEF to lysis by syngeneic MCMV-immune 
T cells* 
18 + 
Time post 
adsorption 
(hrs) 
0 
2 
4 
18 
EDTA control + 
* As for Table 3. 
% lysis BALB/c MEFt 
MCMV-infected Uninfected 
0.4 + 4.7 2.0 + 0. 1 
13.2 + 1.9 -1.0 + 0.7 
24.3 + 1.3 0. 1 + 0.9 
27.1 + 1.2 0.5 + 0.5 
8.3 + 0.8 -1.2+0.l 
t % lysis represents the mean+ standard error of the mean of tri-
plicate assays obtained by the addition of a 1/36 aliquot of 
cultured cells from 6 BALB/c popliteal LN. Forty-five mins 
after mixing of targets and MCMV-immune T cells 0.04M EDTA was 
added. Cell free supernatants were harvested after a further 
4 hrs. 
+ As fort except EDTA containing medium was added immediately 
after MCMV-immune T cells and syngeneic MEF were mixed. 
TABLE 5 
Susceptibility of BALB/c MEF and PEC infected with 
salivary gland stock MCMV to lysis by syngeneic MCMV -
immune T cells* 
Cell type 
and MCMV stock 
dilutions 
MEF 1:8 
PEC 1:4 
PEC 1:8 
PEC 1:16 
PEC 1:32 
* As for Table 3. 
% 1 . t o ys1s 
MCMV-treated cells+ 
39.8 + 0.6 
0.8 + 4.4 
8.6 ·+ 12.7 
3.3 + 0.7 
-10.2 + 2.5 
Untreated cells 
3.6 + 0.2 
-11.0 + 1.7 
-11.0 + 1.7 
-11.0 + 1.7 
-11.0 + 1.7 
t As for Table 1 except that a 1/36 aliquot of MCMV-immune T cells 
was added in a 6 hrs assay. 
+ BALB/c MEF and PEC were treated with dilutions of salivary gland 
stock MCMV as described in Methods and Results. 
TABLE 6 
Susceptibility of BALB/c MEF PEC treated with tissue 
culture stock of MCMV to lysis by MCMV -i mmun e T cells* 
% l ys is t 
Cell type 
and MCMV stock 
dilutions MCMV -treated cells+ Untreated cells 
MEF 1:8 
PEC NEAT 
PEC 1:3 
PEC 1:9 
* As for Table 3. 
t As for Table 5. 
34.9 + 0.2 
55.0 + 2.7 
44.4 + 1.2 
35.o ·+ o.9 
6.1 + 0.5 
4. l + 0.2 
4. l + 0.2 
4. l + 0.2 
+ BALB/c MEF and PEC were treated with dilutions of tissue culture 
or salivary gland stock of MCMV as described in Methods and 
Results. 
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CHAPTER 6 
DISCUSSION AND SUMMARY 
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The work presented in this thesis was undertaken to provi de 
more information regarding T lymphocyte responses to murine 
cytomegalovirus (MCMV) infection. 
That T cells can trigger the elimination of MCMV infection 
was established by the adoptive transfer experiments of Starr & 
Allison (1977) and Ho (1980). The results of these workers do not 
differ from adoptive transfer data obtained using other acute 
viral infection models (Zinkernagel & Doherty 1979). However, 
where infection with MCMV does differ from these other models is in 
the occurrence of latent infection and reactivation. Two hypo-
theses can be entertained to explain the latency phenomenon. 
(i) The induction of anti-MCMV T lymphocyte responses and anti-
bodies or the effector mechanisms mediated by such responses are 
inadequate for complete viral elimination. (ii) The ability of 
virus to remain within a mouse possessing a normal immune system 
is a peculiarity of virus-host interaction determined by non-
immunological factors . 
An obvious instance of the latter would be infection of a 
known immunologically privileged site (Billingham & Boswell 1953! 
Bacsich & Wyburn 1956; Burnet 1959) with resultant failure of cell 
activation and viral elimination. With regard to cell activation 
this certainly does not apply to MCMV since many non-privileged 
organs are infected (Hudson 1979) and an immune response, albeit 
weak, is generated rather than completely absent (Quinnan et al. 
1978; Osborn et al. 1968; Mannini & Medearis 1961). However, the 
privileged site argument may be used to explain the ability of 
MCMV to remain within spleen cells, as judged by DN A-DNA hybridi-
zation or allogeneic co-cultivation techniques in the presence of 
an activated immune system (Olding et~- 1976; Brautigam et~- 1979). 
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Since the normal function of the virus-specific T cell 1s 
dependent upon recognition of both cell surface viral and H-2 
antigens the privileged sites could also arise if H-2 antigen-
negative cells were MCMV-infected; viral infection modulated the 
level of H-2 antigens expressed at the cell surface, or infected 
cells displayed no cell surface viral antigens. 
In this regard it would be of interest to include cell surface 
H-2 antigen levels in the phenotypic characterisation of cells 
known to harbour MCMV genome. 
Dutko & Oldstone (1981) showed certain undifferentiated cells 
did not display viral antigens when infected with MCMV, until 
chemically induced to undergo differentiation. In this instance, 
although cell differentiation was assessed by the cell surface 
levels of H-2 antigen, a cause and effect relationship between 
viral antigen and H-2 antigen expression was not implied. 
On the other hand, can MCMV-infection of cells result 1n 
decreased H-2 antigen levels at the cell surface? Preliminary 
investigations showed decreased binding of anti-H-2d antiserum and 
decreased susceptibility to lysis by anti-H-2d effector T cells of 
MCMV-infected BALB/c mouse embryo fibroblasts (MEF) compared to 
uninfected syngeneic MEF (unpublished observations, King & Sinickas). 
These results suggested that H-2 antigen levels on MEF surface 
membranes were reduced during MCMV infection. Similar observations 
have been reported for ectromelia-infected target cells 
(Gardner et al . 197 5) . 
Environmental factors may also affect the level of cell 
surface H-2 antigens. In Chapter 4 it was demonstrated that 
culture of BALB/c MEF in medium supplemented with Concanavalin-A 
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stimulated spleen cell supernatants (CSS) produced increased sus-
ceptibility to lysis and increased stimulator ability by alloreactive 
T cells, compared with control syngeneic MEF. Similarly, in vitro 
susceptibility to lysis of virus-infected MEF target cells, by MCMV-
immune syngeneic T cells, was increased following growth of MEF in 
CSS-supplemented medium prior to viral adsorption. Hence T cell 
recognition of virus-infected target cells was apparently not limited 
by viral input but rather by some factor(s) related to MEF culture 
conditions. It seems reasonable to suggest that the known increase 
in H-2 antigen levels of MEF in CSS-supplemented medium is respon-
sible for the increased susceptibility to lysis. Although it is 
theoretically possible that increased viral receptors and therefore, 
increased viral input per target cell, may account for the generation 
of increased susceptibility to lysis, there is no precedent for this 
hypothesis. An experimental test of the latter hypothesis would 
show CSS-treated MEF generated increased viral plaque forming units 
(p.f.u.) after MCMV adsorption compared with CSS-untreated MEF . 
During acute primary infection with MCMV or Herpes simplex 
virus (HSV) the development and activity of virus-specific T cells 
can be assessed by a variety of detection systems that include 
adoptive transfer of protection from or elimination of virus 
infections (Starr & Allison 1977; Ho 1980), delayed-type hyper-
sensitivity reactions (Chong & Mims 1982), T cell-dependent anti-
body formation (Oakes 1975; Burns et~- 1975), 2!:_ vitro cytotoxicity 
( Q u i n n a n et a l . l 9 7 8 ; Pf i z en ma i er et a l . l 9 7 7 a ) a n d l ym p h o k i n e 
-- --
production (Chapter 4). However, the inability to generate easily 
detectable virus-specific cytotoxic T cell responses (over and 
above cytotoxicity on uninfected targets) during acute primary 
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infection with MCMV or HSV , has provided a maJor obstacle to 
investigation of the T cell response. This aspect is additionally 
puzzling since the adoptive transfer experiments clearly showed 
MCMV elimination in vivo was Class I, H-2 restricted, suggesting 
the participation of cytotoxic T cells generated in the donor mice 
during immunization with MCMV (Ho 1980). With HSV infection 
T lymphocytes are also important, as discussed previously, but 
which T lymphocyte subsets are involved in recovery is a little 
less clear. Adoptive transfers (intravenously) of in vitro-
restimulated HSV-primed spleen cells into recipients inoculated 
intraperitoneally, with a lethal dose of HSV 24 hours previously, 
produced decreased mortality rates compared with HSV-inoculated 
recipients of cultured normal spleen cells (Larsen et al. 1983). 
Since the cultured HSV-primed spleen cells contained cytotoxic 
T cells specific for HSV the correlation of cytotoxicity and reduced 
mortality indicated a possible role for such cells. 
However, intravenous transfer of donor lymph node cells with 
no detectable cytotoxic T cell activity, obtained from mice 
inoculated with HSV into the ear 7 days previously, resulted in 
lower auricular HSV titres in recipient mice compared with animals 
that received no cells (Nash et al. 1980a,b). The antiviral 
effect was mediated by Lytl+2- cells (Nash & Gell 1983). With the 
protocol utilised (transfer of immune cells into recipients one 
hour prior to HSV inoculation) the possibility exists for HSV-immune 
cells to interact with the viral inoculation and alter the events 
at the inoculation site that lead to productive infection and 
replication. To exclude this, the temporal sequence of viral 
inoculation and cell transfer should be reversed and daily 
monitoring of viral p. f.u. in the ear obtained to 
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show the onset of viral elimination. The abovementioned possibility 
was obviated to some degree by Larsen et al. (1984) who confirmed 
that similar cell phenotypes were responsible for HSV clearance 
from ears of cyclophosphamide treated recipients of intravenously 
transferred HSV-immune cells. The immune cells were obtained from 
donor mice 7 days after subcutaneous inoculation of HSV and trans-
ferred into recipients 2 hours after HSV inoculation into the ear. 
However, the immune responses to HSV in cyclophosphamide-treated 
mice may be altered (Pfizenmaier et al. 1977b; Rager-Zisman & 
Allison 1976) and mitigate interpretation of cell phenotypes 
responsible for HSV elimination. The interpretations may be 
further compounded by the time intervals (3 to 4 days) involved 
before assessment of the effect of cell transfer upon viral 
elimination. Experimentation with cyclophosphamide untreated mice, 
inoculated with HSV prior to adoptive cell transfers and assayed 
for viral p.f.u. 24 hours after infection must be performed. In 
addition, since anti-Lytl+ antiserum and complement (C') treatment 
has the potential to eliminate Lytl+2+ cells it is not possible to 
+ exclude a role for Lyt2 cells in the generation of lower viral 
p.f.u. until such cells are positively selected, transferred and 
effects assessed. 
Two broad hypotheses could account for the inability to detect 
HSV or MCMV virus-specific cytotoxicity. Either (i) the virus-
specific cytotoxic response was quantitatively lower for MCMV than 
for other non-Herpesviridae or (ii) the detection system for MCMV-
specific cytotoxicity was a less sensitive assay than the viral 
elimination techniques used to detect the presence of Class I, H-2 
restricted T cells. With HSV, it is also possible that the targets 
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utilised to detect cytotoxicity are inappropriate . Swain (1983) 
suggested Lyt phenotype correlated with MHC antigen class recognised 
by T cells rather than T cell function. Lyt2+ T cells recognised 
Class I ~HC antigens on cell surfaces whilst Lyt2 T cells 
recognised Class II MHC antigens. Therefore if HSV-immune T cells 
generated during HSV infection are of Lyt2- phenotype (Nash & Gell 
1983, Larsen et al. 1984), and are cytotoxic, the targets utilised 
for detection of cytotoxicity must possess viral antigens and 
Class II MHC molecules. BALB/c MEF do not possess Class II MHC as 
judged by the inability to bind fluorescent labelled anti-IAd 
antiserum (King & Sinickas, unpublished observations). Hence 
target cells such as MEF, and other Class II cells may be inapprop-
riate for detection of Lyt2 antiviral T cells. That Class II 
restricted cytotoxicity can occur was demonstrated with human 
cytotoxic T cell clones against HSV (Yasukawa & Zarling 1984). 
However, since many cells in the body are Class II the usefulness 
of such T cells as antiviral effectors would be limited. 
As a first step to examining the T cell response to MCMV 
a reproducible technique for MCMV -immune T cells generation and 
cytotoxicity testing was sought. The model of hind footpad (f.p.) 
inoculation with virus, removal and culture of draining popliteal 
lymph node (LN) cells described for the generation of HSV-specific 
cytotoxic T cells (Pfizenmaier et~- 1977a) was adapted to MCMV . 
The data in Chapters 2 and 3 confirmed the usefulness of this model 
for the generation of MCMV-specific cytotoxicity dependent upon 
Thyl+, Lyt2+, Class I, H-2 restricted cells, the difficulty in 
detection of MCMV - specific cytotoxicity directly from virus-
stimulated lymphoid cell populations was confirmed (Ho, 1980) and 
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was at variance with Quinnan et a 1. ( 1978, 1980). Even when 
putative cold-target competitor cells, (Immunoglobulin+ cells), 
were removed in an attempt to enhance detection levels, no cyto-
toxicity was observed. 
For detection of MCMV-immune T cells, MCMV inoculation into 
the f.p. followed by a minimum of 4 days~ vivo prior to removal 
of draining popliteal LN cells and 2 days of culture was required, 
but optimal MCMV -specific cytotoxicity was generated by removal of 
draining popliteal LN cells 6 to 8 days after MCMV f.p. inoculation 
and 4 days in vitro. Cellular proliferation in vitro was essential 
+ for generation of cytotoxicity and was dependent upon a Thyl.2 cell 
population. This suggests that the levels of cytotoxicity are not 
regulated by a lack of precursors with potential for cytotoxicity 
but rather a lack of expression of this potential. 
During the course of the investigation Reddehase et al. (1984), 
using immune cells derived by a similar protocol, reported the 
precursor frequencies of cells cytotoxic to MCMV -infected MEF and 
showed two cell populations were present in vitro. One population 
developed cytotoxic activity without added MCMV antigen whilst 
the other, more frequent, cell population was dependent upon added 
MCMV-infected syngeneic MEF during culture. Since not all the 
cytotoxic clones generated in vitro were split and assayed on 
MCMV -infected and uninfected syngeneic MEF some of the clones may 
have been autoreactive rather than virus specific. Autoreactivity, 
1.e. cytotoxicity of uninfected self targets, was noted in Chapter 2 
with maximum levels occurring between day 2 to day 6 of culture 
when lymph node cells were removed 4 days after f.p. inoculation 
of MCMV. With this reservation in mind the total precursor 
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frequency of T cells reactive to MCMV antigens in day 8 popliteal 
lymph nodes was 1:2700-1:7200, figures of the same order of magni-
tude as precursor frequencies noted during acute infections with 
rabies virus (Reddehase ~ ~- 1982) and similar to frequencies 
seen in primed spleen populations restimulated in vitro with minor 
histocompatibility antigens (Teh et~- 1982), male alloantigens 
(Kanagawa et al . 1982), murine sarcoma virus - induced tumours 
(Brunner et al . 1980) and influenza (Askonas et al . 1982). This 
again suggests that lack of direct cytotoxicity is not due to a 
lack of or low levels of precursor T cells against MCMV - infected 
cells. 
Hence, either the clonal expansion of MCMV-immune T cells or 
the maturation to the cytotoxicity function of T cells or both, 
were required prior to detection in vitro. A need for clonal 
expansion of MCMV - immune T cells to detectable levels is favoured 
because (i) optimal cytotoxicity was dependent upon proliferation 
of Lyt2+ cells and (ii) the addition of CSS during culture enhanced 
the levels of cytotoxicity attained. 
Two major events are involved in the generation of a T cell 
r esponse . Induction , mediated by both antigen recognition and a 
second Interleukin-1 (IL-1)-mediated inductive signal, and T cell 
proliferation dependent upon Interleukin-2 (IL-2). To determine 
whether soluble factor(s) in CSS were required for maturational 
events in vitro leading to cytotoxicity, a purified source of IL-2 
would be required, thus allowing T cell proliferation to take place 
in the absence of these putative factors. 
Two models are available to explain activation and clonal 
expansion of antigen or mitogen-reactive T cells (Larsson et al. 1980; 
--
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Lafferty et~- 1980). Both models propose antigen recognition 
and IL-1-mediated signals are necessary for induction of a T cell 
response but differ in the origin of the IL-2 necessary for clonal 
expansion of effector T cell populations. Larsson et al. (1980), 
Wagner et~- (1980) suggest that a special class of T cells 
(T helpers) respond to antigen and IL-l and then provide the IL-2 
necessary for activation and clonal expansion of a separate 
class of responding cells, the precursors of cytotoxic T cells. 
Hence, the model proposes the existence of two functionally distinct 
T cell subsets with different activation requirements; a helper 
subset which is IL-l dependent, and an IL-2 dependent effector 
subset, incapable of IL-2 synthesis. The T helper subset has been 
equated phenotypically with the Lyt2 T cell subset (Wagner et~-
1980). 
On the other hand, Lafferty et al. (1980) do not agree with 
the division of responder T cell populations into separate helper 
and effector subsets but rather postulate all T cells are capable 
of both producing and responding to IL-2 and of expressing other 
effector functions such as cytotoxic activity. 
If the former model is correct as would be suggested by the 
requirement of Lyt2 cells for the in vitro generation of anti-
influenza (Mullbacher & Ashman 1979) or anti-ectromelia cytotoxic 
T cells (Pang et~- 1976), the data 1n Chapter 3 indicating that 
there are low numbers of activated virus-specific Lyt2 cells in 
LN cell populations draining MCMV inoculation sites could account 
for low cytotoxic T cell responses. MCMV-immune LN cell populations 
depleted of Lyt2+ cells were delayed in thymidine incorporation 
and did not achieve the same maximum levels as untreated or 
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C' treated control MCMV-immune LN cells. Inadequate non-antigenic 
culture conditions, or viral inhibition of responses were excluded 
by the equivalent proliferative responses to Concanavalin-A of 
Lyt2+-depleted and untreated MCMV -immune LN cells. 
Table l in Chapter 4 argues against complete absence of Lyt2 
MCMV-specific T cells since Interleukin-3 (IL-3) release from MCMV -
immune T cells incubated alone, was not abrogated by anti-Lyt2 anti-
serum and C' treatment as was the case with anti-Thyl.2 antiserum and 
C' treatment. Furthermore data from HSV infections indicates the 
presence of Lyt2 cells since auricular LN cells or spleen cells 
removed from mice on day 6 after subcutaneous inoculation of virus 
and treated with anti-Lyt2 antiserum and C' can successfully 
transfer HSV-specific delayed-type hypersensitivity to unprimed 
recipients (Nash & Gell 1983; Larsen et~- 1984). With MCMV, 
although adoptive transfer and phenotypic characterisation have not 
yet been performed, the ability to successfully generate and elicit 
delayed-type hypersensitivity responses with live and heat-
inactivated MCMV preparations (Chong & Mims 1982) suggests the 
presence of Lyt2 cells. In addition, the antibody response to 
HSV is T cell dependent (Burns et~- 1975; Oakes 1975) and if its 
requirements are similar to antibody generation to other antigens 
then it would necessitate the presence of Class II H-2 restricted, 
Lytl+2- antigen specific T cells (Katz et al. 1973b; Sprent 1978a,b; 
Swierkosz et a 1. 1978). 
The collective reports would then argue against complete 
absence of Lyt2 MCMV -specific precursor T cells but the data 
cannot address any quantitative variation in total numbers of 
Lyt2 cells or the amount of IL-2 released after stimulation or the 
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proliferative responses to IL-1 or antigen. These facets of MCMV-
specific T cell responses will be amenable to investigation with 
target and stimulator cells, such as macrophages, that possess 
both Class II MHC and MCMV-specific antigens on the cell surface 
(Chapter 5). 
In Chapter 4, MCMV-immune T cells were utilised to determine 
whether lymphokine production and cytotoxicity were mediated by 
the same or two separate T cell subsets. It was shown that IL-3 
+ + release was dependent upon MCMV-specific, Thyl.2 , Lyt2 , 
Class I, H-2 restricted cells which were phenotypically similar to 
MCMV-immune T cells required for virus-specific cytotoxicity. 
This data was consistent with the idea that the same virus-specific 
T cells performed both lymphokine release and cytotoxic functions, 
but anti-MCMV T cell clones would be required to unequivocally 
establish the fact. Hence the Lafferty et~- (1980) hypothesis 
would require that the low anti-MCMV cytotoxicity levels reside in 
either the inability of anti-MCMV T cells to release a particular 
lymphokine, IL-2, or 1n the inability of anti-MCMV T cells to 
proliferate 1n response to IL-2. 
Although, T cell clones (Prystkowski et al. 1982) and 
hybridomas (Zlotnik et al. 1983; Kelso & Glasebrook 1984) are 
capable of multiple lymphokine production, including IL-3 and IL-2, 
subsequent to antigen or mitogen stimulation it is necessary to 
establish whether MCMV-immune T cells can indeed produce both IL-3 
and IL-2. In fact it would be of interest to compare the spectrum 
of lymphokines released by MCMV-specific T cells with the spectrum 
produced by other antiviral T cells and to investigate variations 
in the spectrum of lymphokine production using different prepara-
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tions of MCMV-infected cells as an indication of the effector 
potential of such T cells. Lin & Askonas (1981), Morris et al. 
(1982) and Taylor & Askonas (1983) established that both cytotoxic 
and lymphokine release functions, not just cytotoxicity alone, were 
important for in vivo elimination of influenza infection with anti-
influenza Class I H-2 restricted T cell clones. Since no Class I 
H-2 restricted, non-cytotoxic, lymphokine-producing T cell clones 
were used the data did not indicate if lymphokine production alone 
was sufficient for viral elimination. 
Finally, since T cell proliferation 1s also controlled by 
lymphokine receptor density (Robb et al. 1981; Cantrell & Smith 1984) 
and receptor density is determined by exposure to antigen, antigen 
levels must also modulate T cell proliferation (Cantrell & Smith 1983). 
For MCMV this would explain the additional detection of precursors 
of cytotoxic T cells subsequent to antigen exposure compared with 
the number detected without added antigen (Reddehase et .9l. 1984). 
In addition, the adoptive transfer experiments (Ho, 1980) with 
antigen-primed cells removed from donor mice and transferred into 
virus-inoculated animals can be explained by antigenic restimulation 
and subsequent clonal expansion of primed cells sufficient to 
mediate viral elimination. A prediction of this hypothesis would 
be the presence of detectable direct cytotoxicity from recipient 
tissues but mediated by T cells of donor origin. 
It would also appear that heterogeneity exists with regard to 
the preparations of MCMV capable of stimulating a response. 
Ho (1980) reported MCMV -infected MEF irradiated with ultraviolet 
(UV) light stimulated more proliferation and cytotoxi c T cell 
formation from MCMV-primed spleen cells than did ~-irradiated or 
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unirradiated MCMV-infected MEF. Furthermore, MEF infected with 
MCMV for 2 hours prior to UV-irradiation and subsequently used as 
stimulators did not generate virus-specific cytotoxic T cells, 
whereas MEF infected with MCMV for 18 hours prior to UV-irradiation 
and used as stimulators generated MCMV-specific cytotoxicity. On 
the other hand, Reddehase et al. (1984) used MCMV-infected MEF 
without UV- or ~-irradiation for stimulation of an acute MCMV-
immune LN cell population to generate more virus-specific 
cytotoxicity . The data in Chapter 4 also indicate that MEF infected 
with MCMV for different times will stimulate different levels of 
lymphokine release from MCMV-immune T cells, whilst Chapter 5 shows 
target cell-type and virus preparation are important variables for 
the generation of virus-specific antigenic changes on cell surfaces 
which are recognised by T cells. 
In conclusion it is postulated that the precursors of MCMV-
specific T cells are present within the immune system and that the 
inductive requirements for these T cells are provided to some 
extent during acute MCMV infection but the signals required for 
clonal expansion are limited. Exactly why this limitation occurs 
is not yet resolved . It could be due to low levels of IL-2 
release from activated MCMV-specific T cells, to low levels of IL-2 
receptor density on T cells subsequent to antigen exposure, or to 
insufficient virus-specific antigen on stimulator cell surfaces 
to trigger both IL-2 release from and IL-2 receptor expression on 
T cells. 
These particular possibilities can be addressed by the use of 
IL-2 release and anti-IL-2 receptor antibodies with MCMV-immune 
T cells stimulated by virus-specific antigenic changes on a variety 
of stimulator cells obtained from in vivo and in vitro sources. 
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